Total synthesis of variolin B by Anderson, Regan J.
TOTAL SYNTHESIS 
OF V ARIOLIN B 
A Thesis 
Submitted in Partial Fulfilment 
of the Requirements for the Degree 
of 
Doctor of Philosophy in Chemistry 
at the 
University of Canterbury 
by 
Regan J. Anderson 
February 2002 
11 
Acknowledgements 
I would like to thank Dr Jonathan Morris for his supervision and guidance throughout this 
project. His approachable manner and hands-on supervision have been greatly appreciated. I am 
also grateful for the hours he has put into checking and revising this thesis. 
Thanks also go to the past and present members of the Morris group, for making my time here 
enjoyable and memorable. Many laughs have been had-usually at the expense of one another. 
Particular mention should be made of Bungard, Darbs and Muscroft, alongside whom most of 
this work has been carried out. 
The technical staff in the Chemistry Department have been most friendly and helpful. In 
particular, I would like to thank Bruce Clark for carrying out all mass spectrometry analyses and 
assistance with their interpretation. Thanks also to Gill Ellis for biological testing of compounds 
and helpful discussions in this area. 
The University of Canterbury, the New Zealand Vice-Chancellors' Committee and Pharma Mar, 
SA are gratefully ac1mowledged for financial assistance. 
Thanks to Mum and Dad for their encouragement throughout my PhD. Especially in the last few 
months, their support has been valued and my £1atmates and I have enjoyed their cooking. 
Mostly, thank you Becs for your love and support over the last 18 months. Your continual 
interest in what I have been doing has always been appreciated. Thanks for putting up with not 
seeing much of me and for bringing me food and goodies when I needed them. 
111 
Abstract 
This thesis describes the development of methodology which has led to the total synthesis of 
variolin B, a marine alkaloid with potent antitumour properties. In Chapter One, a brief 
summary of the association of organic synthesis and marine natural products is provided. This is 
followed by an account of the variolin family of natural products and synthetic efforts that have 
been directed towards them. A new strategy is proposed that exploits the hidden symmetry in 
variolin B. 
Chapter Two covers investigations into the synthesis of the variolin skeleton using a variety of 
reagent systems. A rapid entry into the core structure of the variolins was found, with the key 
step being a deoxygenationlcyc1isation protocol, which was mediated by the combination of 
triethylsilane and trifluoroacetic acid. Evidence was obtained to suggest an unexpected 
mechanism for this reaction. Straightforward functional group manipulation led to a synthesis of 
deoxyvariolin B. 
In Chapter Three, the previously established methodology was applied to an alternative starting 
material, appropriate for a synthesis of variolin B. However, the process was low-yielding and 
gave variable results. Some modifications to the methodology led to a reliable and efficient 
procedure for the synthesis of the variolin skeleton, which was subsequently transformed to 
variolin B. The synthesis proceeded in a total of eight linear steps, with an overall yield of 13%. 
The methodology which has been developed lends itself to the production of analogues of the 
variolins. The synthesis and biological testing of some analogues are presented in Chapter Four, 
along with a discussion on the structural features which confer biological activity on variolin B. 
A brief summary of the work described in this thesis and potential future studies is given in 
Chapter Five. 
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1.1 Marine Natural 
Natural products have traditionally played an important role in drug discovery. Over the last two 
hundred years, a diverse array of secondary metabolites numbering well into the thousands has 
been isolated from an equally diverse array of plant, animal and microbial sources. Some of 
these have found uses as biochemical tools for the elucidation of metabolic pathways, 1 and many 
have been developed into medicinal agents for the treatment of disease. Numerous examples can 
be given. One ofthe earliest is that of morphine, from which many synthetic drugs are derived.2 
Another striking example is the multitude of natural and semi-synthetic penicillins, which have 
transformed the treatment of bacterial infections in the last century.3 
In contrast to terrestrially-derived natural products, the manne environment represents a 
relatively unexploited source of natural products. There are specific difficulties associated with 
the isolation and study of marine natural products. Not least of these is the difficulty of 
procuring significant quantities of the source organism from the marine environment. Such 
harvesting is costly and time-consuming and, as with any natural product isolation, has no 
guarantee of producing any useful leads for drug development. If a biologically active substance 
is discovered, it is usually isolated in only minute quantities-sometimes barely enough for 
complete characterisation, let alone drug development or supply. 
Despite these difficulties, the field of marine natural products research has witnessed rapid and 
steady growth over the last thirty years. For example, in the period from 1965 to 1970, around 
100 natural products of marine origin were reported in the literature. This has dramatically risen 
to greater than 3,500 new reports in the period from 1991 to 1995.4 The later emergence of their 
chemistry compared to that of terrestrial natural products is due, in part, to the difficulty of 
access to marine organisms, and the relatively recent development of modem techniques 
HPLC and 2D NMR) for the isolation and structure determination of complex, polar organic 
compounds, such as those often derived from marine sources. 
There are many reasons for searching the oceans for new sources of biologically active 
compounds. For a start~ water covers over two-thirds of the earth's surface and harbours 
tremendous biodiversity, most of which has yet to be investigated. Almost all of the major 
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animal phyla are represented in the marine environment, while just over half occur on land.5 
Second, the marine environment differs from the terrestrial environment markedly in salinity, 
temperature, pressure and light. It is logical, therefore, to expect different types of metabolites to 
be found in marine natural products compared with those from terrestrial sources. Indeed, it has 
been claimed that marine natural products are different in kind to those from terrestrial sources, 
both in shape5 and elemental composition.4 Statistical data reveal an abundance of marine-
derived metabolites containing nitrogen, which is commonly associated with a higher incidence 
of biological activity.4 Third, as many marine organisms are sessile, their survival frequently 
depends on chemical defense systems. There is widespread evidence indicating that secondary 
metabolites are more common in organisms without immune systems, such as marine 
invertebrates.6 These chemicals are often considerably more potent than those found on land, to 
counteract the high dilution of their aqueous environment. 
As early as 1977, Faulkner suggested that marine organisms possess a greater prevalence of 
bioactive metabolites than do terrestrial organisms.? A recent statistical analysis confirms that 
bioactive natural products from marine sources have increased at a greater rate than those from 
terrestrial sources.8 Many examples can be given to support this notion. Food poisonings due to 
the presence of certain toxins in shellfish and other seafoods are not uncommon and have 
received much media attention. Such events have aroused the attention of chemists and 
biologists alike, who were interested in discovering the source of these effects. Their 
investigations have uncovered some of the most structurally complex and toxic natural products 
known. For example, brevetoxin B (1.1)9 is one of the agents responsible for the algal blooms, 
or "red tides", which have resulted in widespread killing of marine life, as well as human 
poisonings. Numerous marine-derived bioactive metabolites have since been discovered, whose 
biological effects are as diverse as their molecular structures (see Figure 1.1 for a selection). 
H 
H H H 
1.1 
brevetoxin B 
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With the abundance of bioactive metabolites to have surfaced from the sea, one may expect that 
marine natural products would be well represented in the pool of drugs in current use. In actual 
fact, very few marine natural products have made it through to the commercial market. Thus far, 
the only contribution from the sea to cancer chemotherapy has been the discovery of the 
arabinoside nucleosides, which led to the development of cytosine arabinoside (ara-C, 1.2) which 
is used for the treatment of acute myeloblastic leukaemia. ll The reasons for this are many. Most 
significant is simply the later emergence of marine natural products chemistry compared with the 
chemistry of terrestrial natural products. Other reasons include problems of supply, which can 
leave potentially valuable compounds unexploited, and the extremely high toxicity of many 
marine natural products, which makes them of limited therapeutic value. 
cytosine arabinoside 
As with natural products in general, organic synthesis has played an important role in the field of 
marine natural products. As can be seen in Figure 1.1, marine natural products display great 
diversity in structure; consequently, they have stimulated the efforts of synthetic chemists 
worldwide. Traditionally, total synthesis has been important in confirming the proposed 
structure of a given compound. While modem techniques such as NMR spectroscopy have been 
very successful in allowing the structures of even very complex natural products to be 
determined, unambiguous structure determination cannot be achieved in every case. Often, 
uncertainty may exist regarding stereochemical issues, and the synthesis of one or more of the 
possible stereoisomers is required to establish the correct structure. And indeed, it has not been 
uncommon for a "total synthesis" to be achieved, only to find that the reported structure of the 
natural product was incorrect. 
A recent example of this is seen in batzelladine F (1.3), a bioactive marine alkaloid isolated from 
a Jamaican sponge in 1997.12 This compound was of interest due to its ability to disrupt the 
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processes involved in immunological responses by T lymphocytes. Such compounds may prove 
to be important in the understanding and treatment of autoimmune disorders. The originally 
proposed structure (1.4) was stated to have an anti relationship between the angular protons at 
C4 and C7. However, this was subsequently revised to syn, on the basis of synthetic studies on a 
model system. 13 A number of stereochemical issues still remained undefined, namely, the 
configuration at C16 and the relative stereochemical relationship between the two tricyclic 
guanidine portions. This meant that there were eight compounds (four pairs of enantiomers) that 
fit the data for the proposed structure of batzelladine F. Where stereochemical elements are far 
removed from each other, as in this situation, their relative stereochemistries are inherently 
difficult to determine. Unless a crystal structure can be obtained, chemical synthesis is often the 
only way to reliably determine the relative and absolute stereochemistry. In an effort to defme 
the exact structure of bat zelIa dine F, Overman and Cohen synthesised one enantiomer of each of 
the four possible diastereomers. None of these, however, corresponded to the natural material 
and it was concluded that the proposed connectivity of batzelladine F was incorrect (compare the 
alkyl chains between the two structures). Re-examination of the spectroscopic data of the natural 
product suggested 1.3 as an alternative structure for batzelladine F. An enantioselective 
synthesis of 1.3 provided material which was identical with the natural product in all respects, 
and thus removed any uncertainty regarding the correct structure. 14 
Me 
1.3 
III 
Me 
batzelladine F 
Another topical example of mis-assignment has very recently been reported. 15 In this case, the 
compounds of interest were diazonamides A and B, two structurally novel marine natural 
products whose structures were reported to be 1.5 and 1.6, respectively.16 These structures were 
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proposed by comparison with a derivative of diazonamide B, whose structure was determined by 
X-ray crystallography to be 
Me Me 
sr"Q HNY"'~N 
I H ~ ~ NIII 0 0 ",} 
CI 
1.7 
1.6 X = Sr, R = H 
The extremely potent anti tumour properties of diazonamide A, combined with the novel 
architecture of these compounds, sparked considerable interest among synthetic chemists.17 
Some ten years later, structure originally proposed for diazonamide A-was produced 
by Harran et al. 1Sa It was immediately apparent that neither the spectroscopic data, nor the 
chemical behaviour of corresponded to those of diazonamide A. Furthermore, synthesis of 
1.7, the reported derivative of diazonamide B whose crystallographic characterisation fonned the 
basis of the intial diazonamide assignments, gave a product which was different from the 
material derived from natural diazonamide B. It appeared that the crystallographic data of the 
diazonamide derivative had been misinterpreted. Further subtle discrepancies in the 
interpretation of mass spectral (MS) data were pointed out by Harran, and alternative structures 
for diazonamides A and B-structures 1.8 and 1.9 respectively-were proposed based on the 
available data. ISb 
Me Me 
1.8 X H, R j: ... ~Y YOH 
o 
1.9 X=Br,R=H 
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The examples of batzelladine F and the diazonamides highlight the importance of total synthesis 
in confinnation of structure-whether establishing unknown stereochemistry, or challenging 
incorrect connectivities-as even very reliable techniques are prone to mis-interpretation. In the 
diazonamide example, the work of Harran et al. also revealed a synthetic derivative 1.10 that 
displayed biological properties indistinguishable from those of natural diazonamide A. 15b This 
result is significant in that it may guide future work in the development of the diazonamides into 
medicinally useful agents. 
1.10 
Chemical synthesis plays an equally important role in providing a supply of a natural product. 
This is no more evident than in the field of marine natural products chemistry. As has been 
mentioned, harvesting large quantities of marine organisms can be costly and time-consuming-
not to mention the ecological impact of removing large amounts of a particular organism from 
the marine environment. In addition, secondary metabolites from marine organisms are usually 
produced in very low quantities and thus, large amounts of the organism are required to obtain a 
reasonable yield of the compound of interest. 
A potent example of this is the marine natural product halichondrin B (1.11). This polyether 
macrolide was isolated from a sponge in Japanese waters, and shows extremely potent 
anti tumour activity against both in vitro and in vivo human tumour models. IS However, 
halichondrin B is present in the natural source in only minute quantities and lack of material has 
prevented further investigation into its clinical potentiaL Accordingly, several groups have 
targeted their synthetic efforts towards halichondrin B, with the total synthesis of 1.11 being 
reported by Kishi's group in 1992.19 While a monumental effort, this synthesis does little to 
provide a practical supply of halichondrin B as the process required a total of ~ 120 steps. 
However, improvements to the sequence have been made; the discovery that the right half diol 
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1.12 exhibited similar activity to the natural product was of particular significance, as this 
intermediate could be generated in ~ 70 stepS.20 Further streamlining of this process may provide 
a useful source of a bioactive halichondrin-type compound, which could allow the development 
of the halichondrins and/or derivatives into medicinal drugs. 
HO 
H 
halichondrin 8 
H 
1.1.1 The State-or-Play Marine Natural 
Thirty years of research in manne natural products chemistry have resulted in numerous 
discoveries of structurally novel compounds with great biological potential. It can now be said 
that the field is at a point where the pharmaceutical industry is on the verge of reaping the 
rewards of this work. Munro and coworkers list several compounds, or families of compounds, 
of marine origin which show strong potential as anticancer agents, some of which are currently 
in advanced stages of clinical trials.4 Of these, one ofthe most exciting is ecteinascidin (Et) 743 
(1.13), which represents the state-of-play in marine natural products research today. 743 
comprises a complex polycyclic framework with a high degree of oxygen and nitrogen 
functionality. Even though the colonial ascidian Ecteinascidia turbinata, from which it was 
isolated,21,22 was known to demonstrate potent antitumour properties since 1969, fifteen years 
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spanned the period between this discovery and the isolation of the active components. This 
interval reflects the relatively recent development of modem chromatographic techniques to 
enable the isolation of this very polar compound. The advent of fast atom bombardment mass 
spectrometry and 2D NMR techniques was also necessary for the structure of the ecteinascidins 
to be umavelled. 
OMe OMe 
Me Me 
Me 
o 
'-0 OH 
0==<10 
o 
1.13 1.14 
ecteinascidin 743 phthaJascidin 
Et 743 (1.13) was shown to possess potent cytotoxicity against a number ofleukaemia cell lines 
(ICso* 0.5 ng/mL against LI2IO leukaemia cells and 1.3 ng/mL against P388 murine leukaemia 
cells) and strong in vivo activity against murine and human tumour models (i.e. human tumours 
growing in athymic mice). In fact, Et 743 is 200 times more potent than the well-known and 
much-touted Taxol®.23 These findings have seen Et 743 advance into phase I clinical trials in 
1996 and more recently, on the basis of promising results, into phase II clinical trials. A new-
drug application is soon to be filed with the European Agency for the Evaluation of Medicinal 
Products for the treatment of advanced refractory sarcoma.24 Concurrent with clinical trials, 
investigation into its mode of action has been an active area of research for several years, 
culminating in the recent discovery that it acts by disruption of the cell's natural nucleotide 
excision-repair system.2S,26 An improved mechanistic understanding of Et 743's role may lead 
to the rational design of new analogues, with greater potency and/or more desirable 
pharmacological properties . 
• ICso is the concentration required to inhibit the growth of a given cell line by 50%. 
Chapter One - Introduction 11 
Comprehensive investigation of any compound as a potential drug relies on a sustainable source 
of the compound. Despite being the most abundant of the ecsteinascidins, Et 743 was isolated in 
a yield of only 0.0001 % from its ascidian source. While aquaculture of the ascidian is a possible 
solution to this problem,23,27 1,000 kg of the organism would be required to produce just one 
gram ofEt 743. 
As such, efforts have been directed towards the synthesis of the ecteinascidins by a number of 
groupS.28 In particular, a total synthesis of Et 743 was achieved by Corey's group in 1996,28b 
which provided a supply of the drug for industrial development. A consequence of this work 
was the discovery that an analogue of Et 743, phthalascidin (1.14), has similar in vitro activity 
and mode of action to Et 743 (1.13), but has the advantages of a more straightforward synthesis 
and greater stability in solution.29 Phthalascidin may become an important compound in the 
development of the ecteinascidins into a commercially available drug. Further improvements 
have been made to the syntheses of both 1.13 and 1.14, resulting in a more reliable and scalable 
process. 30 
From a commercial point of view, however, an even more attractive route has been revealed 
(Figure 1.2).31 Developed in the laboratories of Pharma Mar-a Spanish company which is 
carrying out the pharmaceutical development of Et 743-this process employs cyanosafracin B 
(1.15) as the starting material, which is conveniently obtained on a kilogram scale through 
fermentation of the bacteria Pseudomonas jluorescens. A 22-step sequence is used to convert 
1.15 into Et 743. This process now provides a supply of Et 743, in multigram quantities, for 
OMe 
Me 
Me Et 743 (1.13) 
or Mea 
phthalascidin (1.14) 
1.15 
Figure 1.2 Semi-synthesis ofEt 743 and phthalascidin from cyanosafracin B (1.15). 
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further industlial development. In addition, numerous synthetic delivatives should allow for the 
preparation of a range of ecteinascidin analogues. Researchers in the field are confident that Et 
743 will make a valuable contlibution to cancer chemotherapy in the near future. 
Et 743 stands at the forefront of research in the field of maline natural products. It highlights 
some of the difficulties associated with the study of chemicals from maline sources, such as the 
isolation of very polar compounds in only minute quantities and their development into 
commercially viable drugs. Yet it is clear that, with the current technology, solutions to these 
problems are available. The acute potency of Et 743, and other marine metabolites currently 
under evaluation in clinical tlials, validate marine natural products research as a worthy 
endeavour. 
The oceans remain largely unexplored and doubtless hold many secrets yet to be uncovered. 
Such a great source of biodiversity should continue to provide new lead compounds, which are 
needed to complement the existing arsenal of drugs. Many prevalent diseases have, as yet, no 
available remedies while few successful treatments in use today are totally effective or without 
undesirable side effects. Combine this with the growing problem of drug-resistance, and it is 
clear that chemists and biologists alike need to search for new and improved methods to combat 
the host of diseases and ailments which plague society, including cancer in its valious forms, 
AIDS and multi-drug resistant pathogens. 
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1@2 The a Class of Marine J.. 1.1U'-"""'" 
1.2.1 Introduction 
In 1994, Blunt, Munro and coworkers reported the P388 bioassay-guided isolation of a new class 
of marine alkaloids from the Antarctic sponge Kirkpatrica varialosa.32 The variolins (1.16-
1.19) all possess a fused tricyclic heteroaromatic core-formally a pyrido[3',2':4,5Jpyrrolo[1,2-
c]pyrimidine-bearing a heterocyclic substituent at C5 in the cases of variolins A (1.16) and B 
(1.17) and N(3')-methyl tetrahydrovariolin B (1.18). A fourth compound, named variolin D 
(1.19), bears an ester grouping at C5, and is thought to be a degradation product produced by 
aerial oxidation of the variolins during the extraction process. The pyrido[3',2':4,5]pyrrolo[1,2-
c ]pyrimidine ring system has not been encountered in any other natural products. Prior to the 
isolation of the variolins, the tricyclic system had been described only once (as synthetic 
derivatives), albeit in a different oxidation state to the variolin core.33 
1.16 1.17 
variolinA variolin B 
1.2.2 Structure JLI .. ..,. ......... U"''''Jl'U'AJ1 
1.18 
N{3')-methyl 
tetrahydrovariolin B 
1.19 
variolin 0 
Despite their modest size, the variolins presented quite a challenge in their structural elucidation. 
This was largely due to the presence of several ring-nitrogen atoms and relatively few hydrogen 
atoms in the structure, which makes connectivities difficult to establish using long-range 
NMR techniques. While extensive NMR analysis (HMQC, HMBC, NOE) was carried out, this 
did not result in definitive structures being assigned to the variolins. Resorting to other methods, 
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very small crystals of variolin B were obtained from a TF Alwater solution, which could be 
studied by rotating-anode X-ray diffraction. This resulted in structure 1.17 being assigned to 
variolin B. 32a 
Once the structure of v ari 0 lin B (1.17) had been established with absolute certainty, the wealth of 
NMR data that had been collected could be interpreted. Of particular interest are the 
exchangeable protons of the amino and hydroxyl groups. Two broad signals at 8 8.6 and 9.9 
were assigned to the protons of the same NH2 group at C9. These assignments were supported 
by the fact that irradiation of either of the signals led to the disappearance of the other, and that 
when the spectrum was run at higher temperatures the two signals collapsed into one. The 
difference in chemical shifts suggests that bond-rotation around the C9-NH2 bond is somewhat 
restricted, presumably due to hydrogen bonding between one of the protons and N1. This is 
supported by the crystal structure data, which shows that the two atoms lie 2.063 A apart. 1t-
Overlap of the nitrogen-lone pair with the fused pyrimidine ring may also play a role in 
restricting rotation of the amino group. The other NH2 group displayed no such separation of 
signals, being represented by a broad signal at 8 7.1 integrating for two protons. The remaining 
exchangeable proton, bound to the oxygen at C4, gave rise to a broad signal at 8 16.1. Its 
extremely de shielded nature suggests hydrogen bonding, presumably to N3' of the pendant 
pyrimidine ring. In the solid state, this is indeed the case, with the two atoms lying 2.687 A 
apart. This hydrogen bonding has the effect of drawing the 2-aminopyrimidine ring close to the 
plane of the tricyclic core. This is observed in both the crystal structure, in which the 2-
aminopyrimidine ring is 23.8° out of the pyridopyrrolopyrimidine mean plane, and in the NOE 
experiments which displayed a strong correlation between H6 of the pyridopyrrolopyrimidine 
moiety and HS' of the 2-aminopyrimidine ring. The structure of variolin D (1.19) was 
determined by comparison to the spectral data of variolin B, and also by chemical transformation 
from variolin A. 32a 
As with variolin B, X-ray crystallography was required to establish the structure of variolin A 
(1.16).32b This, in itself, was no mean feat as it was found to be extremely difficult to obtain 
suitable crystals for diffraction studies. Finally, a TF Alwater solution yielded a few small 
needles of variolin A, whose structure was determined to be that of 1.16. This allowed 
interpretation of the NMR data, resulting in the complete assignment of all the IH and 13C 
signals. 
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The NMR analysis of N(3')-methyl tetrahydrovariolin B (1.18) was complicated by the existence 
of axial and equatorial conformers at C4,.32b The natural product was, therefore, allowed to react 
with an excess of methyl iodide, to give hexamethyl derivative 1.20 whose structure could be 
solved by NMR. The results of the NMR analysis were then extrapolated to N(3')-methyl 
tetrahydrovariolin B, enabling a satisfactory structure to be proposed. 
Me Me \ \ N /N--i 
Me +N 
Me' 
1.20 
1.2.3 Biological Activity 
The variolins were tested for biological activity against a range of cell lines and mIcro-
organisms. In the P388 (murine leukaemia cell line) assay, variolin B (1.17) was the most active 
with an ICso of 210 ng/mL/2a while variolin A (1.16) displayed only weak activity (ICso 3,800 
ng/mL).32b N(3')-Methyl tetrahydrovariolin B (1.18) was tested in vivo against P388 murine 
leukaemia, where it prolonged lifespan by 25% at a concentration of 10 mg/kg.32b 
N(3')-Methyl tetrahydrovariolin B was also tested against the RCT 116 (human colon carcinoma) 
cell line, having an ICso of 480 ng/mL. Anti-bacterial activity was observed in 1.18 in its 
inhibition of the growth of Saccharomyces cerevisiae (36 mm zone at 2 mg/mL).32b Variolin B 
(1.17) was inactive against the range of bacteria and fungi, although in anti-viral assays it was 
found to be four times more effective against Herpes simplex than against the Polio virus. 32a 
Variolin D (1.19) was inactive in all the assays, leading to the suggestion that substitution with 
the 2-aminopyrimidine ring at C5 was necessary for biological activity.32a 
In the late 1990s, Pharma Mar (the same company which is developing Et 743) became 
interested in variolin B (1.17)-having the most potent anticancer properties of the variolins-
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as a new lead compound. However, due to the isolated origin of the sponge, a sustainable supply 
of variolin B was not available. Aside from the cost and difficulties of accessing the sponge K. 
varialosa from Antarctica, the 1991 Madrid Protocol to the Antarctic Treaty prohibits any person 
from removing flora or fauna from the region without the authorisation of their government. 34 
As a result of these findings, variolin B (1.17) has emerged as an attractive synthetic target. 
Over the last three years, a flurry of reports has appeared describing syntheses of either 
fragments of the variolin core,35 or the intact core with substituents attached at various 
positions.36, 37, 38 This body of work, from several groups, has been carried out concurrently with 
our own efforts. 39 
To put the work described in this thesis into perspective, a summary of related synthetic work-
although not directed specifically towards the variolins-is given below, followed by an account 
ofthe successful syntheses of the variolin core that have appeared up until the present time. 
1.2.4 Related Synthetic Work 
An examination of the literature (pre-1999) for the pyrido[3 t ,2t:4,5]pyrrolo[1 ,2-c ]pyrimidine core 
found in the variolins revealed just two reports of ring systems which were closely related to the 
variolin core.33, 40 
In the first of these reports,33 the trimethyl-substituted 3H-7-azaindole* 1.21 was reacted with 
either benzoyl isothiocyanate or ethoxycarbonyl isothiocyanate to give 1.22 and 1.23, 
respectively (Scheme 1.1). Heating in pyridine led to the elimination of water or ethanol, 
respectively, to give the cyclised products 1.24 and in excellent yields. It should be noted 
that the cycloadducts differ from the variolin core in both oxidation state and the nature and 
position ofthe substituents . 
• The tenn 7-azaindole is used throughout this thesis for practicality, rather than the less convenient pyrrolo[2,3-
b Jpyridine. 
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90% J py,'d'ne, A 95% J pyridine, A 
;fu ;¢O S N N~ S N N~ 
N=< HN~ 
Ph 0 
1.24 1.25 
Scheme 1.1 
The later publication40 reports the (serendipitous) synthesis of the pyrido[3',2':4,5]pyrrolo[1,2-
c ]pyrimidine moiety as part of a larger fused system (Scheme 1.2). Merour and coworkers 
formed the 2-lithio-7-azaindole 1.26, using the phenyl sulfonyl group to direct metalation to C2, 
and quenched the lithio-species with a range of electrophiles. When tributylstannyl chloride was 
used, the 2-stannyl derivative 1.27 was obtained. This underwent Pd-catalysed cross-coupling 
with the heteroaromatic iodide 1.28 to give 1.29. At this stage, they sought to cyclise 1.29 to the 
azaindole 3-position under Bischler-N apieralski conditions. However, rather than the expected 
reaction at C3, an unexpected dephenylsulfonylation led to a preferred N1 attack on the amide to 
give, after in situ chlorination, the variolin-like product 1.30, isolated in 40% yield. 
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BU3SnCI ro -25°C M83Sn-(D )110 )110 N ~ 70% N /.: 
, N , N , N 
Ph02S Ph02S Ph02S 
1.26 1.27 
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1, N 
Ph02S 
CI ~ 40% 1.29 
1.30 
Scheme 1.2 
While not specifically directed towards the variolins, both of the aforementioned schemes do 
represent a potential approach to the variolin core: an appropriate 2-substituted 7-azaindole is 
cyclised to the indole nitrogen (i. e. N1 of the azaindole) to give the variolin core (or a partially 
hydrogenated version, thereof). This can be viewed retrosynthetically as a disconnection 
between C9 and N10 of the variolin core (Figure 1.3). 
Figure 1,3 Disconnection of the C9-N10 bond of the variolin core. 
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If such a strategy was applied to a synthesis of the variolins, the general requirements would be: 
a) an efficient route to a 4-substituted 7-azaindole; 
b) a means of introducing a side chain at C2 (such as the lithiationltransmetalation and Pd-
catalysed cross-coupling chemistry demonstrated by Merour); alternatively, an 
appropriate handle for functionalisation at C2 may be included in the construction of the 
azaindole system; 
c) a means of cyclising the C2 side chain to the indole nitrogen to gIve the 
pyrido[3',2':4,5]pyrrolo[1 ,2-c ]pyrimidine core at the correct level of oxidation; 
d) an appropriate method of introducing the amino group (or a suitable equivalent) at C9 of 
the variolin core; 
e) either a reactive group at C5 of the variolin core to allow coupling of an intact pyrimidine 
heterocycle, or a carbon substituent upon which, the 2-aminopyrimidine ring can be built 
up. 
Clearly, the first synthesis (Scheme 1.1) is not suited to the variolins as it does not provide the 
functionality at C5 of the variolin core structure, which is required for the introduction or 
construction of the 2-aminopyrimidine ring. Merour's work does (fortuitously) leave a chlorine 
at C5, however, it is doubtful whether this would undergo oxidative addition with palladium. A 
further point to consider from this work is that the Pd-catalysed coupling of stannane 1.27 was 
attempted with a very limited range of iodides. When vinyl iodide 1.31 was used, no coupling 
product was formed, despite a variety of reaction conditions being investigated. Using Pd(PPh3)4 
in refluxing toluene, the dimer of the vinyl species, 1.32, was isolated in 30% yield. This casts a 
shadow on the use of this methodology for a synthesis of the variolins, which would require 
coupling of a vinyl iodide similar to 1.31. 
~C02Me 
Me02C -
1.31 1.32 
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1.2.5 .. .all ... ',. ...... Efforts Towards the Variolins 
As has been mentioned, a munber of syntheses of the variolin core have recently been reported 
by three separate groups-all based in Spain. All three syntheses employ the strategy described 
above, i. e. disconnection between C9 and NIO, leading to a 2-substituted 7 -azaindole. 
1.2.5.1 Fresneda and Molina's Approacll to tile Variolin Core and Syntllesis of Va rio lin B 
Fresneda, Molina and coworkers were the first to report their synthesis of the 
pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidine core, which is shown in Sclleme 1.3?6a Their 
approach began using 3-fonnyl-4-methoxypyridine (1.33), available in one step from 4-
methoxypyridine,41 Condensation with ethyl azidoacetate gave the vinyl azide 1.34, which was 
cyclised via a nitrene insertion process to produce the 2-substituted azaindole 1.35. This is a 
modification of the Hemetsberger indole synthesis.42 The side-chain was extended through a 
four-step sequence (again, employing ethyl azidoacetate) to give the protected vinylazide 1.36. 
This underwent the Staudinger reaction with triphenylphosphine to give (after deprotection of 
the SEM group) the iminophosphorane 1.37, which was set up for ring-closure to the variolin 
core 1.38,43 This was effected by treatment with several dielectrophilic isocyanates (or 
ethoxycarbonyl isothiocyanate), in excellent yields. 
EtOzC 
OMe 
OHC~ 
t.J 1\1 
1.33 
OMe 
1.38 
N3CHzCOzEt, 
NaOEt, -15°C 
)0 
61% 
RN:::C=O,rt 
0IlI 
90% 
OMe 
EtOzC~ 
~~ l . .J 3 N 
1.34 
Scheme 1.3 
f1_V1iJlAr'A reflux 
67% 
OMe 
EtOzc ~ 
--{NJL . .J 
H N 
1.35 
4 steps j 
57% 
OMe 
1, PPh3,rt -rOO 2, TBAF, SiOz tJ I "'.:::: 
0IlI 57% EtOzC ¥ N ~ 
I 
N3 SEM 
1.36 
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Fresneda and Molina's ten-step synthesis of the variolin core successfully introduces the oxygen 
and nitrogen functionalities at C4 and C9 respectively, as required by all of the variolins. 
However, it leaves unaddressed the issue of the superfluous ethoxycarbonyl group at C7. 
Neither was any mention made as to how the pyrimidine heterocycle might be introduced at C5. 
In January 2002, while this dissertation was being prepared, these workers reported their 
progress in regard to both of these matters. This work has culminated in a total synthesis of 
variolin B.36b The construction of the pyrimidine heterocycle was based on methodology they 
had previously used for a series of related natural products, meridianins 
1.41).35d,36a,44 
meridianins C (1.39) Rl, R3, R4 H, R2::: Br 
R2 D (1.40)Rl,R2,R4 =H,R3 :::Br 
E (1.41) R1 ::: OH, R2, R3::: H, R4 Br 
(1.39-
Functionalisation at C5 of the variolin core was achieved in a highly efficient manner by reaction 
with bromine in pyridine to give 1.42 (Scheme 1.4). This regioselectivity observed in the 
pyrido[3',2':4,5]pyrrolo[I,2-c]pyrimidine system is analogous to the behaviour of indoles with 
electrophiles, which generally react at C3 of the 5-membered ring. Pd-catalysed coupling with 
(a-ethoxyvinyl)trimethylstatmane gave ketone 1.43, which was extended by treatment with 
dimethylfonnamide di-t-butyl acetal to give 1.44. The 2-aminopyrimidine ring was closed by 
heating with guanidine hydrochloride and anhydrous K2C03. Under these conditions, hydrolysis 
of the ester occurred concurrently, giving in 89% yield. Decarboxylation of proved to 
be rather difficult. Similar difficulties were encountered by another Spanish group when 
attempting to decarboxylate a related fused pyrimidine derivative.35a Eventually, it was found 
that decarboxylation and simultaneous deprotection of the methoxy group could be accomplished 
in 35% yield by heating at 260 DC in diphenyl ether, to give 1.46. The final step involved 
treatment of 1.46 with triflic acid at room temperature to remove the a-methylbenzyl protecting 
group, giving the natural product variolin B (1.17) in 90% yield. 
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DMF di-t-butyl 
acetal, 80 ·C 
70% 
35% 
K2C03, 
2-methoxyethanol, 
reflux 
1.44 
89% 
1.45 
This synthesis should be amenable to the production of analogues, varying in the substituents at 
both C5 and C9 of the variolin core. However, the linear nature of this synthesis does draw it out 
somewhat, the variolin core requiring ten steps for its synthesis, while a further 
were necessary to convert this to the natural product. The overall yield for the sequence was 
1.2%. 
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1.2.5.2 to tbe Variolin Core 
Shortly after the appearance of Fresneda and Molina's original communication/6a Vaquero's 
group published a four-step synthesis of the variolin core. In their approach, intact azaindoles 
were utilised as starting materials, with the variolin core being formed by annelation of a side-
chain attached to C2 of the azaindole. Thus, azaindoles 1.47 were protected at the indole 
nitrogen, and dibrominated to give the bromomethyl compounds 1.48 (Scbeme 1.5). These 
products incorporate the functionality required both at C3 (what would become C5 of the 
variolin core) and the C2 side chain. Extension of the bromomethyl group was achieved using 
tosylmethyl isocyanide under phase-transfer conditions. Unexpectedly, the product isolated 
from this reaction was, in fact, variolin core structure 1.49. This was presumed to have formed 
due to an intramolecular transfer of the N-protecting group, which enabled nucleophilic attack by 
the indole nitrogen on the isocyanide to produce 1.49. 
Me02C 
1.49 
a 65% 
b 61% 
c 27% 
R 
Me ~ 
-{N-l . .J 
H N 
1.47 
a R = H 
b ROMe 
c R=CI 
HS02Ar 
1. CIC02Me 
2. NBS, CCI4 
3. NBS, CCI4 , (PhC02h 
82% for a (R = H) 
Scheme 1.5 
1.48 
J 
CNCHzTs, 
NaOH, CH2CI2 
TBAI 
Three examples were given, including one that possessed a methoxy group suitably positioned 
on the pyridine ring, which would serve as a synthetic equivalent for the hydroxyl group found in 
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all the variolins. This certainly offers a much more direct route to the variolin core than 
Fresneda and Molina's ten-step sequence and should allow the introduction of a variety of 
heterocycles at CS. As with Fresneda and Molina's synthesis, however, the procedure suffers in 
that the methoxycarbonyl group is retained at C7. The procedure also requires introduction of 
the amino group at C9. However, to date, there has been no report on how this is to be 
accomplished. 
1.2.5.3 Alvarez and Joule's Synthesis of Deoxyvariolin B 
The third synthesis of the variolin core, which appeared within approximately six months of 
Fresneda and Molina's original communication, was due to the group of Alvarez and Joule.38 In 
this paper, they elected to ignore the hydroxyl group found in the variolins, their goal being a 
synthesis of the deoxy-analogue of variolin B, termed deoxyvariolin B (1.50). Their overall 
strategy involved initial formation of the variolin core, followed by selective functionalisation at 
CS and introduction of an intact pyrimidine heterocycle. 
1.50 
deoxyvariolin B 
Their synthesis of the variolin core is portrayed in Starting with commercially 
available 7-azaindole, Alvarez adapted Katritzky's method45 for lithiation of indoles at the 2-
position. This was found to be more convenient than the phenylsulfonyl-directed lithiation 
method described by Merour4o and gave superior results. Thus, the lithio-species with was 
quenched with N-pthalirnidoaminoacetaldehyde to give the 2-substituted azaindole 
Following protectionldeprotection steps, cyclisation to tetrahydropyrimidinone 1.53 was effected 
upon treatment with triphosgene and Hiinig's base. Conversion to pyrimidinone was 
readily achieved by hydrolysis of the protecting group and dehydration via the mesylate. 
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Their strategy for introduction of the 2-aminopyrimidine ring was based on their earlier work, 
which had been conducted on a simpler system.35b In this paper, stal1l1ane 1.55, which was 
obtained from the corresponding bromide 1.56, was coupled with a range of aryl and heteroaryl 
halides under Pd-catalysis, to give aryl-susbstituted azaindoles 1.57 (Scheme 1.7). 
Sr Me3Sn 1. Pd(PPh3)4. ArX, Ar 
1. t-BuLi, THF. -90°C LiCI, THF, reflux tcJ 2. Me3SnCI tcJ 2. 10% aq HCI, rt tcJ • ,. N ~ 99% N ~ N ~I N I N H N 
R R 
1.56 1.55 1.57 
Ar X % Yield 
4-methoxyphenyl Sr 38 
4-nitrophenyl Sr 50 
thien-3-yl Sr 57 
2-(methylthio )pyrimidin-4-yl CI 60 
2-(methylthio )pyrim idin-5-yl Br 53 
Scheme 1.7 
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However, application of this methodology to the variolin system presented some difficulties 
which had to be overcome. While 1.54 could be efficiently halogenated at the 5-position 
(Scheme 1.8), the halo-derivatives 1.58 could not be efficiently converted to the corresponding 
5-stannyl compounds. Neither could 1.58 (Hal = I, R MOM) be coupled with the 
stannylpyrimidine 1.59. To circumvent these difficulties, it was decided to convert 1.54 to the 
amine 1.60. This was achieved in a two-step procedure involving O-silylation followed by 
nucleophilic substitution with ammonia in a pressure vessel. After N-acylation, selective 
iodination at C5 gave 1.61, which participated in Pd-catalysed coupling with 1.59 more readily 
than did the corresponding 5-halopyrimidinones 1.58. Finally, S-oxidation of 1.62, followed by 
substitution of the resulting sulfone with ammonia, produced the target compound deoxyvariolin 
B (1.50). 
1. TMSCI, HMDSA, 
2,6-lutidine 
2. NH3, 150 ·C, 60 psi 
1.54 
30% 
J 
1. N-protection 
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N~SMe 
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A notable feature of this synthesis is the selective iodination at C5 of the variolin core, and 
subsequent introduction of the intact heterocycle. This methodology should allow introduction 
of a wide range of heterocycles (and other groups) at C5, providing access to a variety of useful 
analogues. The synthesis is, however, quite a lengthy sequence for a compound of relative 
structural simplicity, and this situation is likely to worsen if the strategy was applied to variolin 
B (1.17). The overall yield for the 14-step sequence was 2.2%. 
1 Work Described in this Thesis 
As demonstrated in all the aformentioned syntheses of the variolin core, disconnection of the 
C9-NIO bond (Figure 1.3, p 18), or double-disconnection of the N8-C9 and C9-NIO bonds, 
gives rise to a 2-substituted azaindole, which in turn, must be built up from simpler building 
blocks. Once the variolin core is constructed, further steps must be taken to introduce the 
heterocycle at C5. Examination of variolin B revealed another possible disconnection, which 
could lead to a much simplified, more direct synthesis compared to those mentioned above. 
The basis of the new approach was to make the key disconnection between NlO and CIOa 
(Figure 1.4). This would give rise to a synthon in which a negative charge rests on the 
pyrimidine nitrogen, and a positive charge is placed at the electrophilic 2-position of the pyridine 
ring, thus exploiting the natural reactivity found in both ofthese units. 
1.17 
variolin B 
> 
Disconnection of the NIO-ClOa bond of va rio lin B (1.17). 
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An appealing feature of this strategy lies in the realisation that a suitable synthetic equivalent for 
this synthon would be a triarylmethane substituted with a pyridine ring and two identical 
pyrimidine units. As noted by Corey and Cheng, structural symmetry can usually be exploited to 
reduce the length or complexity of a synthesis.46 
In designing the synthesis of variolin B (1.17), it would be prudent to perform some functional 
group interconversions (FGIs) before disconnection of the NIO-CIOa bond is carried out, so as 
to avoid having to carry the polar amino groups throughout the synthesis. Thiomethyl groups are 
often used as synthetic equivalents for amines due to their relative non-polarity and stability, and 
should be able to be converted to the amines late in the synthesis.47 The hydroxyl function 
would also require protection, most easily as the methyl ether. Numerous methods exist for the 
deprotection of methyl aryl ethers,48 which again, could be conducted after the key bond-forming 
reactions had been carried out. Implementation of these FGIs reduces the problem to a synthesis 
of 1.63 (Figure 1.5). 
1.17 
variolin B 
1.66 
FGI 
> 
+ 
1.63 
o OMe 
CI~ 
X N 
1.67 
Retrosynthetic analysis of va rio lin B (1.17). 
1.64 
DFGI 
X = leaving group 
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Disconnection of the Nl O-C 1 Oa bond of 1.63 gives the symmetrical triarylmethane 1.64, where 
would be a suitable leaving group. The triarylmethane could conceivably be produced by 
reduction of the tertiary benzylic alcohol 1.65, which itself could result from the reaction of two 
equivalents of the known49 lithiated pyrimidine 1.66 with acid chloride 1.67. 
It is to be noted that this strategy prescribes a highly convergent process, whereby all the carbons 
and ring-nitrogens present in the target are assembled in a single step. It exploits the natural 
reactivity of the pyrimidine and pyridine rings, as well as the symmetry embedded in the 
structure of variolin B. The method would not be so well-suited to the other naturally occurring 
variolins, as it specifically relies on the symmetry found in variolin B (1.17). Having said this, it 
is possible that the other variolins may be accessible by further functionaHsation of variolin B 
itself. In addition to this possibility, there is the probability that a range of analogues should be 
accessible by substitution of the thiomethyl groups with various amines or other nucleophiles. 
The substituent X would have to be carefully selected-it needs to be a good leaving group, yet 
it must be stable to a range of reaction conditions, which may include low-temperature lithiations 
and reducing conditions. It was felt that the chloro group would be an appropriate choice. 
While acid chloride 1.67 (X = CI) has not been reported in the literature, 2-chloronicotinoyl 
chloride (in which the methoxy group of 1.67 (X CI) is replaced by a proton) is available from 
commercial sources. 50 It was decided, therefore, to initially investigate the potential of the 
strategy using 2-chloronicotinoyl chloride as a convenient starting material. The main purpose 
was to determine the feasibility of this approach to the variolin core. It could also result in a 
synthesis of deoxyvariolin B (1.50), which would serve as a useful analogue for biological 
studies. If the methodology proved successful, application to the acid chloride 1.67 would 
provide a potential method for the synthesis of va rio lin B (1.17). 
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As discussed in Chapter One, it was decided to first investigate the synthesis of the 
pyrido[3',2':4,5]pyrrolo[1 ,2-c Jpyrimidine ring system found in all the variol1ns. convenient 
starting materials were available for the deoxy-system, efforts were initially focused on the 
synthesis of the deoxyvariolin core structure 2.1. If successful, this could be extended to a 
synthesis of deoxyvariolin B (1.50). 
The retrosynthetic strategy for deoxyvariolin B is outlined in Figure 2.1, with the key 
disconnection being between NIO and CI0a of the variolin core 2.1. It was anticipated that this 
bond could be fonned by an addition-elimination reaction of triarylmethane To generate 
this system, it was decided to investigate the deoxygenation of triarylmethanol 2.3, as it was felt 
that this could be readily generated from commercially available 2-chloronicotinoyl chloride 
(2.4) and lithio-species 1.66. 
FGI 
> 
1.50 2.1 2.2 
o 
+ CI~~ 
CI N 
1.66 2.4 
2.3 
Retrosynthetic analysis of deoxyvariolin B (1.50). 
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2.2 ()f Triarylmethan()l 2.3 
Non-heteroaromatic triarylmethanols have enjoyed much attention in the literature as precursors 
to stabilised triarylmethyl carbocations.51 Generally, triarylmethanols are synthesised using 
either aryllithium or aryl-Grignard reagents with suitable electrophiles. For symmetrical 
triarylmethanols, reaction of three equivalents of an aryllithium species with diethyl carbonate is 
a typical procedure (Figure 2.2a).51f 
0 Ar 
a 3 Ar-M + 
RoAOR 
liIo Ar+OH 
Ar 
0 Ar' 
b Ar-M + 
Ar,AAr' 
liIo Ar+OH 
Ar' 
0 Ar 
C 2 Ar-M + Ar,)loR 
... Ar+OH 
Ar' 
I M = Li or MgX 
Figure 2.2 Variations on the use of polar organometallics to form triarylmethanols. 
Even very hindered products have been produced from such reactions, although high 
temperatures and extended reaction times are often required. For example, the hexa-o-methoxy-
substituted product 2.5 was formed in 80% yield upon reaction of the aryllithium species with 
diphenyl carbonate at 80°C for h.51b Less hindered products have been produced under 
milder conditions. For example, tetra-o-methoxy-substituted products, as represented by 2.6, 
were formed in 78% yield, upon reaction of the appropriate aryllithium species with a 
symmetrical biaryl ketone in diethyl ether at room temperature for 7 h (Figure 2.2b).51c 
Alternatively, aryl-Grignard reagents (two equivalents) have been added to arylcarboxylic esters 
to produce triarylmethanols in 71-95% yields (Figure 2.2c). 52 
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Application of such methodology to the synthesis of 2.3 requires lithiation of an-deficient 
heterocycle-a widely used tool, but one which deserves some comment. Much work has been 
done with heteroaryllithium and heteroaryl-Grignard reagents, which have been formed by direct 
metallation (usually with the aid of an ortho-directing group, although this is not always 
required)53 or by halogen-metal exchange of a suitably functionalised heterocycle.49, 54, 55, 56 
With n-deficient heterocycles, low temperatures (usually -78°C or below) are required for 
optimum results due to the electrophilic nature of the azomethine bond (NI-C2 in pyridine and 
NI-C6 in pyrimidine), which is readily attacked by nUcleophiles at higher temperatures. The 
pyrimidine azomethine linkage (NI-C6) is more susceptible to nucleophilic attack than that of 
pyridine,57 and pyrimidines have been studied correspondingly less than pyridines. In ortho-
directed metallations of n-deficient aromatics, highly hindered bases such as lithium 
diisopropylamide (LDA) and lithium 2,2,6,6-tetramethylpiperidide (LTMP) have found 
widespread use for deprotonation, as they have a much lesser propensity to act as nucleophiles 
than alkyllithiums.53 The heteroaryllithiums that are generated, however, are very reactive 
species which may undergo dimerisation or polymerisation before the electrophile can be 
introduced.55,58 When halogen-metal exchange is used to form the heteroaryllithium, the more 
nucleophilic alkyllithium reagents must be used. 
An example which typifies these difficulties is given below. Gronowitz and Roe have found that 
5-lithiopyrimidine could be formed by halogen-metal exchange of 5-bromopyrimidine with n-
BuLi at -105°C. 55 Quenching with CO2 produced the 5-substituted carboxylic acid 2.7 in 68% 
yield (Scheme 2.1). If the lithiation is carried out at -80°C, however, only a trace of 2.7 was 
obtained. The lithio-species does form, but it immediately reacts with starting material, adding 
to the 3,4-azomethine linkage to produce the 3,4-dihydro product 2.8, which was isolated from 
the aqueous phase. Small amounts of 2.9 were also produced, which presumably arises as a 
result of aerial oxidation of2.8. When the reaction was conducted at temperatures above -30°C, 
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direct addition of n-BuLi predominated over halogen-metal exchange, giving 2.10 as the major 
product. 
N N ~ ~ Br C02H NH Br /- N 1. n-BuLi Br Br A 2. CO2 A + I ""=:: + I ""=:: + rArBU ~ 
1\1-....::;:-1\1 I\I-....::;:-N 1\1-....::;:-1\1 N-....::;:-I\I No/NH 
2.7 2.8 2.9 2.10 
Scheme 2.1 
However, if care is taken with the selection of reagents and reaction conditions (altering base, 
solvent, additives and reaction temperature), it is possible to successfully metallate a wide 
variety of n-deficient aromatics, quenching with all manner of e1ectrophi1es. In some cases, 
selectivity can often be achieved for different positions on the ring,59 constituting a powerful tool 
in the functiona1isation ofheterocyc1es. 
The use of 4-lithio-2-(methy1su1fanyl)pyrimidine (1.66) appealed for a direct synthesis of 
triary1methano1 2.3. Reaction of two equivalents of 1.66 with 2-ch10ronicotinoy1 chloride (2.4) 
should give 2.3 through the intermediacy of ketone 2.11 (see Figure 2.3). 
° c,:o 
CI N 
1.66 
+ 
1.66 2.4 2.11 2.3 
Figure 2.3 Proposed reaction of 4-1ithio-2-(methy1su1fany1)pyrimidine (1.66) with acid 
chloride 2.4 to form 2.3. 
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Lithio-species 1.66 was first reported by Undheim and Sandosham,49 being formed from the 
corresponding iodide 2.12 by halogen-metal exchange with n-BuLi (Scheme The iodide is 
available in one step from commercially available 4-chloro-2-(methylsulfanyl)pyrimidine 
(2.13).60 Presumably 2.13 is not reactive enough to undergo halogen-metal exchange with n-
The lithiation conditions involve stirring iodide 2.12 and n-BuLi at -95°C for 1 h, 
followed by addition of the electrophile (in the original paper, tributylstannyl chloride) and 
gradual warming to room temperature. Stannane 2.14 was produced in 76% yield. Interestingly, 
the stannane was coupled with heterocycles 2.15 and 2.16 to afford the biatyl products 2.17 and 
2.18 in good yields. It is remarkable that reaction of 2.14 with 2.16 proceeds at -78 °C and 
requires no metal catalysis. 
r(YX n-BuU 
[ r(YU j BU3SnCI r(YsnBu3 ;!so 'I!O NyN -95°C NyN 76% NyN 
SMe SMe SMe 
2.13 X=CI 1.66 2.14 
aq HI, rt 
76% 2.12 X = I 
0 
~HO Br-Q-CHO CI>-O ~ /, 0 ~ ~ ::::,.... 2.15 2.16 I .. 2.14 ... NyN PdCI2, DME, THF, -78'C NyN 
80°C, 10 h (64%) 
SMe (82%) SMe 
2.17 2.18 
Scheme 2.2 
Thus, the synthesis of triarylmethanol began with preparation of the iodide 2.12 from 
according to Undheim's procedure6o (Scheme 2.3). This involved stirring the chloride 2.13 in 
55% aqueous HI solution for 48 h at room temperature. Efficient stirring of the thick sludge thus 
produced was necessary to obtain the maximum yield, and it was important that any lumps were 
regularly broken up with a glass rod to give a homogeneous brown paste. After workup with 
aqueous NaHC03 s01ution, recrystallisation from hexanes gave iodide 2.12 as large white 
needles in 79% yield. 
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The other component required for the synthesis of 2.3 is 2-chloronicotinoyl chloride (2.4). 
While this compound is commercially available, it was found that hydrolysis to the carboxylic 
acid occurs slowly, even when carefully stored under anhydrous conditions. It was more 
convenient (and economical), therefore, to freshly prepare it from 2-chloronicotinic acid (2.19) 
one day before use. This was effected in 97% yield by refluxing in thionyl chloride 6 1 with 
catalytic DMF, and distilling the crude material under vacuum in a Kugelrohr oven. 
Using the lithiation protocol reported by Undheim and Sandosham,49 a solution of iodide 2.12 in 
THF at -95 DC was treated with n-BuLi. After 1 h at -95 DC, 0.5 equivalents of 2-
chloronicotinoyl chloride (2.4) in THF were added and, after 15 min, the temperature was 
allowed to slowly rise to room temperature. The IH NMR spectrum of the crude reaction 
mixture indicated the presence of at least six products. Flash chromatography allowed the 
isolation ofthe major product, which was determined to be the desired triarylmethanoI2.3. 
i [ 2.13 X= CI 
2.12 X == I 
iii 
1.66 
2.3 
o c,:o 
CI N 
ii 
2.4 2.19 
Scheme 2.3 Reagents and yields: (i) 55% aq HVrt (79%); (ii) SOCh/cat. DMFlreflux (97%); (iii) 
n-BuLi (1 equiv)/THF/-95 DC, 1 h; (iv) 2.4 (0.5 equiv)/THF/-95 DC to rt (20%). 
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The IH NMR spectrum of 2.3 is shown in Figure 2.4. The 2,3-substituted pyridine unit gives 
rise to a distinctive ABX splitting pattern, while the identical pyrimidine rings produce a pair of 
doublets, each of which integrates for two protons. A sharp singlet is seen for the hydroxyl 
proton at 0 6.33, and a large singlet at 0 2.49 represents the six thiomethyl protons. The mass 
spectrum displays a molecular ion at mlz 391, as expected for Interestingly, the base peak in 
this spectrum has a mass of 356, which corresponds to a loss of chlorine. While simple 2-
chloropyridines can fragment in this manner,62 the loss of chlorine from 2.3 appears to be a much 
more facile process. It is thought that the alcohol may be cyclising under the MS conditions to 
give a pyridopyrrolopyrimidine-type species. It was hoped that this would be indicative of 
things to come. 
SMe 
6' 5' CHCI3 
OH 
4 
6 
/ 5 
t I 
iliillliiiJlllil(illijiiJ'liiiiiitl 
2.60 2.45 ppm 
i i if i iI I I II Ji I IIi 'I' II II Ii "I i Ii i ji I II JI II I jill II iii II Ii i I I f1 I II Ii i i Ii Ii iii i II P Ii I I i Ii Ij i Ii II i j Ii II I , I I i I II I' i j i Ii ii, I i I I I I II " iii 11 Iii 1 'Iii i Ij i II I P 
8.6 8.4 8.2 8.0 7.8 7.6 7.4 7.2 7.0 6.8 6.6 6.4 6.2 6.0 ppm 
Figure 2.4 300 MHz IH NMR spectrum oftriarylmethanol 2.3. 
Unfortunately, however, the isolated yield of 2.3 was only ~20%. Other products identified in 
the reaction fell into two classes-those which were simply pyrimidine-containing byproducts of 
the lithiation step (2.20-2.22), and those containing both a pyridine and a pyrimidine ring (2.11 
and The 2,3-disubstituted pyridine moiety was easily recognised by its distinctive long-
range coupling in the IH NMR spectrum, whereas the 2,4-disubstituted pyrimidines give rise to 
simple splitting patterns. 
Chapter Two - Synthesis of the Variolin Core and Deoxyvariolin B 
2.20 2.21 
2.11 
AI ~Jl. N~-:?" N 
MeS N I ~ N SMe 
2.23 
NyN 
SMe 
2.22 
38 
The major byproduct was the deiodinated pyrimidine 2.20, being present in almost the same 
proportion as 2.3 (judging from the IH NMR spectrum of the crude material). It must be fomled 
by the quenching of the lithio-species 1.66 with an adventitious proton source. Pyrimidine 2.20 
could not arise from protonation of 1.66 upon workup, as 1.66 would have decomposed long 
before the reaction had reached room temperature. Significant quantities of 2.20 were always 
obtained, despite using standard inert atmosphere techniques, base-washed glassware and freshly 
purified solvents and reagents. It is possible that 2.20 may result from deprotonation of the 
solvent, THF. Such reactions have been documented with n-BuLi at room temperature, which 
quantitatively produces the enolate of acetaldehyde after 16 h (see Figure 2.5).63 It is surprising 
that the aryllithium 1.66 (which is presumed to be less basic than n-BuLi) is reactive enough to 
deprotonate THF at temperatures well below room temperature. 
GOG 
+ 
2.5 Deprotonation ofTHF by n-BuLi. 
The presence of products indicate that the lithio-species 1.66 is unstable and can react 
via a number of pathways which compete with the addition to the acid chloride. Presumably 
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tributylstannyl chloride, the electrophile used by Undheim and Sandosham, is reactive enough 
that these competing pathways do not present a significant problem.49 The bipyrimidine 2.21 is 
formally the result of a Wurtz coupling64 (Figure 2.6a), although there are several alternative 
processes that could be considered. For example, addition of 1.66 to 2.12, followed by 
elimination of LiI would give rise to the bipyrimidine (Figure 2,6b). However, n-deficient 
heteroaromatics can also undergo addition to unsubstituted azomethine bonds, as in Figure 2,6c, 
in preference to those with a substituent on the carbon. 65 The resulting anion 2.24 could undergo 
halogen-metal exchange to form the dianion 2,25 which, when protonated and oxidised in air, 
would produce 2,21. 
a 
1.66 2.21 
b + .. [ 
~ V~ j N, ;---\ "N rN N~ 
MeS Li+ SMe 
.. 2.21 
1.66 2.12 
c + 
[ 
N~~ j rN N~ 
MeS Li+ SMe 
n-BuLi 
[ 
~ r-=<Li j r{ M /;N rN N~ 
MeS Li+ SMe 
2.21 
1.66 
2.12 
2.24 2.25 
Figure 2.6 Possible mechanisms of formation of the bipyrimidine product 2,21. 
The presence of 2.22 can be explained by a combination of process (c) and either processes (a), 
(b) or (c). For example, (c) + (a) would involve formation of dianion 2.25 which reacts with 
another equivalent of lithio-species 1.66 to produce 2.26. Oxidative workup of 2.26 would result 
in the formation of 2,22 (Figure 2.7). 
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Figure 2.7 Possible mechanism of formation of 2.22. 
The ketone product 2.11 is an expected intermediate en route to triarylmethanol 2.3. Its presence 
indicates that not enough 1.66 was available for complete reaction-a hardly surprising result 
based on the presence of products 2.20-2.22. The biarylmethanol 2.23, however, was 
unexpected and is not so easily explained. Common sense would suggest that it is formed from 
the ketone 2.11 by an adventitious reducing agent. For example, if route (a) (Figure 2.6a) is 
involved in the production of 2.21, the electrons produced would be expected to readily reduce 
the benzylic ketone 2.11, thereby explaining the formation of2.23. 
The conclusion from all this conjecture is that the lithio-species 1.66 is an extremely reactive 
intermediate which requires careful control of the reaction conditions to prevent it reacting with 
itself or unreacted iodide 2.12. It was surmised that side-products 2.20-2.22 most likely form 
upon warming of the reaction to room temperature. These products were expected to be 
minimised, therefore, if the following stipulations were adhered to: slow addition of precooled 
reagents (both n-BuLi and acid chloride 2.4) to avoid an exotherm in the reaction mixture; 
maintenance of low temperature until the reaction is complete; and dilution of the reaction 
mixture (this should disfavour dimerisation of 1.66 to give 2.21). 
To this end, a specialised piece of glassware was used to conduct the reaction in, shown in 
Figure 2.8. The reactor was first described by Suzuki and Noyori, who required careful control 
of temperature in their prostaglandin synthesis.66 The reactor is immersed in the cooling bath up 
to the level of the top coil. Addition of reagents through the coiled side-arm ensures that these 
solutions are already cooled to the temperature of the external bath before making contact with 
the bulk reaction. 
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Magnetic stirrer 
Figure 2,8 Reactor used to carry out large-scale lithiations of 2,12. 
Use of the reactor in the lithiation of iodide 2,12, with application of the aforementioned 
stipulations, led to significantly cleaner reactions. The reactor was particularly useful for large 
scale reactions, in which intemal exotherms were a significant problem. The side-products 1 
and 2,20--2,23 were still observed in the reaction, but in much lower proportions. 
It was important to ascertain exactly how long was required for complete reaction to occur at 
DC. This was determined by using methanol to quench the reaction (while still at -95 DC) after a 
fixed period. If any unreacted acid chloride 2.4 still remained, it would be identified in the 
NMR spectrum as the methyl ester. (Quenching with aqueous acid would convert any remaining 
2.4 to 2-chloronicotinic acid. This would be extracted into the aqueous phase upon workup and 
consequently, would not be observed in the IH NMR spectrum.) If any 2.4 did remain, this 
could be due to either the reaction not being left for long enough at -95 DC, and/or insufficient 
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lithio-species 1.66 (which presumably would have been consumed via the competing pathways 
discussed previously). To distinguish between these two possibilities, the reaction was quenched 
at -95°C with deuterated methanol (CH30D). If any active lithio-species remained, the 
deuterated pyrimidine 2.27 would be formed (and any unreacted would still be isolated as the 
methyl ester). Pyrimidine can be distinguished from 2.20 in the IH NMR spectrum, as 
illustrated in Figure 2.9. Comparison of the 1 H NMR spectra for and 2.20 (present in the 
cmde mixture of the lithiation reaction) reveals that the chemical shifts do not differ between the 
two compounds, merely the splitting pattern. The coupling between deuterium and hydrogen is 
too small to be observed and so gives rise to a simple AX pair of doublets (Figure 2.9a). 
H5 of 2.20, however, couples to its two neighbouring protons and consequently gives rise to a 
triplet at i5 6.95 (Figure 2.9b). 2.9c shows the IH NMR spectmm of a reaction mixture 
quenched at -95°C. Even though the signals for 2.20 and 2.27 overlap, it can be clearly seen 
that 1.66 was still present in the reaction at the time of quenching. 
H5 
6 H6yYD 5 I~ 
2.27 
a NyN CHCI 3 
SMe 
b 
c 
Aromatic regions of the l\TMR spectra of: (a) 4-deuterio-2-(methylsulfanyl)-
pyrimidine (2.27); (b) lithiation reaction containing 2-(methylsulfanyl)pyrimidine (2.20) as a 
byproduct; (c) lithiation reaction quenched at -95°C with CH}OD. 2.27 (circled) was observed, 
thereby indicating the presence ofthe lithio-species 1.66 at the time of quenching. 
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Thus, by quenching the reaction with CH30D at -95°C, it can be determined whether or 1.66 
remain. If both are still present, the reaction needs to be left longer at -95 DC before quenching. 
If remains, but not 1.66, the reaction requires the use of greater than two equivalents of 1.66. 
After several reactions, the best conditions found involved using three equivalents of (with 
respect to 2.4), and conducting the reaction at -95 °C for at least 3.5 h. Under these conditions, 
the triarylmethanol 2.3 was isolated in 56% yield (90-95% purity). As chromatographic 
separation of the two alcohols 2.3 and 2.23 proved difficult, the partially purified mixture was 
subjected to oxidation to Mn02 in refluxing benzene. This converted the secondary alcohol to 
the ketone 2.11, which was easily removed from tri arylmethano I 2.3 by flash chromatography. 
Complete elimination of 2.11 and 2.20-2.23 could not be achieved, hence the need for greater 
than two equivalents of It should be mentioned that extremely careful control of the bath 
temperature and addition rates of reagents was required for consistent results. As the scale of the 
reaction was increased beyond -20 mmol of iodide 2.12, it became particularly difficult to 
preclude the formation of 2.20-2.22. Prolonged periods of BuLi-addition (e.g. 60 min for 30 mL 
of n-BuLi in hexanes) meant that 1.66 had a significant opportunity to degrade before the acid 
chloride could be added. 
In summary, triarylmethanoI 2.3 has been generated on a 4.5 mmol scale in 56% yield 
(calculated from 2.19, the limiting reagent), starting with the readily available materials 2-
chloronicotinic acid (2.19) and 4-chloro-2-(methylsulfanyl)pyrimidine (2.13). This method 
assembles all the carbons and ring-nitro gens of deoxyvariolin B in a single step. With a 
successful route to the production of 2.3 on a gram-scale, its deoxygenation and subsequent 
cyclisation to the variolin skeleton 2.1 could now be investigated. 
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2.3 Variolin Core 
Perusal of the literature reveals numerous methods that have been devised, or discovered, for the 
deoxygenation of alcohols. Some of these methods are well-established, being in common use 
for thirty years or more,67 while methods are still being reported at the present time.68 Two 
general methods for the deoxygenation of alcohols exist-radical deoxygenation69 and ionic 
hydrogenolysis. Within these two categories, there exist numerous reagent systems that have 
been developed; such variations are necessary, as the balance required between reactivity and 
selectivity varies from one application to another. . 
2.3.1 Radical Deoxygenation of Triarylmethanol 2.3 
Radical reduction of triarylmethanol 2.3 may be a feasible process as the triarylmethyl radical 
2.28 is expected to be stabilised by the 1[-deficient heterocycles. Provided that it could be 
formed, 2.28 could abstract a hydrogen atom (e.g. from tributylstannane) to produce the 
triarylmethane 2.2 or, alternatively, it may cyclise directly to the variolin core (Figure 2.10). 
In either case, a chain process can be envisaged due to the elimination of tributyltin or chlorine 
radicals, respectively. 
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2.3 2.28 2.2 
2.1 
Figure 2.10 Proposed use of radical deoxygenation of2.3. 
2.3.1.1 Barton-McCombie Deoxygenation 
Of the numerous procedures described for radical deoxygenation of alcohols,69 the most widely 
used is the Barton-McCombie method, first reported in 1975.70 In this procedure, the alcohol is 
converted into either a thiobenzoate 2.30 or a dithiocarbonate/xanthate 2.31, which is 
subsequently reduced with tributyltin hydride in refluxing toluene (Figure 2.11). The reduction 
proceeds via a chain process, in which addition of a tributylstannyl radical to sulfur gives a 
carbon-centred radical 2.32, which can then fragment to produce a new radical 2.33. This is 
intercepted by tributyltin hydride to give the reduced product 2.34, with regeneration of the tin 
radical so that the chain process may continue. 
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Figure 2.11 a) Fonnation ofthiobenzoates and xanthates; b) Tributyltin hydride-mediated 
reduction ofthiobenzoates/xanthates to give alkanes. 
Accordingly, functionalisation of triarylmethanol 2.3 was attempted using the standard protocol 
for xanthate fonnation (see Figure 2.11a). However, mixtures of products were always 
obtained, with the major component of the mixture being the starting alcohol 2.3. Despite 
repeating the reaction with excess reagents andlor longer reaction times, no improvement could 
be gained. Other groups have also experienced difficulties in preparing (and reducing) hindered 
xanthates.71 ,72 
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2.3.1.2 Deoxygenation of Methyl Oxalyl Esters 
Dolan and MacMillan have described the use of methyl oxalyl esters as alternative radical 
precursors to xanthates and thiobenzoates.72 While preparation of tertiary xanthate and 
thiobenzoate derivatives of 2.35 proved difficult, the methyl oxalyl esters 2.36 were readily 
prepared. These products were subsequently reduced by tributyltin hydride, in the presence of a 
radical initiator, to produce good yields of the 13-deoxygibberellins (Scheme 2.4). 
1. oxalyl chloride, rt 
2. MeOH 
2.35 
R1 R2 =Hor 
R< R2 = double bond 
Scheme 2.4 
2.36 
j BU3SnH, radical initiator, toluene, reflux 
65% over two steps 
for R 1, R2 = double bond 
However when triarylmethanol 2.3 was stirred with oxalyl chloride in dry dichloromethane, 
followed by methanolic workup, only the starting alcohol was obtained. When triethylamine 
was included in the reaction, up to three minor products were produced, but the starting alcohol 
was still the major component of the mixture. It is assumed that the hindered nature of 
triarylmethanol 2.3 is the cause of its reluctance to undergo functionalisation to either xanthates 
or methyl oxalyl esters. As a consequence, this line of research was discontinued. 
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2.3.2 Ionic Hydrogenolysis of Triarylmethanol 2.3 
Many methods exist for the direct reduction of alcohols, without the need for functionalisation to 
a more reactive derivative. As has been mentioned, triarylmethanols have been the subject of a 
number of studies in regard to their direct deoxygenation to stabilised triarylmethane 
carbocations.51 A benzylic carbocation experiences considerable stabilisation over a normal 
alkyl carbocation, due to overlap of the empty p orbital of the carbocation with the conjugated n-
system of the aromatic ring. Exceptional stabilisation can be achieved by substituting the 
carbocation with three aromatic rings. For example, the trityl cation 2.37 is considerably less 
susceptible to nucleophilic attack than the simple benzyl cation. However, this is largely due to 
steric effects rather than electronic effects. While it may seem tempting to delocalise the 
positive charge over all three rings, these resonance structures actually play only a small part in 
the electronic nature of the molecule. This is because the steric bulk of the aromatic rings forces 
the cation into a propeller conformation.73 This arrangement lessens the extra stabilisation that 
could be gained from overlap of the 2p orbital of the cation with the aromatic n-electrons, but 
increases the stability of the cation by making it more hindered. Further stabilisation of such 
benzylic cations can be gained if the phenyl rings are substituted with electron-donating groups, 
such as the methoxy group. This stabilisation is probably a combination of both steric effects (if 
the substituent is in the ortho position) and electron-donating effects.5Id Conversely, electron-
withdrawing groups destabilise the cation, as they are unable to assist in delocalisation of the 
charge. 
2.37 2.38 
In the case of triarylmethanol 2.3, the heteroaromatic groups may play a part in resonance-
stabilisation of the incipient carbocation 2.38, however this would be offset to some extent, by 
the highly n-deficient nature of these rings. It is difficult to predict, in any quantitative manner, 
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just how stable the cation may be. Suffice it to say, it was anticipated that more forcing 
conditions would be required for its formation than are required for the generation of the trityl 
cation 2.37. If, however, the cation could be produced, it was thought that a suitable hydride 
source could be found to reduce it to the triarylmethane 2.2. 
Such processes are referred to as ionic hydrogenolyses, and as the name suggests, they proceed 
by an ionic mechanism and involve an intermediate carbocation. These reactions require a two-
component reagent system consisting of an acid (Lewis or Bmnsted) to ionise the alcohol and a 
hydride source to reduce the incipient cation. Of special concern in the case of the variolins was 
the reactivity of heterocyclic systems to such conditions. As quarternised pyridines are known to 
undergo reduction of the azomethine bond with sodium borohydride or lithium aluminium 
hydride,74 the possibility existed that the n-deficient heterocycles of 2.3 may not withstand such 
reducing conditions. Thus, conditions would have to be found of sufficient reactivity to intercept 
the triarylmethylcation 2.38, yet with the selectiVity to leave the n-deficient heterocycles 
untouched. 
A preliminary screening ofthe more commonly used methods was carried out to ascertain which, 
if any, would be most suitable for the deoxygenation of 2.3. These included NaCNBH3/Znh75 
Pd-CIAICh/cyclohexene/6 P/I2IHI,77 NaBH4/TFA,78 H2/Adams' catalyst (Pt02)/TFA79 and 
LiAIH4/AICh. 80 In general, these reagent systems returned only starting material or formed 
complex product mixtures. In some cases, poor mass-return after workup indicated that 
destruction of the alcohol 2.3 was a problem. Reduction of the aromatic heterocycles may have 
been responsible, based on the IH NMR spectra of the crude reaction mixtures. 
One reagent system, however, held promise for reduction of triarylmethanol 2.3. This system 
utilises an organosilane as a mild and selective reducing agent in the presence of an acid (usually 
trifluoroacetic acid).67 This system effectively reduces substituted alkenes, cyclopropanes, 
certain alcohols, esters and ethers, and aromatic ketones and aldehydes to the corresponding 
alkanes. A number of other functional groups can also be reduced, including a,p-unsaturated 
and saturated ketones, p-quinones, disulfides and acetals to give a variety of products. However, 
the trifluoroacetic acid/organosilane system is tolerant of many functional groups which are 
reduced by other methods. These include carboxylic acids and simple esters, amides, nitriles, 
nitro groups, sulfonates and aromatic rings. In addition, many alcohols, ethers, alkenes and alkyl 
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halides survive the reaction conditions. Significantly, pyridine, isoquinoline and acridine are all 
reported to resist reduction by the trifluoroacetic acid/organosilane hydrogenolysis pair.67 
However, no mention was made regarding pyrimidines. In contrast to these n-deficient 
heterocycles, substituted indoles and thiophenes are reduced, to dihydroindoles and 
tetrahydrothiophenes respectively. 67 
The high yields obtained from the trifluoroacetic acid/organosilane hydrogenolysis system, 
combined with its wide application, particularly in the reduction of benzylic alcohols, and 
tolerance of many functional groups gave it significant appeal for the reduction of2.3. 
Initially, the attempted reaction of 2.3 in CH2Ch at room temperature with I equivalents of 
triethylsilane (TES) and 2 equivalents of trifluoroacetic acid (TF A) gave only starting material. 
Even after refluxing for 30 h, only starting material was isolated. However, when the reaction 
was carried out in refluxing TF A as solvent (i.e. CH2Ch was not present in the reaction), the 
starting material did react to form a number of products. As the IH NMR spectrum of the crude 
reaction mixture was rather complicated, it was difficult to determine whether the desired 
triarylmethane 2.2 had formed. To shed some light on the reaction, the mixture was subjected to 
chromatographic separation. Careful flash chromatography was used to separate the products, 
however HPLC was required to achieve complete purification. 
2.3.2.1 Products from the Ionic Hydrogenolysis of Triarylmethanol 2.3 
It should be noted that although many products were formed in the TF AlTES reaction, the 
products isolated were those that were most readily obtained after silica flash chromatography. 
They also corresponded (in general) to the more predominant compounds observed in the IH 
NMR spectrum of the crude mixture. The poor mass-balance obtained from the reaction, 
combined with the extensive chromatography that was required, meant that yields for most ofthe 
compounds were not determined-the initial focus was to identify the reaction products, and to 
attempt to ascertain what processes had occurred. 
Four products D, C and were isolated from the reaction. The IH NMR spectrum of 
triarylmethane 2.2-the desired product of the reaction-should contain a rather deshielded 
singlet for the proton attached to the central carbon. One of the new products (A) does indeed 
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give rise to a singlet in its IH NMR spectrum, at (5 7.43 (see Figure 2.12). It is clear, however, 
that this spectrum cannot belong to triarylmethane 2.2. The triarylmethane should contain only 
two doublets, each integrating for two protons, as the pyrimidine groups in 2.2 are identical. 
Product A, however, appears to possess two non-identical pyrimidine rings, based on the 
presence of four doublets in the aromatic region of the spectrum. Two separate peaks, which can 
just be resolved, at (5 2.43 and 2.44 (not shown in the Figure) were assigned to the thiomethyl 
groups and help to confirm the non-identical nature of the pyrimidine rings. The AMX splitting 
pattern due to the 2,3-substituted pyridine ring is also clearly visible. 
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Figure 2.12 Aromatic region of the 300 MHz IH NMR spectrum of A. Stars and crosses 
indicate pyrimidine signals that are coupled to each other. 
Mass spectral analysis gave the surpnsmg result that A had the molecular formula 
C16H14CINsOS2 and thus, was simply a rearranged isomer of the starting material 2.3. 
Application of 2D NMR techniques led to the conclusion that A had the structure 2.39. The 
wealth of correlations in the HMBC (see Figure 2.13), particularly from the central methine 
proton to each of the three aromatic rings, was instrumental in the elucidation of this structure. 
The formation of 2.39 from triarylmethanol 2.3 is certainly an interesting transformation. 
However, before any mechanisms that may lead to 2.39 are discussed, the identity of the other 
products from the TF AlTES reaction will be addressed. 
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2.39 (A) 
Important HMBC correlations for 2.39 (A). 
The aromatic regions of the IH NMR spectra of the three remaining products B, C and Dare 
displayed in Figure 2.14. It is immediately apparent that none of these products corresponds to 
the desired triarylmethane 2.2. Yet these spectra are intriguing, in that they are all consistent 
with what would be expected for the variolin core structure 2.1. It would appear that the 
triarylmethane may have been formed and then reacted further to produce the 
pyridopyrrolopyrimidine core. In each of the three spectra, two separate thiomethyl signals 
(which appear between 2 and 3 ppm) were seen, in addition to two pairs of doublets in the 
aromatic region (Figure 2.14). This would indicate that for each product, the two pyrimidine 
units are non-identical. The distinctive AMX coupling due to the pyridine ring is also seen for 
each product. 
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Figu.re 2.14 Aromatic regions of the IH NMR spectra of three compounds C and isolated 
from the TF AJTES reaction. Stars and crosses indicate pyrimidine signals that are coupled to 
each other. 
Mass spectrometry revealed that two of the compounds, C and D, both had molecular masses of 
355 and the same molecular formula of C1JIJ3NsOS2 • This corresponds to a loss of HCI from 
the starting material suggesting that they may have cyclised to form the 
pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidine system. Apparently, however, neither had been 
deoxygenated. The other compound, B gave a molecular ion of 339 with the molecular formula 
C16H13NsS2, which is exactly that required by the variolin core structure 2.1. 
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All the data obtained for B is consistent with this structure. With the aid of HSQC and 
HMBC experiments, nearly all of the IH and l3C signals were able to be assigned. However, it 
was unclear which pair of doublets (staned or crossed in Figure 2.14B) belonged to which 
pyrimidine ring. The answer was found by way of a difference NOE experiment. When the 
doublet at 7.36 ppm was irradiated, three other signals displayed enhancement 
One was the doublet at 8.52 ppm (to which the doublet at 7.36 is coupled); another was the 
doublet of doublets at 8.65 ppm (which had already been conclusively assigned to H4); the third 
was the doublet at 8.07 ppm, which belonged to the other pyrimidine ring. Only H5' of could 
exhibit NOEs with three different protons. On the basis of this experiment, the doublet at 7.36 
ppm was assigned to HS' of the pendant pyrimidine ring and therefore, the doublet at 8.07 ppm 
must belong to H6 of the fused pyrimidine ring. There is obviously some steric crowding around 
the biaryl linkage, rendering H4 and H6 of the pyridopynolopyrimidine core close in space to 
HS'. Assignment of the other pyrimidine signals (in both the IH and l3C spectra) followed 
without difficulty (see 2.16). 
6' 6 7 
4 2 
8.6 7.9 7. 9 
NOE irradiation ofHS' of2.1, giving enhancement of three other signals. 
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Figure (a) Important HMBC correlations that helped to confirm the identity of B as 2.1; 
(b) IH and 13C NMR chemical shift values for 2.1. 
The IH NMR chemical shifts of the fused pyrimidine ring are most unusual as H6 is more 
downfield than H7 (which is a. to the nitrogen). Compared to the precursor 2.3, the signal for H6 
has moved downfield by almost 0.7 ppm, while the signal for H7 has moved upfield by just over 
0.7 ppm. These substantial shifts can be explained by a combination of electronic and 
anisotropic effects. Electronically, the fused pyrimidine ring can be regarded as being less 
aromatic than in 2.3, an asseliion which is reflected in the chemical shift values of the ring. 
(This assertion will be further substantiated later in this Chapter.) In a normal aromatic 
pyrimidine, n-polarisation towards the nitrogens leaves the 4- and 6-positions with less electron 
density. Consequently, higher chemical shifts are observed in the IH and l3C NMR spectra for 
these positions. In 2.1, however, there can be no significant delocalisation of the n electrons 
onto either N8 or NIO. This argument explains the lower chemical shift of H7 (and also C7, 
which appears 18 ppm lower than in Why then does H6 appear so far down field? This is 
almost certainly due to its position in relation to the pendant pyrimidine ring. It has been 
demonstrated that HS' promotes significant NOE enhancement for both H4 and H6. Both of 
these protons, therefore, must spend some time in the deshielding zone of the pendant aromatic 
ring. It is well-known that protons which lie around the periphery of an aromatic ring experience 
a greater magnetic field in a NMR magnet than they ordinarily would, due to the induced 
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aromatic ring current. 81 These protons are said to be deshielded and appear at higher chemical 
shifts than normal. This explains the increase of 0.7 ppm in the chemical shift of H6, when 
compared to 2.3. Proton H4 experiences an even greater increase in its chemical shift, appearing 
1.4 ppm further downfield than in 2.3. 
The combination of all the spectroscopic data convincingly proves that the 
pyrido[3',2':4,5]pyrro10[1,2-c]pyrimidine ring system has indeed been produced. However, it is 
important to note that while the variolin core 2.1 was formed in just one step from 2.3, the yield 
of purified material was only 5%. If a practical synthesis of the variolins was to be developed, 
conditions would have to be found that minimised the formation of the other side-products. To 
do so, it was necessary to identify the remaining products C and D, and to reflect on how A, C 
and D may have formed. 
As discussed earlier, products C and D have identical molecular formulas, C16H13N50S2 and 
differ from 2.1 by a single oxygen. From the lH NMR spectrum of C, it appears to contain a 
pyridine unit and two non-identical pyrimidine units (Figure 2.17, following page). In addition, 
the absence of chlorine in its molecular formula indicates that cyclisation to the 
pyridopyrrolopyrimidine ring system may have occurred. This was confirmed by the use of 2D 
NMR spectroscopy, which allowed the determination of two partial structures-the 
pyridopyrrolopyrimidine core 2.40 (which is also found in 2.1) and the remaining 2-
(methylsulfanyl)pyrimidine ring 2.41. However these could not be connected to each other. 
From the molecular formula, the only element unaccounted for is the oxygen. It is assumed, 
therefore, that the two fragments must be separated by oxygen, which gives 2.42 as the structure 
for C. It should be noted that a close structural relationship exists between 2.1 and 2.42 which 
differ only by the presence of an oxygen between C5 and C4'. Some important HMBC 
correlations which helped to determine this structure are shown in Figure 2.183. 
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Figure 2.17 Aromatic region of the 300 MHz IH J\ilVIR spectrum of C. Stars and crosses 
indicate pyrimidine signals that are coupled to each other. 
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Figure 2.18 (a) Important HMBC correlations for 2.42 (C); (b) IH and l3C NMR chemical 
shift values for 2.42. 
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The chemical shifts differ from those in 2.1, exactly as would be expected upon insertion of 
oxygen between CS and C4' (compare Figure 2.18b and Figure 2.16b). In the 13C NMR 
spectrum, CS and C4' both move downfield by 18 and 7 ppm, respectively, with the 
incorporation of an oxygen between them. HS' and CS', on the other hand, move upfield by 0.75 
and 11 ppm respectively, due to the +R effect of the oxygen. CSa experiences a similar effect, 
shifting upfield by 11 ppm. It is interesting to compare the chemical shifts ofH4 and H6 of 
and 2.1. Neither of the protons in the oxygen-containing product experience the anisotropic 
deshielding of the pendant aromatic ring which was observed in 2.1. Their NMR signals appear 
upfield by 0.8 and 1.1 ppm respectively, relative to those in 2.1. Neither is any NOE seen 
between these protons and HS'. Both of these observations are to be expected, if the two ring 
systems are separated by oxygen. These chemical shift arguments give weighty support to the 
structure for which is further substantiated by all of the 2D NMR data (see Figure 2.18). 
The final product (D) possesses some rather different spectroscopic features to the former three. 
For example, one of the pyrimidine rings (starred in Figure 2.19, below) appears to be more 
alkene-like than aromatic, based on the chemical shifts of the IH NMR signals (at 8 S.96 and 
6.76). A distinctive feature in the l3C spectrum is a signal at 8 193, strongly suggestive of a 
ketone. The IR spectrum confirms this with a strong peak at 1732 cm-1, which is typical of a S-
membered ring ketone.82 In the HMBC, correlations from H4 of the pyridine ring (8 7.96) and 
the doublet at 8 S.97 are seen to this carbonyl carbon. 
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Figure 2,19 Aromatic region of the 500 MHz IH NMR spectrum of D. Stars and crosses 
indicate pyrimidine signals that are coupled to each other. 
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Consideration of these findings and other data suggests the partial structure 2.43. This leaves 
only CSa with a free valence to aecommodate the other pyrimidine ring. This is confirmed in the 
HMBC, which displays a correlation from HS' of this ring (7.14 ppm) to CSa. The structure ofD 
is therefore, proposed to be Selected H-C correlations observed in the HMBC are shown in 
Figure 2.20, along with the complete set of IH and l3C NMR chemical shift values. Further 
evidence for the structure is gained from an NOB between and H6, while no NOB is 
observed between HS' and H4 (as was observed with 2.1). This structure also rationalises the 
alkene-like IH NMR signals for the fused pyrimidine ring as no aromatic resonance contributors 
are possible. 
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2.20 (a) Important HMBC correlations for 2.44 (D); (b) lH and l3C NMR chemical 
shift values for 2.44. 
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Thus, a total of four compounds were isolated and identified from the attempted lOllIC 
hydrogenolysis oftriarylmethanoI2.3: 
"Product 2.39 is a rearrangement product of the starting material. 
.. Product B is the desired variolin core structure 2.1, which was thought to have been formed in 
situ from triarylmethane 2.2 (although this intermediate was not observed in the reaction) . 
.. Product C, 2.42 also possesses the pyridopyrrolopyrimidine ring system, although it has 
retained the oxygen from the starting material. 
• Product D, 2.44 is an Isomer of C, in which the 2-(methylsulfanyl)pyrimidine has 
undergone a 1,2-shift. 
~)----SMe N~SMe ):)----SMe N-
-N ~ ~N Mes~ h 0 0 0 
rW N ceo 1 N N/-NyNCI N/- N~ 
SMe SMe 
2.39 (A) 2.1 (8) 2.42 (C) 2.44 (0) 
Several other minor products were formed in the TF AlTES reaction, but only the four discussed 
were isolated and their structures detelmined. It is important to note that three out of the four 
structures possess the pyridopyrrolopyrimidine skeleton found in the variolins. With the mystery 
of their respective struchrres solved, the question of how they were formed had to be answered if 
the formation ofthe undesired products was to be minimised. 
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2.3.2.2 Some Mechanisms which may lead to Products 2.1, 2.44 
It was initially thought that core structure 2.1 was formed from triarylmethanol 2.3 by a step-
wise process involving deoxygenation of 2.3 and reduction of the incipient cation, and then 
cyclisation of the intermediate triarylmethane 2.2. However the fact that triarylmethane 2.2 was 
never detected in the reaction mixture, and the presence of the other cyclised compounds 2.42 
and 2.44, which still contain oxygen, raised the possibility that an alternative mechanism may be 
operating. Further evidence for this alternative mechanism was found when it was attempted to 
cyclise ether 2.39 to form This process would be analogous to the suggested cye1isation of 
triarylmethane 2.2 to produce the variolin core 2.1. It was thought that, in either case, 
elimination ofHCI to give the cye1ised products 2.1 or 2.42 would be a facile process. However, 
when 2.39 was heated at reflux in either toluene or TF A, only starting material was returned 
(Figure 2.21). This was a most-unexpected result, and cast serious doubt on the suggestion that 
triarylmethane 2.2 was an intermediate in the formation of2.1. 
2.39 2.42 
2.21 Attempted cye1isation of 2.39 to give 2.42. 
An alternative mechanism can be envisaged in which cyc1isation of triarylmethanol precedes 
deoxygenation. This would produce the pyrimidinium salt 2.45 Hydride 
reduction at C5a of 2.45 would give 
core 2.1. 
which could eliminate H20 to produce the variolin 
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2.3 2.45 
2.1 2.46 
Figure Proposed mechanism of formation of 2.1, where cyclisation precedes 
deoxygenation. 
The same intermediate 2.45 can also account for the formation of the other cyclised products, 
and 2.44. In the case of incorporation of oxygen into the 4'-position of the pyrimidine 
ring must arise from intramolecular attack of the hydroxyl group at the substituted azomethine 
bond, as shown in path (a), Figure Presumably, protonation of the pyrimidine nitrogen 
(N3') aids this process. This would produce the strained epoxide which could either revert 
to or irreversibly produce 2.42 by breaking the C-C bond of the epoxide. 
Migration of the pyrimidine ring of intermediate 2.45 (path (b), Figure 2.23) would produce a 
new cation 2.48, which is stabilised by the attached oxygen. Deprotonation of the hydroxyl 
group would result in the formation of ketone 2.44. 
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Figure 2.23 Proposed mechanisms of formation of enol ether 2.42 and ketone 2.44. 
This leaves only the uncyclised product 2.39 to consider, with a possible mechanism for its 
formation shown in Figure 2.24. Starting from the triarylmethanol 2.3, an analogous process to 
that shown in path (a), Figure 2.23 would account this product. 
'" 
2.3 2.39 
Figure 2.24 Proposed mechanism of formation of 2.39. 
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2.3.2.3 Observations on the Mechanism of the TF AlTES Reaction 
Of the four products isolated from the TF AlTES reaction, the variolin core is the only 
product in which any reductive process involving TES has occurred. The other three products 
are the result of acid-catalysed processes and should not require TES for their formation. Indeed, 
when trialylmethanol was heated at reflux in neat TF A for 10 h, the starting material was 
completely consumed and all three products 2.39, 2.42 and 2.44 were observed in the crude 
mixture, while no trace of 2.1 could be detected. The following observations are given in an 
attempt to clarify the processes involved in the TF AlTES reaction. 
" If the reaction with TF A, alone, is subjected to basic workup, ketone 2.44 is isolated as the 
major product with small amounts of 2.39 and 2.42 also being produced. 
" If the reaction mixture is simply concentrated (without workup), IH NMR analysis of the paste 
reveals a new product which is the major component of the mixture (see Figure A 
CH2Clz-solution of X is relatively stable to water, however when exposed to base (5% aq 
NaHC03 solution), ketone 2,44 is produced, together with small amounts of2.39 and 
.. If the reaction is repeated with the inclusion of TES (2 equivalents), the same product IS 
produced after 10 h (although not as cleanly). Basic workup, again, produces ketone 
Small amounts of the variolin core 2.1 are also present in the crude mixture . 
.. If the reaction (with the inclusion of TES) is left for 66 h, X is not observed (pre-workup). 
Basic workup gives the variolin core as the major product. Ketone 2.44 is not observed. 
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Figure 2.25 500 MHz IH NMR spectrum of X. Stars and crosses indicate pyrimidine signals 
that are coupled to each other. 
These observations suggest that the following mechanistic pathways operate: 
Heating 2.3 in TF A initially forms intermediate X, which we propose to have the structure 2.45 
(Figure 2.26). This product is stable in acidic solution, and in the presence of TES, it reacts 
slowly to give the variolin core 2.1. A competing pathway involves rearrangement of X to enol 
ether 2.42. If, on the other hand, X is subjected to basic workup, it immediately rearranges to the 
ketone 2.44. The uncyc1ised product 2.39 does not form through X, but is rather produced from 
2.3 as described earlier. 
Chapter Two Synthesis of the Variolin Core and Deoxyvariolin B 66 
2.1 
2.3 2.42 
2.45 (X) 
\ ~asic 
\workuP 
2.39 
2.44 
Figure Proposed mechanistic pathways leading to products from the TF AlTES reaction. 
The foregoing discussion has covered some intriguing aspects of the TF AlTES reaction, 
including the successful identification of some side-products and possible mechanisms of their 
formation. Much of the latter is merely speculation. However speculation is useful, if it leads to 
conclusions which can be tested experimentally. 
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2,3,2.4 A Stabilised Triarylmethyl Cation? 
It was surmised that the three highly electron-deficient heterocyclic rings make the triarylmethyl 
cation 2,38 (p 48) prohibitively high in energy. Therefore, it was decided to investigate the ionic 
hydrogenolysis of an alternative triarylmethanol, 2.49. The carbocation produced by ionisation 
of this alcohol is expected to be considerably stabilised over 2,38, due to the electron-donating 
anisole ring. If the cation could be produced, reduction with TES would produce a 
triarylmethane 2,50 (Figure 2,27). This compound could be used to ascertain whether the 
cyclisation of a triarylmethane to the pyridopyrrolopyrimidine ring system 2.51 is achievable. 
OMe OMe MeO 
2.49 2.50 2.51 
Figure 2,27 Proposed use of an electron-rich triarylmethanol for the formation of a 
pyridopyrro lopyrimidine system. 
Triarylmethanol 2.49 was readily produced by reaction of 4-methoxyphenyllithium with the 
biaryl ketone 2,11 (Scheme 2,5). When this was heated with TES (1.2 equivalents) in excess 
TF A, a yellow product was cleanly produced, which was clearly neither triarylmethane 2,50 nor 
the pyridopyrrolopyrimidine compound 2.51. MS and NMR analysis led to the identification of 
the product as 2,52. Slow evaporation of a hexanes solution of 2.52 gave green needles, which 
were analysed by X-ray crystallography. The results from the diffraction analysis confirmed the 
structure of2,52 (see Figure 2,28). 
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Scheme 2.5 Reagents and yields: (i) BuLi (1 equiv)/THF/-78 °C120 min, then 2.11 (1 equiv)/-97 °C to 
rt (45%); (ii) TES (1.2 equiv)/TFAIreflux (53%). 
Figure 2.28 X-ray crystal structure of 2.52. Aromatic protons have been omitted for clarity. 
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An explanation as to how this interesting structure might be formed is shown in ...,"' ....... "" It 
is believed that the electron-donating anisole ring does, indeed, allow the formation of a 
stabilised carbocation However, before this can be reduced by TES, intramolecular attack 
of the pyrimidine ring on the anisole ring gives intermediate 2.54. This requires only the loss of 
a proton to give the reaction product, formally a pyrimido[1,6-a ]indole. Evidently, this model 
system offers no insights as to how the yield of the variolin core might be improved. 
2.3.2.5 Optimisation of the Yield of Variolin Core Structure 2.1 
It was reasoned that since products 2.39, 2.42 and 2.44 are produced by acid-catalysed processes, 
their formation might be minimised by decreasing the ratio of acid to reducant in the reaction. A 
series of experiments was conducted which led to the optimisation ofthe reaction for the variolin 
core Table clearly shows that reducing the amount of acid in the reaction, as well as 
increasing the proportion of reducing agent, had a beneficial effect on the yield of . The best 
results were obtained when 2.3 was heated at 75°C for 66 h, with 4 equivalents of TF A and 8 
equivalents of TES (Entry 4). Under these conditions, 2.1 was isolated in 34% yield. The 
relative proportions of2.1, 2.39 and 2.42 were 140: 5 : 13 Gudging by IH NMR analysis of the 
crude material). Ketone 2.44 was not detected in the reaction mixture. Reducing the amount of 
TF A below 4 equivalents did not further improve the yield of 2.1 (Entry 5). 
Entry Equiv ofTFA EquivofTES Yield of 2.1 (%) 
1 8.3 2.0 15 
2 8.2 4.0 18 
3 8.2 8.0 22 
4 4.3 8.1 34 
5 2.0 7.8 33 
Table Optimisation of the reaction conditions for the synthesis of 2.1 from 
• 2.3 (500 mg) was heated with TF A and TES under argon, at 75°C for 66 h. Yields refer to purified 
products. 
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This result was most pleasing and represents a significant improvement on the initial 5% yield of 
While a yield of 34% may seem modest, it is important to realise that the variolin core 
has been generated in just three steps from commercially available 4-chloro-2-
(methylsulfanyl)pyrimidine. Sufficient quantities of would now be available to investigate 
its elaboration to deoxyvariolin B (1.50). 
Summary 
After a considerable amount of effort directed towards the reduction of triarylmethanol 2.3, the 
TF AJTES reaction has been determined to be a feasible, and indeed, successful approach to the 
variolin core 2.1. Triaryhnethanol 2.3, which is produced in just two steps from commercially 
available materials, can be directly converted to 2.1 in 34% yield. While only one new bond has 
been created in this process, the transformation constitutes a significant increase in molecular 
complexity, by creating a fused tricyclic ring-system from a simple triaryl-substituted methanol 
precursor. This methodology would hopefully allow the synthesis of deoxyvariolin B (1.50), and 
should be able to be adapted to provide a synthesis of the natural product variolin B (1.17). 
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2.4 Elaboration the Variolin Core 
Completion of the synthesis of deoxyvariolin B (1.50) requires substitution of the thiomethyl 
groups of with amino groups. Generally, such a procedure involves two distinct steps: 
oxidation of the thiomethyl groups to either sulfoxides or sulfones, followed by displacement 
with an appropriate amine. Brown and Ford have demonstrated that simple 2-chloro, 2-
(methylsulfinyl) and 2-(methylsulfonyl)pyrimidines are all of comparable reactivity m 
nucleophilic displacements with alkyl amines.83 An earlier study84 showed that 2-
chloropyrimidines were 05 times more reactive than 2-(methylsulfanyl)pyrimidines *. The 
corollary inferred83 was that oxidation of a (methylsulfanyl)pyrimidine to either the 
corresponding sulfoxide or sulfone would improve the rate of aminolysis by >105-fold. 
2.4.1 Direct Substitution of Thiomethyl Groups 
In certain cases, however, thiomethyl groups have been directly displaced by ammes, or 
synthetic equivalents, without prior oxidation. For example, Kos and van der Plas have shown 
that reaction of2-(methylsulfanyl)purine (2.55) with potassium amide in liquid ammonia gave 2-
aminopurine (2.56) in 90% yield (Scheme 2.6).85 This reaction, although simple in appearance, 
proceeds through a ring-opening mechanism in which the amide anion attacks exclusively at the 
6-position of the purine. The mechanism was determined by the use of 15N-labelled potassium 
amide. When position 6 of purine was blocked by a methyl substituent, nucleophilic attack did 
not occur at any other position.86 Both the complex mechanism involved in formation of 
and the absence of nucleophilic attack at the 2-position of 6-methylpurine make this procedure 
unsuitable for substitution of the thiomethyl groups in 2.1. 
N:):N " 
* 
*J:N KNHz/NH3 N:>' I ~ A I ~ If 
H NAN N MeS N ~ 90% z H 
2.55 2.56 
Scheme 2.6 
* The trivial telTIl thiomethyl is used throughout this thesis, while methylsulfanyl is used for proper names. 
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Acetamide has also been used in nucleophilic substitutions as a synthetic equivalent for 
ammoma. For example, the thiomethyl group of 2.57 was displaced in 81 % yield by the 
acetamide anion (Scheme 2.7).87 The amide was deprotected later in the synthesis, in 84% yield, 
by heating in aqueous TF A, to complete a total synthesis of the nucleoside antibiotic 
cadeguomycin (2.58). 
-
-
81% 
2.57 2.58 
cadeg uomyci n 
Scheme 2.7 
In this reaction, the nucleoside substrate can be considered an extended Michael acceptor due to 
the a,lf-y,c5-unsaturated carbonyl group. Its presence may render 2.57 a more reactive 
electrophile than, for example, the 2-(methylsulfanyl)pyrimidine attached at C5 of the variolin 
core 2.1. Even so, the reaction required rather harsh conditions, proceeding at 135°C in the 
presence of excess sodium acetamide and absence of a solvent. Attempted application of this 
methodology to the variolin core 2.1 gave a complicated product mixture. No attempt was made 
to identify any of the products-it was uncertain whether the pyridopyrrolopyrimidine nucleus 
had even survived the reaction conditions. 
2-(Methylsulfanyl)pyrimidines, or related compounds, have occasionally been substituted with 
amines or synthetic equivalents under neutral conditions. For example, reaction of 2.59 with 
excess hydrazine hydrate resulted in substitution of the thiomethyl groups in 71-76% yield 
(Scheme 2.8).88 The hydrazine functions were subsequently nitrosated to give azides 2.60, 
which were later reduced with zinc dust in acetic acid to yield amines 2.61 in 54-58% yield. 
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The same substrates 2.59 were also directly substituted (under acid catalysis) with a variety of 
anilines to give amines 2.62. 
2.62 
ArNH2' 
cone HCI (caL), 
180-200°C 
46-67% 
R1, R2 = Me or 
R1, R2 = -(CH2)4-
2.59 
2.61 
Scheme 2.8 
NH2NH2@H20, 
reflux 
.. 
71-76% 
-
-
69-71% J ~~~?c!' aq Hel, 
2.60 
In all of the examples mentioned, the substitutions are performed on fused derivatives of the 
pyrimidine nucleus. However, the 2-thiohexyl group of pyrimidine 2.63 undergoes direct 
substitution with a variety of amines at 80 DC in dioxane (Scheme 2.9).89 As there are two sites 
for substitution, mixtures of products 2.64 and 2.65 were isolated. While substitution of the 
more activated 4-SMe group occurred more readily, appreciable yields of products 2.65 were 
obtained. Selective substitution ofthe thiohexyl group could be achieved when the hexyl S-atom 
was oxidised to the sulfoxide using m-CPBA, prior to aminolysis. 
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1. m-CPBA (1.2 equiv) 
66-96% 2. amine, dioxane, 
rt-80 °C 
2.65 
2.64 
+ 
Amine 
2.65 
Yield (%) of 
2.64/2.65 
58/40 
63/32 
74 
1\ 
o N-CH2CH2NH2 55/33 
"---! 
Scheme 2.9 
The prospect of introducing both amines into the variolin core in a single step, without the 
need for S-oxidation, held significant appeal and thus, pyrrolidine was chosen as a convenient 
nucleophile to examine this possibility with. Heating of2.1 with excess pyrrolidine (20 equiv) in 
dioxane at 80°C for 28 h (as described in reference 89) resulted in the clean formation of a new 
product. Judging from the IH NMR spectrum, substitution of just one of the thiomethyl groups 
had taken place. This was readily deduced as only one thiomethyl peak (at 8 2.65) was 
observed, in addition to two signals from the eight methylene protons of the pyrrolidine moiety. 
It appeared that it was the 9-SMe group which had been replaced, based on the chemical shift 
differences between the starting material and product. Application of 2D NMR spectroscopy, 
and comparison with the and l3C chemical shifts of the starting material, confirmed that the 
product was indeed 2.66, as shown in Scheme 2.10. 
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2.1 2.66 
Scheme 2.10 Reagents and yields: (i) pyrrolidine (20 equiv)/dioxane/80 °C (50%) 
While it was not possible to displace both thiomethyl groups, this result was very encouraging as 
it meant that nuc1eophiles should be able to be selectively introduced at C9. Provided that 
oxidation of the 2'-SMe group was achievable, other substituents could then be introduced at this 
position, thus enabling a series of related analogues to be synthesised. Efforts to this end are 
described in Chapter Four. If identical substituents were required at C9 and C2' (as for 
deoxyvariolin B and variolin B), the most direct route would entail S-oxidation followed by 
aminolysis at both positions simultaneously. Accordingly efforts were turned towards the 
oxidation of the thiomethyl groups of the variolin core 2.1. 
Oxidation/Nucleophilic Substitution of Thiomethyl Groups 
Many systems have been described for the oxidation of sulfides.9o In many cases, the reaction 
can be controlled, allowing isolation of either the sulfoxide, or if excess oxidant andlor higher 
temperatures are used, the sulfone. In the present case, it should not matter which product was 
favoured as both have been shown to be of comparable reactivity to amine nuc1eophiles (see 
discussion above). Due to the presence of two non-identical thiomethyl groups in several 
oxidised products were possible. Either of the sulfurs could be oxidised to the sulfoxide or 
sulfone, in addition to the possibility of both sulfurs being oxidised. Thus, up to eight products 
were possible. [n addition, the chiral nature of the sulfoxides could lead to further 
diastereomeric products. However, even if several products were obtained, aminolysis of the 
clUde mixture should, in theory, give only one product-a bis-amine. The only requirement, it 
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seemed, was that the 2'-SMe group be oxidised, at least to the sulfoxide, as it has already been 
shown that the 9-SMe group is readily displaced without requiring oxidation. 
A cheap and convenient reagent which has been extensively used in the oxidation of thiomethyl 
groups is Oxone®,90c which contains 49.5% potassium peroxymonosulfate (KHSOs) as the active 
oxidant. When 2.1 was treated with 6 equiv of Oxone® in THF/water at room temperature, the 
starting material was consumed after 30 min. The major component of the mixture was the 
sulfoxide 2.67, as determined by IH NMR spectroscopy and MS analysis (Scheme 2.11). 
Scheme 
2.1 2.67 x = 1 
2.68 x 2 
Reagents and yields: (i) Oxone® (6 equiv)/aq THF/rt (2.67 24%). 
In this situation, the chemical shifts of the SOxCH3 signals (x = 0, 1 or 2) are diagnostic of the 
oxidation level of the sulfur. In 2.1, the thiomethyl groups give rise to singlets at 8 2.68 and 
2.74, while sulfoxide 2.67 displayed peaks at 8 2.74 and 3.03. The second value is fairly typical 
of 2-(methylsulfinyl)pyrimidines.91 The signals for H5' and H6' display similar shifts, moving 
downfield by 0.36 and 0.25 ppm, respectively, upon oxidation of the sulfide (Figure 2.29). 
Conclusive evidence for the position of oxidation was obtained from the HMBC. A correlation 
from the sulfoxide protons (8 3.03) to C2' (8 173.6) showed that it must be the pendant 
pyrimidine ring that has been oxidised. The analogous position of the fused pyrimidine ring (C9) 
has a quite different chemical shift of 8 155.6. As with 2.1, H5' showed strong NOEs to three 
other protons: H6', H4 and H6. 
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Figure 2.29 1H and BC NMR chemical shifts of (a) the variolin core structure 
sulfoxide 2.67. 
and (b) 
Closer examination of the 1H NMR spectrum of the crude reaction mixture revealed a small 
singlet at cS 3.41, which probably corresponds to the sulfone 2.68 (Scheme 2.11). This <:i-value is 
typical of the S02CH3 protons of 2-(methylsulfonyl)pyrimidines.47,91 A trace amount of 
oxidation of the 9-SMe group to the sulfoxide may be indicated by a very small peak at cS 3.22. 
This selectivity in oxidation is interesting and can be explained with a mechanistic understanding 
of sulfide oxidation. Most sulfide oxidising agents (including Oxone®) are electrophilic in 
nature. The mechanism of oxidation involves nucleophilic attack by sulfur on the oxidising 
agent, as shown in Figure 2.30. Such a mechanism explains why sulfoxides are oxidised less 
readily than the comparatively electron-rich sulfides (and why they can often, therefore, be 
isolated before further oxidation to the sulfone occurs). In 2.1, the non-bonding electrons of the 
sulfur at C9 must be delocalised, to some extent, within the fused pyrimidine ring of the variolin 
core--they are less available, therefore, for oxidation by an electrophilic oxidant than those of 
the sulfur at C2'. 
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The low yield of 2.67 (24%) was due, in part, to the difficulties experienced in chromatography. 
These products tend to stick to silica and consequently elute over many fractions, making 
separation from other products very difficult. This seems to be a general phenomenon for 
compounds derived from the variolin core 2.1. For example, flash chromatography of 2.1, 
following the guidelines given by Still and coworkers,92 caused the product to elute over more 
than 15 fractions. Three consecutive purifications were required to obtain the bulk of the 
product in a pure state. 
In the case of 2.67, however, the low yield was not solely attributable to losses from 
chromatography. A yellow precipitate was observed in the reaction, which was not soluble in 
either aqueous or halogenated solvents. Longer reaction times led to increased amounts of 
precipitate, while shorter reaction times left significant amounts of starting material unreacted. It 
was speculated that the insoluble material may be a product of pyridine N-oxidation. 
While it was encouraging to find that the use of Oxone® allowed the selective oxidation of the 
SMe group, this reagent did not provide the clean oxidation that is typical of most sulfides and 
was therefore not suitable for the present synthesis. One drawback of the Oxone® reagent (other 
than the poor results of the reaction) was that it required water-soluble solvents-2.1 is only 
modestly soluble in such solvents. As 2.1 has good solubility in CH2Ch and chloroform, it was 
decided to find a homogeneous oxidant that performs well in these solvents. 
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The obvious choice was m-chloroperoxybenzoic acid (m-CPBA), a strong (albeit, not very 
selective) oxidant which is routinely used in CH2Cb or chlorofonn. When 2.1 was stirred at 
room temperature with 4 equivalents of m-CPBA, a yellow precipitate fonned almost 
immediately. As with the precipitate encountered earlier, this was insoluble in both aqueous and 
organic solvents. Suspecting that N-oxidation may once again have taken place, the reaction was 
repeated, but using only 1.9 equivalents of m-CPBA at -15°C. This time, no yellow precipitate 
was produced, and TLC analysis indicated the fonnation of several products of greater polarity 
than 2.1. The major product appeared to be the bis-sulfoxide 2.69, judging from the IH NMR 
spectrum of the crude mixture. As with mono-sulfoxide 2.67, the signals for the SMe protons 
had moved downfield significantly, appearing at 8 3.03 and 3.23 for 2.69. As 2.69 contains two 
sulfoxide groups, the molecule can exist in four diastereomeric fonns (two pairs of enantiomers). 
The diastereomers should give rise to slightly different signals in the 1 H NMR spectrum. Indeed, 
IH NMR analysis showed that the compound is a 1:1 mixture of diastereomers. In some cases, 
the signals for the two diastereomers can almost be resolved, while other signal pairs completely 
coincide. 
2.69 
Closer examination of the IH NMR of the reaction mixture indicated the presence of mono-
sulfoxide 2.67. In addition, a very small peak was observed at 83.4, which probably indicates a 
small amount of sulfone, as observed in the Oxone® oxidation. It appears then, that as with 
Oxone®, the 2'-SMe group is oxidised by m-CPBA to the sulfoxide faster than the 9-SMe group. 
However, the selectivity differs from that seen with Oxone®, in that the remaining thiomethyl 
group (9-SMe) is then oxidised to the sulfoxide, in preference to oxidation of 2'-SOMe to the 
sulfone. 
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It should be noted that the only products observed were those of S-oxidation, with none of the 
insoluble precipitate seen earlier being fonned. Thus, the stage is set for the introduction of the 
amino groups. It was decided to use a protected amine rather than ammonia itself, even though 
this would require at least one extra step in the synthesis (for amine deprotection). The desired 
product of this reaction, bis-protected amine 2.70, would be more easily handled than 
deoxyvariolin B (1.50), both in tenns of polarity and solubility. Variolin B was found to be 
extremely insoluble in all solvents other than DMSO/2a and deoxyvariolin B was expected to 
exhibit similar properties. p-Methoxybenzyl (PMB) groups were chosen as they are readily 
removable by a variety of methods, whereas the deprotection of benzylamines cannot always be 
easily realised.93 Hopefully, reaction conditions could be found for clean deprotection of 2.70, 
so that minimal purification of 1.50 would be required. 
ii 
2.1 2.69 2.70 
Scheme 2.12 Reagents and yields: (i) m-CPBA (1.9 equiv)/CHCb/-15 DC; (ii) p-methoxybenzylamine 
(26 equiv)/90 DC (62% from 2.1). 
Thus, the crude oxidised mixture was taken, without further purification or characterisation, and 
heated in neat p-methoxybenzylamine. After 14 h at 90 DC, TLC analysis showed just one 
yellow spot. Careful flash chromatography allowed the isolation of the desired product 2.70 in 
62% yield over the two steps (Scheme 2.12). The presence oftwo PMB groups was clearly seen 
in the IH NMR spectrum. In addition to the aromatic and methoxy signals, two doublets were 
observed at () 4.69 and 4.89 for each of the benzyl methylene groups. The first doublet was 
coupled to a broad signal at () 5.52, assigned to the 2'-NH proton. The second doublet was 
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coupled to a slightly broadened triplet at b 10.36, which was assigned to the 9-NH proton. The 
downfield chemical shift of this signal can be explained by hydrogen bonding to the pyridine 
nitrogen (N1), which has been seen in the natural product variolin B.32a Interestingly, when the 
NMR sample of 2.70 was shaken with D20, this proton did not exchange. This provides further 
confirmation of a strong hydrogen bond between these two atoms. No hydrogen bond acceptor 
is available for the 2'-NH proton, hence its appearance much further upfield. The signals from 
the pyrimidine protons all move upfield, as expected, upon introduction ofthe electron-donating 
ammes. 
The introduction of both amine functionalities in one step was a pleasing result. In addition to 
taking the synthesis of deoxyvariolin B (1.50) one step closer to completion, this methodology 
should allow incorporation of an almost limitless range of amines (and presumably other 
nucleophiles), the products of which can be tested in a range of assays for potency and other 
desirable pharmacological properties. 
2.4.3 Removal of the p-Methoxybenzyl Protecting Groups 
The removal of both N-protecting groups would result in a concise synthesis of deoxyvariolin B. 
It would also validate this methodology for application to the natural product variolin B (1.17). 
p-Methoxybenzyl groups are often removed under oxidative conditions, occasionally with DDQ 
(2,3-dichloro-5,6-dicyano-1,4-benzoquinone),94 but more commonly with CAN (ceric 
ammonium nitrate).93 Attempted deprotection of 2.70 with DDQ produced a number of minor 
products, but mainly starting material was retained. The use of CAN led to a complex mixture in 
which no variolin-type compound could be detected. 
Another simple method for deprotection of PMB groups, although not so commonly used, 
involves standing the protected amine in neat TF A at room temperature.95 This was deemed 
appropriate for the variolins, as they are reported to be stable to acid and, indeed, are most easily 
handled as their trifiuoroacetate salts.3230 Dissolving 2.70 in TF A immediately produced a 
blood-red solution. After 24 h, TLC analysis indicated that a significant portion of starting 
material remained, so the reaction was heated at 60°C. After 3 h at this temperature, one major 
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product was observed, which was of greater polarity than 2.70. From the NMR spectrum of 
the crude reaction mixture, it appeared that only one PMB group had been removed. 
When the stronger acid triflic acid was used, a new product of even greater polarity was 
produced after just 4 h at room temperature (Scheme 2.13). The crude NMR spectrum (in 
DMSO-d6) contained just seven aromatic signals, consistent with what would be expected from 
deoxyvariolin B (1.50). Purification of the product from the PMB bypro ducts proved difficult, 
requiring the use of reversed phase chromatography. A yellow band eluted (when 70% 
MeOHlwater + 0.1 % was used as the eluant) to give an acidic product. This was 
neutralised with solid potassium carbonate and extracted with boiling CH2Cb (in which it is only 
sparingly soluble), to afford deoxyvariolin B in an acceptable yield of 56% . 
.. 
2.70 
Scheme 2.13 Reagents and yields: (i) triflic acid/rt (56%). 
1.50 
deoxyvariolin B 
The IH NMR spectrum, shown in Figure 2.31, contains seven aromatic signals and displays no 
peaks below 6.5 ppm, consistent with the removal of both N-protecting groups. The usual 
NMR experiments were used to assign the 'H and J3C signals. As with 2.1, the pyrimidine 
signals were assigned with the aid of an NOE experiment. Thus, H5' (8 7.05) exhibited NOEs 
with three other protons: H6' (its coupling partner, 8 8.22), H4 (dd, 8 8.90) and H6 (87.67). The 
signals for the NH2 protons are similar to those seen for variolin B. The 2'-NH2 protons give rise 
to a sharp singlet at 8 6.51, integrating for two protons. Two broad signals at 8 8.5 and 9.4 are 
seen for the 9-NH2 protons. As with variolin B (1.17), this is explained by restricted rotation 
around the C9-N bond which is, itself, a consequence of hydrogen bonding between one of the 
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9-NH2 protons and Nl of the pyridine ring. The hydrogen bonded proton is not as deshielded as 
that of va rio lin B, whose signal appears at 8 9.8. This difference is best explained by the absence 
of the hydroxyl group on the pyridine ring of variolin B. Its electron-donating effect would 
make Nl of variolin B a stronger hydrogen bond donor than that of deoxyvariolin B, with the 
consequence that the 9-NH proton ofvariolin B is more deshielded. 
/ 
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Figure 2.31 500 MHz IH NMR spectrum of deoxyvariolin B (1.50) in DMSO-d6. The 
phasing artefact at 8 9.4 is of unknown origin, and was also present in the spectrum of the 
solvent alone. 
Further comparisons ofthe IH and I3C NMR data can be drawn between deoxyvariolin B and the 
natural product variolin B from Table The major differences lie in positions 3 and 4a (due 
to the +R effect ofthe hydroxyl group of va rio lin B), and C4 (due to the -1 effect of the hydroxyl 
group). Also noteworthy is H6 of deoxyvariolin B, whose signal appears almost 0.5 ppm 
downfield of that in the natural product. This is presumably due to the anisotropic deshielding 
effect of the pendant pyrimidine ring (see discussion on p 55). H4 also gives rise to an urlUsually 
downfield signal, presumably for the same reason. 
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position 
2 
3 
4 
4a 
5 
5a 
6 
7 
9 
lOa 
2' 
4' 
5' 
6' 
9-NH2 
9-NH2 
2'-NH2 
4-0H 
Table 2.2 
(1.17).32a 
IH (ppm) l3C (ppm) 
L50a 1.17b 1.50c 1.50d 1.17 
8.44 8.14 8.51 140.3 143.2 143.8 
7.57 6.78 7.64 121.0 107.6 120.7 
8.90 8.99 129.4 159.9 129.1 
121.7 111.2 121.6 
99.6 99.6 99.5 
138.3 137.1 142.8 
7.67 7.19 7.70 101.9 100.4 101.7 
7.62 7.61 7.76 144.0 144.6 140.1 
149.9 150.3 163.5* 
143.0 145.0 149.7 
163.6 158.4 161.4* 
161.6 161.5 138.2 
7.05 7.11 7.12 107.1 106.1 106.8 
8.22 8.25 8.29 158.2 160.1 158.0 
8.5 8.5 
9.4 9.8 
6.51 6.95 6.63 (IH) 
16.0 
IH and l3C NMR chemical shifts for deoxyvariolin B (1.50) and variolin B 
a Recorded in DMSO-d6 at 500 MHz. b These values have been adjusted by -0.12 ppm from those in the 
original paper, so that the solvent reference peak (0 2.62) corresponds to the present system (0 2.50 ppm). 
C These values reported by Alvarez, Fernandez and 10ule.38 (No value was provided for the solvent 
reference peak.) d Recorded in DMSO-d6 at 75 MHz. 
The ]\lMR data for deoxyvariolin B (1.50) repolted by Alvarez, Fernandez and louIe has also 
been included in the Table. The IH chemical shifts of this thesis are consistently lower than 
those of Alvarez et al., probably due to differences in solvent referencing. However, it is likely 
that H6 and H7 have been confused by these workers-an easy trap to fall into if assigmnents are 
based solely on chemical shift arguments. Their 13C assignments also appear to be rather 
muddled. Chemical shifts are likely to differ, somewhat, with small differences in pH and 
Chapter Two - Synthesis of the Variolin Core and Deoxyvariolin B 85 
possibly the amount of water present in the solvent. However, their chemical shifts compare 
very well to those obtained in this thesis (all are within 0.3 ppm); therefore, it is their 
assignments which are at fault. It should be emphasised that all new comounds in this thesis 
were characterised by 2D NMR techniques (COSY, HSQC and HMBC or CIGAR experiments). 
If any uncertainties regarding signal assignments existed, these are made clear in the 
Experimental section ofthis thesis (Chapter Six). 
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2.5 Summary 
Using the strategy shown in 2,1, a convenient and direct synthesis of the 
pyrido[3"2':4,5]pyrrolo[I,2-c ]pyrimidine ring system, found in all of the variolins, has been 
realised. Conditions were found to optimise the formation of the variolin core structure 2.1, 
which was produced in just three steps from commercially available materials. In addition, the 
route was extended to provide a six-step synthesis of deoxyvariolin B (1.50), which is 
summarised in Scheme 2.14. The overall yield of this sequence was 5.2%. This compares 
favourably to the synthesis reported by Alvarez et aI., which proceeded in 2.2% yield over 14 
steps.38 
This work employs a strategy which should be readily adapted to a total synthesis of the natural 
product variolin B (1.17). It has also been highlighted that the method is particularly suited to 
the production of analogues which vary in their substituents at C9 and C2'. This will allow 
structure-activity-relationship (SAR) studies to be undertaken, which may result in new leads for 
potential drug-development. 
Chapter Two - Synthesis of the Variolin Core and Deoxyvariolin B 87 
N~SMe 
N X 
~ /, N 
iii 
~ 
NyN 
SMe 
2.13 X::: CI 
2.12 X= I 2.3 2.1 
J j, 
0 
\\ 
N.:::{NH2 .:::{NH{PMB) N~SMe N-.. 
~ /,N ~ /, N ~ /, N 
v 
<I 
1.50 2.70 2.69 
deoxyvariolin B 
Scheme 
o 
2.4 CI~ 
CI N 
Reagents and yields: (i) 55% aq HVrt (79%); (ii) n-BuLi (1 equiv)/THF/-95 °C, 30 min 
then 2.4 (0.33 equiv)/THFI-95 °C, 3.5 h (56%); (iii) TFA (4 equiv)/TES (8 equiv)175 °C 
(34%); (iv) m-CPBA (1.9 equiv)/CHCh/-15 °C; (v) p-methoxybenzylamine (26 equiv)/90 
°C (62% from 2.1); (vi) triflic addlrt (56%). 
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Triarylmethanoll.65 
As has been discussed in Chapter Two, a direct route to the pyrido[3',2':4,5]pyrrolo[1,2-
c ]pyrimidine ring system found in the variolin natural products has been developed, employing 
the tandem deoxygenationlcyclisation of a triarylmethanol as the key step. Having shown that 
this methodology was applicable to a synthesis of deoxyvariolin B, our attention turned to the 
application ofthis methodology to the synthesis of variolin B (1.17). 
The retrosynthetic analysis for variolin B is displayed in Figure 3.1. It must be noted that this 
has been modified slightly from the original plan discussed in Chapter One due to the results 
obtained for the deoxy-system (Chapter Two). The retrosynthesis differs from that of 
deoxyvariolin B by the requirement of the hydroxyl group in the natural product. In our 
retrosynthetic plan, this group is protected as the methyl ether throughout most of the sequence. 
At some stage, its deprotection would be required. It was intended that this would be carried out 
after the variolin core had been constructed, however, the exact order of steps may depend upon 
the reactivity, stability and ease of handling of the intermediates in the sequence. 
1.17 
variolin B 
1.63 
Figure 3.1 Retrosynthetic analysis of va rio lin B (1.17). 
> 
1.66 
1.65 
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Acid Chloride 1.67 
Adaptation of the methodology developed in Chapter Two to variolin B (1.17) requires access to 
2-chloro-4-methoxynicotinoyl chloride (1.67). While neither this compound, nor the parent 
carboxylic acid, have been reported in the literature, the bromo analogues have.96 Kasum and 
Prager generated 2-bromo-4-methoxynicotinic acid (3.1) via an efficient four step sequence 
shown in Scheme . This compound was required as an intermediate in the proposed synthesis 
of the alkaloid perloline. First, condensation of ethyl cyanoacetate (3.2) with trimethyl 
orthoacetate (3.3) gave ethyl 2-cyano-3-methoxybut-2-enoate (3.4). This product contains the 
methoxy group that would later be found at position 4 of the nicotinic acid. Heating with 
dimethylformamide dimethyl acetal gave enamine 3.5, which could be readily cyclised to 
bromopyridine 3.6 by treatment with anhydrous HBr in acetic acid. The ester was hydrolysed 
with aqueous sodium hydroxide solution to give the carboxylic acid 3.1. 
OMe 
Et02C~CN HOAc, ~ Et02CY-Me + (MeOhCMe jIio 
80% CN 
3.2 3.3 3.4 
85% I Me,NCH(OMe)" 
o 140 QC 
OMe HBr, HOAc, OMe 
RO,Cn 50-75 QC EtO,Cn I ~ .. 89% CN NMe2 Br N 
3.6 R Et 3.5 
aq NaOH, reflux 
80% 
3.1 R = H 
Scheme 3.1 
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If anhydrous HCI could be substituted for HBr, the chloro analogue of 3,6 should be produced. 
Indeed, bubbling dry HCI gas through a solution of 3.5 (produced by Kasum and Prager's 
method) in acetic acid produced the desired chloropyridine 3.7 (Scheme 3.2). This was partially 
purified by vaccum distillation, with the remaining impurities being conveniently removed in the 
following step. A minor product of this reaction was 2-chloro-4-methoxypyridine (3.8). This 
must be formed by ester hydrolysis and subsequent decarboxylation, although it is not known if 
this occurs before formation of the pyridine ring, or after. Hydrolysis of ester 3.7 provided the 
carboxylic acid 3.9 in 77% yield for the two steps. No purification was necessalY, other than 
repeated washing of an aqueous alkaline solution of 3.9 with an organic solvent. Refluxing 3.9 
in thionyl chloride with catalytic DMF did not cleanly produce the desired acid chloride 1,67, 
which is in contrast to the deoxy-equivalent 2.4. However, 1.67 was formed in 97% yield when 
oxalyl chloride was used in place of thionyl chloride. 
3.2 
i, ii iii 
+ 
3.3 
3.5 
.. 
iv [ 
v[ 
3.7 R OEt 
3.9 R =OH 
1.67 R cr 
+ 
3.8 
Scheme 3.2 Reagents and yields: (i) HOAc/b. (70%); (ii) Me2NCH(OMe)i140 °C (79%); (iii) dry 
HCIIHOAc/65-70 °C; (iv) 1.5M aq NaOWreflux (77% from (v) (COCl)icat. 
DMF/CH2Ch/rt (97%). 
Addition Jl.AJUUl"Jl.JI. .... to Acid Chloride 1 
Use of the Lithiated "JUJU, ... u .• .., 1.66 
With a straightfOlward route to the acid chloride, the double addition of lithio-species 1.66 was 
attempted using the conditions previously established for the synthesis of trialylmethanol 2.3. 
Disappointingly, after 4.5 h at °C, the triarylmethanol 1.65 was isolated in less than 15% 
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yield (Scheme 3.3). The side-products of the lithiation step were, once again, all 
observed in the present reaction. In fact, the deiodinated pyrimidine 2.20 was the major 
component of the mixture. However, two other products were isolated from the reaction-the 
biaryl ketone 3.10 and biaryl alcohol 3.11. These products are analogous to ketone 2.11 and 
alcohol 2.23, which were formed as side-products during the synthesis of triarylmethanol 
(Chapter Two). Both 3.10 and 3.11 were present in greater quantities than the triarylmethanol 
1.65, with the ketone 3.10 being formed in ~25% yield and the alcohol 1 in 15% yield. 
ii 
2.12 1.66 
1.65 
2.20 2.21 2.22 
3.10 3.11 
....,."' .... "' ..... '" 3.3 Reagents and yields: (0 n-BuLi (1 equiv)/THP/-95 °C, 30 min; (ii) 1.67 (0.33 
equiv)/THF/-95°C, h «15%). 
When the reaction was quenched at °C with deuterated methanol (CH30D), both 4-deuterio-
2-(methylsulfanyl)pyrimidine (2.27) and the methyl ester 3.12 were observed. As discussed in 
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Chapter Two, this clearly indicates that both the lithio-species 1.66 and acid chloride 1.67 were 
present in the reaction mixture at the time of quenching. Evidently, longer reaction times would 
be required to improve the yield of the triarylmethanol Clearly, the presence of large 
amounts of the ketone 3.10 also leads to this conclusion. 
o OMe Meo)6 
CI N 
2.27 3.12 
Conducting such a reaction for extended periods requires regular top-ups of the cooling bath 
(MeOH/liquid N2) with liquid nitrogen to ensure that the temperature does not rise above -95°C. 
An all-night vigil allowed the reaction to be stirred at -95 °C for at least 20 h, followed by 
gradual warming to room temperature. * Every precaution was taken to ensure optimum results. 
These included the use of standard inert atmosphere techniques; freshly purified solvents and 
reagents; the use of the reactor described in Chapter Two (Figure 2.8, p 41); slow, smooth 
addition of reagents (both n-BuLi and acid chloride 1.67); and careful monitoring of the cooling 
bath temperature, such that it never rose above -93°C. Much to our consternation and disgust, 
the IH NMR spectrum of the crude material showed only trace amounts of the desired 
triarylmethanol1.65. The major product was, once again, the deiodinated pyrimidine 2.20. This 
was foHowed closely by the product of mono-addition, ketone 3.10. A small, but significant, 
amount of the methyl ester 3.12 was also present as the reaction was quenched (after warming 
somewhat) with methanol. As usual, small amounts ofthe biaryl alcohol 
and the trim eric product 2.22 were also present in the mixture. 
, bipyrimidine 2.21 
The conclusion from this egregious result is that the second addition of the lithio-species 1.66 to 
the ketone is extremely slow at dc. This is in contrast to the double addition of 1.66 in 
the deoxy-series, where good yields of triarylmethanol 2.3 were obtained after 3.5 h at -95 DC. 
The presence of the methoxy group on the pyridine ring must greatly hinder attack at the 
• Julian Browne is gratefully acknowledged for taking part of the "night watch". 
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carbonyl group of both the acid chloride 1.67 and the biaryl ketone 3,10. A crystal structure of 
the ketone was obtained and is shown in Figure 3,2. In this structure, the two aromatic rings lie 
almost orthogonal to each other. This causes the methoxy group and the chlorine of the pyridine 
ring to block both faces of the carbonyl group, making attack by a nucleophile-particularly a 
large one such as the pyrimidinyllithium 1.66--extremely difficult. 
Figure 3,2 
clarity. 
X-ray crystal structure of 3,10. Aromatic hydrogens have been omitted for 
The sensitivity of these reactions to temperature should be highlighted. Product ratios differed, 
somewhat, from one reaction to another. It seems that slight (unintentional) increases in 
temperature resulted in greater amounts of the triarylmethanol being formed. But this would be 
accompanied by increased proportions of side products such as the biarylmethanol 3,11. In no 
instance was the triarylmethanol ever isolated in greater than 15% yield. 
3,1.2,2 DMPU as Cosolvent 
To improve this reaction, it was necessary to both increase the nucleophilicity of the 
heteroaryllithium species and decrease its basicity, so as to favour attack at the carbonyl group 
over unwanted side-reactions. Additives such as hexamethylphosphoramide (HMPA)97 and, 
more recently, N,N'-propyleneurea (DlVIPU)98 have been widely used to increase the 
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nucleophilicity of organometallic reagents. Organolithium and magnesium reagents commonly 
form oligomeric structures in non-polar or weakly polar solvents (hydrocarbons, diethyl ether). 
In more strongly coordinating solvents such as THF, these aggregates are broken down to some 
extent, which has the effect of increasing the reactivity of the organometallic reagent.99 The 
addition of dipolar cosolvents such as HMP A or DMPU can cause further deaggregation to give 
monomeric species. HMP A has also been shown to coordinate to the lithum cations of a number 
of organolithium species,100 leaving a "naked" anion with enhanced nucleophilicity. 
It was thought that the use of a polar cosolvent may enhance the nucleophilicity of 1.66. For 
these studies, t-BuLi (two equivalents) was used for lithium-iodine exchange to avoid the 
generation of the potentially reactive n-BuI, which would be formed if n-BuLi was used. The 
use of two equivalents of t-BuLi destroys any alkyl iodide produced, as t-BuI immediately 
eliminates HI in the presence of the second equivalent of base to produce 2-methylpropene and 
isobutane (Figure 3.3), which normally do not interfere with subsequent reactions. lOl DMPU 
was chosen as the cosolvent, primarily due to its lower toxicity when compared to the highly 
mutagenic HMP A. 
Ar-I + t-8uLi 
lithium-iodine 
exchange 
Ar-U + +1 
t-8uU 
- HI 
Figure 3.3 Lithium-iodine exchange using t-BuLi as metallating agent. 
+ 
However, lithiation of iodopyrimidine in THF using two equivalents of t-BuLi, followed by 
the addition of DMPU (10% volume relative to THF) and then acid chloride did not 
improve the outcome of the reaction. In fact, the only recognisable product in the mixture was 
the familiar pyrimidine The presence of various signals in the lH NIVlR spectrum at 8 
5.5 may indicate nUcleophilic addition to the 1t-deficient heterocyclic rings to give dihydro-
pyridines and/or -pyrimidines. As a consequence, the use of polar cosolvents was not explored 
any further. 
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Organocerium Reagents 
Organocerium reagents have been shown to be considerably less basic than the corresponding 
organolithium or Grignard reagents, while being of comparable or greater nucleophilicity.lo2 
These reagents have been especially useful for nucleophilic addition to enolisable carbonyl 
groups, whereas the more basic organolithium and Grignard reagents often give low yields due 
to competitive enolisation. 
The organocerium reagents are generally derived by transmetallation of either organolithium 
species at low temperature (-78 DC) or Grignard reagents at 0 DC. If the cerium equivalent of 
1.66 could be generated, it may provide an effective means of avoiding unwanted side-products 
and increasing the yield of the triarylmethanol 1.65. It may also allow higher reaction 
temperatures to be used if it is less prone to protonation than 1.66. The lithio-species was 
generated at -95°C in the usual manner and a suspension of dry CeCb in THF,102a which had 
also been cooled to -95°C, was transferred to the yellow-brown solution. A colour-change to 
red-brown was observed and the solution was allowed to stir for 0.5 h at -80°C, after which 
time, the acid chloride 1.67 was introduced. However, prolonged stirring at this temperature 
gave no triarylmethanol1.65, nor even the ketone 3.10. Despite quenching the reaction with 
methanol, the methyl ester was not isolated either. In fact, the only pyridine-containing product 
appeared to be the starting material, acid chloride 1.67, which must have survived both 
methanolysis and aqueous workup The major product was, once again, the pyrimidine 2.20, 
accompanied by small amounts of 2.21 and 2.22. 
When the reaction was repeated, but using reverse addition (i.e. the cooled lithio-species 1.66 
was added to CeCh via a cannula), the results were the same except that much more of the 
bipyrimidine was present (and correspondingly less 2.20). The predominance of III 
this case is probably due to significant warming of the unstable lithio-species during transfer, 
even though it had been cooled to below -100°C immediately before transfer. Even so, some 
active aryl-metal species (either lithium or cerium) was still present after 3.5 h at -78°C, as 
evidenced by quenching with CH30D. However, it should be reiterated that the only pyridine-
containing species observed in any significant amount was the starting material 1.67. Neither the 
biaryl ketone 3.10 nor triarylmethanol1.65 were produced. 
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When the ketone 3.10 was used as the electrophile in place of the acid chloride, starting material 
was again recovered, along with the usual pyrimidine byproducts. It has been observed that 
amine and alkoxide ligands greatly reduce the reactivity of organocerium species, presumably by 
coordination to the cerium. 102b It is possible that the abundance of heterocyclic nitrogens in the 
present system may contribute to the pyrimidinylcerium species' pronounced unreactivity. 
However, it is unclear if the cerium reagent had even formed. In any case, it was evident that 
this line of work offered no improvements to the synthesis oftriarylmethanol1.65. 
3.1.2.4 Pyrimidinyl Grignard Reagents 
Around this time, Queguiner and coworkers reported their investigations into the use of the 
pyrimidinyl Grignard reagent 3.13.56 This species is formed from the iodide 2.12 by iodine-
magnesium exchange with i-PrMgCI and is reported to be stable at 0 °C. Reaction with a limited 
range of electrophiles gave moderate to good yields of substituted pyrimidines 3.14 (Scheme 
3.4). 
(YI 
i-PrMgCI, 
[ (yM9Clj o °C, 0,5 h II> NyN NyN 
SMe SMe 
2.12 3.13 
Electrophile 
PhCHO 
NC-COOEt 
DMF 
Scheme 3.4 
electrophile, 
o °C, 2-12 h 
.. 
E 
PhCH(OH) 
C5H11 CH(OH) 
-COOEt 
-CHO 
(YE 
NyN 
SMe 
3.14 
Yield (%) 
57 
55 
35 
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It was hoped that would be reactive enough to add to acid chloride 1.67 at 0 DC. However, 
after stirring the two reagents at 0 °C for 3.5 h and quenching with CH30D, the major product 
was the pyrimidine 2.20, along with some of the deuterated equivalent 2.27. A significant 
amount of the bipyrimidine 2.21 had also formed at this temperature. Only traces of the 
triarylmethanol 1.65 were observed and the ketone 3.10 was present in even lower amounts. 
Surprisingly, the acid choride was not recovered, either in that form or as its methyl ester 
When the reaction was repeated, but at -78°C (after formation of the Grignard species at 0 DC), 
the deuterated pyrimidine 2.27 was, by far, the major product. Again, almost none of the methyl 
ester was produced, despite quenching with CH30D at -78°C and then allowing to warm to 
room temperature. It appears that the acid chloride is destroyed by the Grignard reagent. In both 
reactions, it was noted that upon addition of the acid chloride, a sudden colour change from 
brown to bright red occurred. This may be due to the acid chloride coordinating/chelating to the 
magnesium centre. How this then decomposes is not known. 
The use of the methyl ester 3.12 (at room temperature) or ketone 3.10 (at 0 DC) as electrophiles 
gave essentially no reaction. In each case, only trace amounts of 3.10 or triarylmethanol 1.65 
respectively were observed. When DMPU was used as cosolvent with the ketone as electrophile, 
again, no reaction occurred. Transmetalating to cerium from the Grignard reagent was equally 
unsuccessful, returning the ketone and pyrimidine byproducts. In this case, a series of small 
peaks in the NMR spectrum between 05.00 and 7.20 may indicate a small amount of addition 
to the p)'lidine or pyrimidine rings(s). However, no addition to the carbonyl group took place, as 
was not present in the crude mixture. 
Figure 3.4 summarises the attempted variations using the Grignard reagent 3.13. The failure to 
produce any ofthe desired triarylmethanol1.65 meant that a new strategy for its synthesis would 
have to be developed. 
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o OMe 
~ ~Y~CI)tNJ 
~Me o °C (with or without DMPU) 
Figure 3.4 
3.13 
Attempted reactions with Grignard reagent 3.13. 
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3.2 An Alternative Synthesis of Triarylmethanol1.65 
3.2.1 Strategy 
Having explored a variety of options for the metalation of iodopyrimidine 2.12, most of which 
had met with resounding failure, a new strategy was developed for the synthesis of 1.65 (Figure 
3.5b). The new approach employs an alternative disconnection to that shown in Figure 3.5a. 
These two approaches can be compared to the general approaches to triarylmethanols depicted in 
Figure 2.2b and c, p 32. The disconnection shown in Figure 3.5b would generate the 
symmetrical biaryl ketone 3.15 and a lithiated pyridine 3.16. It was hoped that the use of the 
alternative aryllithium species would allow higher temperatures to be used than was possible for 
the unstable pyrimidinyllithium species 1.66. The latter would still be required, however, for 
generation of the symmetrical ketone by reaction with a suitably reactive electrophile (Figure 
3.5b ). 
cySMe JySMe /.:N HO iSe HO~S > ~\: I ~ I ~ /1 ~ 
NyNCI N NyNCI N/.: 
SMe SMe 
b 
JySMe 
/.:N 
I ~ 0 
NyN 
SMe 
3.15 
+ 
+ 
Li~e 
)t . .J CI N 
3.16 
1.66 X = leaving group 
Figure 3.5 (a) Previous disconnection of 1.65; (b) New approach to triarylmethanol1.65. 
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3.2.2 Synthesis of the Pyridine 
A literature search of 2-chloro-4-methoxypyridine (3.8), the precursor required for the generation 
of lithiated pyridine 3.16, revealed only a few reports of its synthesis and use. 103, 104,105 
Encouragingly, these reports detailed the lithiation of 3.8 at C3 using either LTMpl04 or LDAI05 
at -78 DC, to form the required lithio-species 3.16. However, it was stated that attempted 
lithiation of 3.8 using alkyllithium reagents (n-, s- or t-BuLi) failed due to competing substitution 
or halogen-metal exchange. \05 
While 3.8 was observed as a minor side-product in the formation of the pyridine carboxylic ester 
3.7 (Scheme 3.2), a more practical route was required for the new approach to triarylmethanol 
1.65. Finger and Starr have produced 2-chloro-4-nitropyridine (3.17) in three steps from 2-
chloropyridinel06 (Scheme 3.5). The nitro group of 3.17 has been substituted with sodium 
methoxide in refluxing methanoll03 or dioxanel05 to produce 3.8 in 77% and 55% yields 
respectively. 
~ ~NA.CI 
o 
HO, )( 
o Me, HOAc, Ll 
80% 
... 
OMe 
~ 
IN,lCI 
3.8 
Scheme 3.5 
69% 
NaOMe, MeOH 
or dioxane, reflux 
55-77% 
91 0/ j PCI3, /0 EtOAc, Ll 
J;' lNJ-.CI 
3.17 
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Walters and Shay have reported that 3.17 could be produced in one step by treating 4-
nitropyridine-N-oxide with a mixture of POCh and PCls. 104 However, no experimental details 
were given and attempts to repeat the reaction in this Department failed to produce any of the 
chloropyridine 3.8. 107 
In the end, 4-nitropyridine-N-oxide was converted to the desired 2-chloro-4-methoxypyridine by 
a three-step procedure, which is outlined in Scheme 3.6. The nitro group was displaced by 
sodium methoxide, following Ochiai's general procedure,108 to give 4-methoxypyridine-N-oxide 
(3.18) in 75% yield. * Attempts to directly convert the N-oxide 3.18 to 2-chloro-4-
methoxypyridine (3,8) using POCb 109 or mixtures of POCh and PC15 failed. Oxalyl chloride 
with catalytic or stoichiometric DMF was also ineffective, while refluxing in thionyl chloride 
resulted in deoxygenation to give 4-methoxypyridine in 82% yield. However, the N-oxide 3.18 
could be isomerised to 4-methoxy-2-pyridone (3.19) in 61 % yield, following a literature 
procedure. llo This involved heating 3.18 in refluxing acetic anhydride and subsequent 
hydrolysis of the acetoxy intermediate. The pyridone was converted to 3.8 by heating in 
POCh. lll Inconsistent results were obtained when this reaction was performed at reflux. 
Inattention to the temperature of the oil bath was the cause. It is thought that as the reaction 
progresses, phosphoric acid (or a related phosphorus-product) is produced which raises the reflux 
temperature of the mixture. If a particularly hot oil bath is used, the internal temperature rises 
significantly, resulting in lower yields of product. When the oil bath temperature was 
maintained at 95°C, consistent results were obtained and 3,8 was isolated in 79% yield. 
N02 OMe OMe OMe 
6 6 ii Q iii oc\ Ii< Ii< l> 
+N +N N 0 N~ CI I I H 
-0 -0 
3.18 3.19 3.8 
Scheme 3.6 Reagents and yields: (i) NaOMe (l equiv)/MeOHIrt (75%); (ii) AC20/refiux then aq 
MeOHIrt (61 %); (iii) POCb/95 °C (79%). 
• While 3.18 is commercially available from Aldrich Chemical Company, it was convenient to prepare it from 4-
nitropyridine-N-oxide, which is also available from these suppliers at a substantially lower cost. 
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3.2.3 Synthesis of the Symmetrical Ketone 
The other component required for the synthesis oftriarylmethanol1.65 is the symmetrical ketone 
3.15. Symmetrical biaryl ketones have been formed by metal carbonyl-catalysed carbonylations 
of aryl halides1l2 or aryl mercuric species,113 or by reaction of aryllithium reagents with an 
appropriate carbonyl compound (e.g. diethyl carbonate ).114 Due to our familiarity with the 
pyrimidinyllithio-species 1.66, the latter option was adopted. 
Lithiation of 2.12 in the usual manner (n-BuLi, THF, -95°C in the reactor described in Figure 
2.8) produced the lithiated pyrimidine 1.66 (Scheme 3.7). A solution of diethyl carbonate (0.5 
equivalents) in THF was added slowly and the reaction was allowed to warm slowly to room 
temperature. Between -75 and -70°C the dark brown solution took on a cherry-red colour, 
which intensified to deep violet on further warming. The major component of the crude mixture 
did indeed appear to be the desired ketone 3.15, judging by IH NMR spectroscopy. The product 
gave only two aromatic signals-a pair of doublets at 8 7.54 and 8.79. These values compare 
well to the pyrimidine signals of the non-symmetrical ketones 2.11 and 3.10. A singlet was also 
present at 8 2.51, representing the thiomethyl protons. Pleasingly, only very small amounts of 
the lithiation byproducts 2.20 and 2.21 were present and 2.22 was not detected in the mixture at 
all, in contrast to the use of2.12 in the syntheses oftriarylmethanols 2.3 and 1.65. 
0 
nYl [ nYUl ii nY~ NyN ~ NyN ~ NyN NyN 
SMe SMe SMe SMe 
2.12 1.66 3.15 
Scheme 3.7 Reagents and yields: (i) n-BuLi (1 equiv)/THPI-95 °e, 30 min; (ii) diethyl carbonate (0.5 
equiv)/THPI-95 °e to rt (53%). 
When subjected to flash chromatography, the product exhibited unusual behaviour, smearing 
badly on silica (although it did elute, given enough solvent) and sticking to alumina (only eluting 
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with methanoVethyl acetate mixtures). After some experimentation, it was found that it was 
most convenient to distil the crude product under high-vacuum in a Kugelrohr apparatus (3.15 
melts at 106 °e and distils at 160 °e, 0.03 mm Hg), and then to remove the remaining impurities 
by flash chromatography on silica. In this manner, the pure ketone could be isolated in 53% 
yield. 
When ethyl chloroformate was used as the electrophile in place of diethyl carbonate, the ketone 
was not produced as cleanly. Pyrimidine byproducts 2.20 and 2.21 were both present in greater 
quantities than when diethyl carbonate was used, and a new product was observed. Although 
this product was not isolated, it is most likely the symmetrical triarylmethanol 3.20, produced 
from the addition of three equivalents of the lithio-species 1.66 to ethyl chloroformate. It 
displays a pair of doublets in the IH NMR spectrum at 0 7.49 and 8.48 and a broad peak at 0 
6.15. These values compare fairly well to the pyrimidine and OH signals oftriarylmethanols 2.3 
and 1.65. 
3.20 
When the Grignard reagent 3.13 was used in place of 1.66, the reaction with diethyl carbonate 
gave only small amounts of the ketone, with deiodinated pyrimidine 2.20 and bipyrimidine 2.21 
being the major products. If ethyl chloroformate was the electrophile, no ketone could be 
detected. Thus, despite the greater stability of the magnesium species, the lithiated pyrimidine 
1.66 has proven to be the superior reagent in the author's experience. 
Formation of the 
"".lllL"""'A""""".)''' 1.65 
As has been mentioned, 2-chloro-4-methoxypyridine (3.8) has been lithiated between the 
chlorine and the methoxy group using either LTMp 104 or LDA105 at -78 °e, to give the lithiated 
pyridine 3.16 (Scheme 3.8). In both of these reports, the lithio-species thus generated was used 
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as a precursor to 4-methoxy-2,3-pyridyne (3.21 )-warming the reaction to room temperature 
results in elimination of LiCL Evidence of pyridyne formation is seen by in situ trapping with 
furan to give the Diels-Alder adduct 3.22. 
OMe 
Jr 
l-NJlCI 
3.8 
LTMP or LOA, 
THF, -78·C 
[ 
OMe 1 O( 
N CI 
3.16 
Scheme 3.8 
o o OMe ¢cD 30-37% 
3.21 3.22 
As it was the lithio-species 3.16 that we required, the formation of the pyridyne was the cause of 
some concern-it was not known how readily elimination ofLiCl from 3.16 would occur. It was 
hoped that the lithio-species would be stable at -78 DC and reactive enough to add to the 
symmetrical ketone 3.15. 
It should be noted that with either LTMP or LDA, starting material was recovered from the 
reaction (37% in the case ofLDA). Comins and LaMunyon have found that when LDA is used 
to deprotonate ortho to the methoxy group of 3- and 4-methoxypyridines, only low amounts 
of deuterium incorporation are obtained when the reaction is quenched with D20.41 This was 
ascribed to the existence of an equilibrium between LDA and the metalated pyridine, in which 
the position of equilibrium lies in favour of LDA and the pyridine (Figure 3.6). Clearly, LDA 
was too weak a base in this situation. 
OMe 
6 
N 
+ 
)-
Li-N )-
OMe 
~Li 
~.) 
N 
)-
+ H-N )-
3.6 Equilibrium between 4-methoxypyridine/LDA and the metalated pyridine/ 
diisopropy lamine. 
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In the case of 2-chloro-4-methoxypyridine (3.8), the inductive effect of the chlorine would 
increase the acidity of H3 relative to H3 of 4-methoxypyridine. However, the fact that starting 
material was isolated when either LTMP or LDA were used suggests that these bases do not 
effect complete deprotonation of 3.8. For this reason, it was decided to examine the metalation 
of 2-chloro-4-methoxypyridine (3.8) with a variety of alkyllithium bases, even though Connon 
and Hegarty have claimed that n-, s- and t-BuLi could not be used to lithiate 3.8.105 
As mesityllithium has been successfully used by Cornins to deprotonate 4-methoxypyridine, this 
base was applied to the present situation. Comins' optimum conditions for metalation involve 
stirring the reagents at °C for 3 h, followed by introduction of the electrophile. However 
these conditions would not be suitable for 2-chloro-4-methoxypyridine (3.8) as pyridyne-
formation is likely to occur at this temperature. Therefore, 3.8 and mesityllithium (1.1 
equivalents) were stirred at -78°C for 1 h and quenched with CH30D. Under these conditions, 
only starting material was isolated-no deuterium was incorporated into the pyridine nucleus. 
Presumably, this very hindered base requires higher temperatures to deprotonate the pyridine and 
is therefore unsuitable in the present situation. 
When t-BuLi was used at -78°C, the major component of the mixture appeared to be the result 
of nucleophilic addition (85% of the mixture, judging by 1 H NMR spectroscopy). The addition 
product was not isolated, but is presumed to be dihydropyridine 3.23, in which the t-butyl group 
has added to the unsubstituted azomethine bond. This is a surprising result, based on the 
observation of Connon and Hegarty that exclusive lithium-chlorine exchange occurred between 
t-BuLi and 2-chloro-4-phenoxypyridine. 105 However, some metalation had occurred in the 
present case, with about 8% of the deuterated pyridine 3.24 being present in the mixture, in 
addition to a similar amount of starting material 3.8. 
3.23 3.24 
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When n-BuLi was employed as metalating agent, the situation was markedly improved. After 
stirring the pyridine and n-BuLi (1.1 equiv) in THF at -78°C for 1 h and quenching with 
CH30D, deuterated pyridine 3.24 was produced in 84% yield Gudging by IH NMR 
spectroscopy). Some starting material (~7%) was still present and a small amount of addition 
product (~9%) was also observed. When the lithiation was repeated at lower temperature (-95 
DC), the addition product was virtually eliminated, although some starting material was still 
present (~13%). Pleasingly, no products indicative ofpyridyne formation, or oflithiation at C5 
were observed, either at -78 or -95°C. Over the course of the lithiation at -78°C, an intense 
dark cherry colour developed, which may be due to trace amounts of pyridyne. However, at -95 
DC, the colour of the solution never progressed any further than orange. 
These findings indicate that n-BuLi is an effective base for the deprotonation of 3.8, in contrast 
to claims otherwise. It remained to see if the lithiated pyridine 3.16 would react with the ketone 
3.15 to provide the desired triarylmethanol. Pleasingly, when the two reagents were stirred at -
78°C for 10 h, followed by quenching with methanol at this temperature, triarylmethanol 1.65 
was isolated in 57% yield-a significant improvement on the previous method. It was 
subsequently found that 3.5 h at -78°C was sufficient time for reaction to occur, as quenching 
with CH30D gave no deuterated pyridine 3.24. However, it was observed that a significant 
amount of unreacted pyridine 3.8 was returned (~35% by IH NMR analysis). When 3.8 was 
freshly distilled prior to use, however, the amount of pyridine remaining after quenching the 
reaction was reduced to ~ 12%. Despite the incomplete consumption of 3.8, triarylmethanol1.65 
was isolated in a yield of 76%, based on ketone 3.16 (Scheme 3.9). The presence of unreacted 
3.8 may indicate that the metalation step required longer times or excess n-BuLi. However, 
neither of these (nor the combination of both) had any effect on the amount of 3.8 which 
remained. Therefore, it may be that 3.8 is produced on quenching of the lithiated pyridine 3.16 
with an adventitious proton source. In any case, recovery and recycling of starting materials 
would add to the efficiency of the process. 
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Scheme 3.9 Reagents and yields: (i) n-BuLi (1 equlv)/THFI-95 to -78°C, 1 h; (ii) 3.15 (0.93 
equiv)/THFI-95 to DC, 3.5 h (76%). 
3.2.5 Summary 
Using the lithiation methodology established for the synthesis of triarylmethanol 2.3 (Chapter 
Two), it was difficult to obtain consistent results and the desired triarylmethanol 1.65 was 
produced in a maximum of 15% yield. No improvement on the yield was seen when different 
metal-species (magnesium and cerium) were employed and consequently, the approach was 
abandoned. 
The second approach involved reacting a lithiated pyridine 3.16 with a symmetrical 
bipyrimidinyl ketone 3.15. The pyridine precursor 3.8 was generated in three steps from readily 
available 4-nitropyridine-N-oxide, while the ketone was formed by reaction of the lithiated 
pyrimidine 1.66 with diethyl carbonate. Conditions were found for the successful lithiation of 
3.8, and the resulting lithio-species 3.16 could be reacted with to give the desired 
triarylmethanol in 76% yield. While an extra step is required in this synthesis of 1.65 compared 
to the former approach, the overall yield is much improved (40% from iodide compared to 
<15%). Importantly, this synthesis of 1.65 is a very reproducible process which glves 
consistently high yields, in contrast to the difficulties encountered in the former approach. 
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Formation aV'A~'" Core 1 
Now that a reliable synthesis of the triarylmethanol 1.65 had been developed, its cyclisation to 
the variolin core could be investigated. Based on the successful use of the TF AlTES 
hydrogenolysis pair on the deoxy-system, this methodology formed the basis of our approach to 
the methoxy-containing variolin core 1.63. 
TF A1TES "Ionic Hydrogenolysis" of Triarylmethanol1.65 
3.3.1.1 Preliminary Results 
The methoxy-containing triarylmethanol 1.65 was subjected to the same conditions (4 
equivalents TF A, 8 equivalents TES, 70°C) that had been optimal for the deoxy-system. One 
major component was observed in the IH NMR spectrum of the crude mixture, which, by all 
appearances was a rearrangement product, 3.25. This is analogous to compound 2.39, which was 
isolated as a side-product in the formation of the deoxy-variolin core 2.1 (Chapter Two). A 
minor product appeared to be the desired core structure 1.63. Flash chromatography allowed the 
isolation of the two compounds in 54% and 9% yields respectively. 
N=;:" Mes--\-{ 5" 
o OMe 
3.25 1.63 
Spectroscopic analysis of the purified products confirmed their structures. The uncyclised ether 
displays two separate thiomethyl signals in its IH NMR spectrum at 8 2.36 and 2.44, and a 
methoxy signal at 8 3.84. Each of these peaks integrate for three protons. In the aromatic 
region, seven well-separated signals were observed, each integrating for one proton (Figure 3.7). 
Most prominent was the singlet corresponding to the central methine proton, appearing at 87.79. 
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The remaining signals (three pairs of doublets) correspond to the protons on the three, non-
equivalent aromatic rings. 
H6' H6" H6 H* HS' HS" HS 
i I 'I Ii Ii (l i t J Ii ti i Ii I i q J II I II iii I Ii i ij iii iii i i ij iii i I' i i It iii II iii J Ii i I I I I I It I I I I I I' I I , I I I I I f 1 I , I I I i I I I i I I I I i I I 
B.6 B.4 B.2 8.0 7.B 7.6 7.4 7.2 7.0 6.S 6.6 ppm 
Figure 3.7 Aromatic region of the 500 MHz IH NMR spectrum of3.25. 
The IH NMR signals of the variolin core 1.63 match very well to those of the deoxy-equivalent 
2.1 (see Figure 3.8). The main differences lie in the pyridine ring, due to the methoxy group at 
C4. As there are only two protons on this ring, rather than three in 2.1, the signals appear as 
doublets-not doublets-of-doublets as seen in 2.1. The +R effect of the methoxy group shifts the 
signal of H3 0.6 ppm further upfield than is seen in the deoxy-core 2.1. The signals for H6 
and H7 of 1.63 all appear ~0.1 ppm upfield of the same signals of 2.1, while the signals for the 
pendant pyrimidine ring (HS' and H6') are relatively unchanged. As with 2.1, H6 appears more 
downfield than H7, presumably for the same reasons-a combination of the electronic nature of 
the fused pseudo-pyrimidine ring and the anisotropic deshielding effect associated with the 
aromatic ring current of the pendant pyrimidine ring. 
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3.8 Aromatic regions of the 500 MHz IH NMR spectra of (a) the variolin core 1.63, 
and (b) the deoxy-equivalent 2.1. 
In the l3C NMR spectrum, no major differences are seen between the two compounds except for 
positions 3, 4 and 4a. Specifically, C3 and C4a shift upfield by 19 and 10 ppm respectively upon 
introduction of the electron-donating methoxy group, while C4 moves downfield by 32 ppm due 
to the -I effect ofthe oxygen. 
It should also be pointed out that MS analysis confmned the molecular formula of 1.63. While 
comparison of the NMR chemical shifts of 1.63 and the deoxy-equivalent provided good 
evidence for the structure of 1.63, MS analysis was necessary to prove the absence of oxygen in 
the formula. Thus, the product must be the desired variolin core and not a structure 
analogous to the oxygen-containing compounds and 2.44 discussed in Chapter Two. 
The low yield of 1.63 was rather disappointing. However, it must be noted that the reaction 
proceeded much more cleanly than in the deoxy-system. Even with the best conditions for 
formation of the deoxy-variolin core several other side-products (both identified and 
unidentified) were present in significant amounts. In the present system, however, any other 
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side-products comprised only a very minor part of the mixture. It is interesting that no products 
analogous to 2.42 and were detected in the reaction mixture. 
3.3.1.2 Optimisation of of the VarioHn Core 1.63 
A comprehensive senes of reactions were carried out to determine the best conditions for 
formation of the variolin core 1.63. The use of a solvent, less TF A and longer reaction times all 
had beneficial effects on the yield of 1.63. However, the greatest improvement was observed 
when the reaction was conducted at higher temperatures in a sealed tube. The optimum 
conditions found consisted of heating 1.65 (100 mg) with TFA (2 equivalents), TES (8 
equivalents) and 1,2-dichloroethane (DCE) (0.5 mL) in a sealed tube at 100°C for 43 h. In this 
manner, the variolin core was isolated as a yellow solid in 47% yield (Scheme 3.10). The 
uncyc1ised ether 
28% yield. 
1.65 
was the only other significant component of the reaction, being isolated in 
N4 sMe ~ /, NOMe Mes~:( 
0 OMe 
+ ceo NyNCI N"':': 
SMe 
1.63 3.25 
Scheme 3.10 Reagents and yields: (i) TFA (2 equiv)/TES (8 equiv)IDCEIlOO 
28%). 
(1.63 47%, 3.25, 
As explained for the deoxy-system in Chapter Two, it is assumed that anses from 
intramolecular attack of the hydroxyl group at C4 of a pyrimidine ring (Figure 3.9). 
Presumably, protonation of the pyrimidine ring aids this process. Two strategies were devised to 
minimiselblock this pathway. It was thought that using a weaker acid would favour protonation 
of the more basic pyridine ring over the pyrimidine ring. This should favour formation of the 
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desired variolin core 1.63 over the uncyclised product However, conducting the reaction in 
acetic acid (without DCE as solvent) gave only starting material. 
1.65 3.25 
Figure 3.9 Proposed mechanism of formation of 3.25. 
3.3.2 Alternative Substrate for the TF AlTES Reaction 
3.3.2.1 Improved Synthesis of the Variolin Core 1.63 
The alternate strategy was to block the hydroxyl group's ability to act as a nucleophile by 
protecting it in some form. As discussed in Chapter Two, functionalisation of triarylmethanol 
2.3 as either the xanthate or methyloxalyl ester was unreliable, at best. The present system poses 
a more difficult situation, being more hindered around the hydroxyl group. However, the alcohol 
may be able to be protected with a simpler, more stable group such as an acetyl group. If 
hydroxyl protection could be achieved, the pathway shown in 3.9 would be effectively 
blocked. Cyclisation to the variolin core, however, should not be adversely affected. 
Acetylation of triarylmethanol was effected with acetic anhydride, triethylamine and 
catalytic 4-( dimethyl amino )pyridine (DMAP) in CH2Cb. Acetylation of alcohols under these 
conditions usually proceeds with ease at room temperature. In this case, however, the 
conversion proved to be a very slow process, even at reflux. Several further additions of 
reagents were required throughout the course of the reaction. After eight days, the conversion 
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was about 97% complete, judging by IH NMR spectroscopy. The sluggishness of this reaction is 
testimony to the extremely hindered nature of the central hydroxyl group of this compound. 
The nuc1eophilicity of the triarylmethanol 1.65 should be increased if the alcohol was 
deprotonated to the alkoxide. As the required alkoxide is generated in the synthesis of the 
triarylmethanol, quenching this reaction at -78 °e with acetyl chloride may provide a method of 
producing the acetate without the need for an extra step. Pleasingly, using the same conditions 
for formation of triarylmethanol except that the alkoxide was quenched at -78 °e with 
acetyl chloride, triarylmethylacetate 3.26 was readily produced, with the alcohol not being 
detected (Scheme 3.11). After chromatography, acetate 3.26 was isolated in 68% yield. 
3.8 
Scheme Reagents and yields: (i) AC20 (3 equiv)/Et3N (2 equiv)/cat. DMAP/CH2Ch/reflux 
(97% conversion after 8 days); (ii) n-BuLi (1 equiv)/THF/-90 °C to -78 °C, 1 h then 3.15 
(1 equiv)/THF/-90 °C to -78°C, 3 h then AcC! (4 equiv)/-78 °C to rt (68%). 
The NMR spectrum of 3.26 is similar to that of the a1coholl.65. A new peak at 8 2.30 was 
observed for the acetyl protons, while the OH peak of 1.65 had disappeared. Small shifts (up to 
0.2 ppm) were seen for the other signals. Two extra peaks were noted in the l3e NMR spectrum 
for the carbonyl and methyl carbons, while the IR spectrum confirmed the presence of the ester 
group with a strong peak at 1755 cm- I . In the EIMS spectrum, the molecular ion (mlz 463) was 
barely detectable, with strong peaks at mlz 428 (- el) and 421 (- Ac, + H). The base peak, 
however, was at mlz 369, which corresponds to the loss of chlorine and the acetoxy group. It is 
tempting to speculate that this ion possesses the structure of the variolin core 1.63, and it was 
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hoped that this facile fragmentation in the mass spectrometer would be reproduced in the 
forthcoming reaction. 
To this end, the acetate 3.26 was treated to the same conditions that were used for reaction of the 
triarylmethanol 1.65 (2 equivalents TF A, 8 equivalents DCE, sealed tube). However, 
before the oven had warmed to 100°C, it was noted that the visible appearance of the mixture 
was quite different to what had previously been observed. The mixture had developed a dark 
yellow-brown colour which had come to be associated with fOlmation of the variolin core. In 
addition, an orange-brown solid had precipitated out of solution-also indicative of the variolin 
core. What was most surprising was that these observations were noted after justO.5 hat 80°C 
or less! The reaction was left: at 80 °C for a total of 26 h and, after cooling to room temperature, 
was worked up as usuaL Other than triethylsilyl byproducts, the crude material consisted of 
essentially pure variolin core structure 1.63! No trace of the uncyclised product could be 
detected. The product was obtained in a pure state in 75% yield, after flash chromatography on 
silica (Scheme 3.12). * 
3.26 1.63 
Scheme 3.12 Reagents and yields: (i) TFA (2 equiv)/TES (8 equiv)/DCE/80 °C, sealed tube (75%). 
This gratifying result demonstrates the value of positively identifying unwanted side-products of 
a reaction, in order that steps may be taken to minimise/eliminate their formation. However, it 
was apparent that acetylation of the alcohol did not just block nucleophilic attack of oxygen at 
the pyrimidine ring. It also greatly increased the rate at which 1.63 formed. 
It has subsequently been shown by Jonathan Hill (of this Department) that this methodology is also applicable to 
the deoxy-system, allowing the core structure 2.1 to be isolated in 70% yield. 
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An Intermediate of1.63? 
Some insights into the mechanism of cyc1isation were gained when acetic acid was used in place 
of TF A. When acetic acid was used, the reaction was visibly slower than with TF A, however, 
the variolin core 1.63 did fonn, in 67% yield after chromatography. It should be reiterated that 
no reaction occurred when acetic acid was used with the triarylmethanoll.65. A minor product 
of this reaction displayed quite unusual signals in its lH NMR spectrum. A combination of 
reversed phase and nonnal silica flash chromatography allowed isolation of the product "Y" in 
sufficient purity for characterisation by lH, 13C and 2D NMR spectroscopy. 
From the IH NMR spectrum, "Y" possesses four methyl groups-two thiomethyl groups, one 
methoxy group and one acetate. Most interesting were the two signals at 8 3.66 and 4.33 ("a" 
and "b" in Figure 3.10a). These doublets-of-doublets were coupled to each other (J = 17 Hz) 
and also to "c" at 8 6.50 (J= 3.4 and 1.7 Hz respectively). Two pairs of doublets were also seen 
in the aromatic region. These features suggest a cyc1ised product (i.e. containing the 
pyridopyrrolopyrimidine core) with seven protons (apart from the various methyl protons). 
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3.10 (a) A portion ofthe 500 MHz lH NMR spectrum ofY. Signals a, band c are all 
coupled to each other; (b) 126 MHz 13C NMR spectrum ofY. 
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The large coupling constant of 17 Hz had never been observed in any other compounds 
associated with this work. This type of coupling is typical of geminal protons of a cyclic -CHz-
group. This was confirmed in the HSQC, which indicated that the two protons were attached to 
the same carbon at 3 50.2. In the CIGAR experiment (the equivalent of a HMBC), these two 
protons showed correlations to a carbon at 3 150.1, as did the protons of one of the thiomethyl 
groups (see Figure 3.11). This is convincing evidence that we are dealing with the fused 
pyrimidine ring of a pyridopyrrolopyrimidine system, in which two protons are attached to C7 
and the carbon at 3 150.1 would be C9. Invariably, the signal for C9 of these 
pyridopyrrolopyrimidine systems lies in the range 3 148-156, while C2' (the equivalent carbon 
of the pendant pyrimidine ring) gives rise to a signal between 3 170 and 173 (provided it is 
substituted with a thiomethyl group). 
The 2D NMR data (see 3.11 for some important correlations) did not locate the position 
of the acetate group. Initially, it was assumed that it is attached to C5 (which would require a 
double bond between C5a and C6), as it is located at this position in the starting material. This 
would give 3.27 as the structure for Y. However, the signal for C5 appears at 3 113.1 (see 
Figure 3.10b), a value which surely indicates spz character. Additionally, the signal for C6 (3 
61.3) is much too low for an alkene/aromatic carbon, but is reasonable for an oxygenated Sp3 
carbon centre. Structure 3.28 is, therefore, presented as an alternative structure for Y, which fits 
the spectroscopic data more adequately. 
Further evidence for this structure was obtained when the CIGAR experiment was re-run under 
different conditions. In HMBC and CIGAR experiments, the parameter nJCH represents the IH_ 
l3C coupling constant selected for in the experiment, where "n" is the number of bonds 
separating the two nuclei. This parameter is typically set to 8.3 Hz, which allows correlations to 
be observed for n = 2 or 3 bonds. However, some 2- or 3-bond correlations may not be observed 
with nJcH = 8.3, so for more thorough investigations, an arrayed value oCJCH = 4 and 9 may 
be used. Correlations over 4 bonds are not usually seen, due to 4JCH coupling being very small. 
However, very small couplings can sometimes be observed if a lower value of nJcH is used. 
When the experiment was repeated with nJCH 2 Hz, some additional correlations became 
apparent. The most important of these was a weak, but real, correlation from the acetate protons 
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to C6. This result verifies the assertion that the acetate group is situated at C6, not C5, and that 
the structure ofY is indeed 3.28. 
3.27 
3.28 (Y) 
Figure Important HMBC correlations for Y eJcH = 4 and 9 Hz). 
The isolation of 3.28 from the acetic acid/TES reaction may represent a significant advance in 
establishing the mechanism of the cyclisation, as it could be an intermediate in the formation of 
1.63. It should be mentioned that this product was also observed in the TFAITES reaction if that 
reaction was conducted at reflux for shorter periods. A possible mechanism for its formation is 
given in Figure 3.12. Initially, cyclisation to the pyridopyrrolopyrimidine cation 3.29 takes 
place. In Chapter Two, it was suggested that hydride reduction of such a species would occur at 
C5a. However, it would appear that, in the present case, the hydride attacks at C7 to produce the 
uncharged intermediate 3.30. At this stage, the acetate undergoes a rearrangement to give the 
isolated product 3.28. The driving force for the latter step is probably the formation of the 
aromatic indole nucleus, however, the combination of relief of steric strain at the central carbon 
and relief of bond angle strain by making the central 5-membered ring planar may also playa 
part. 
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Figure 3.12 Possible mechanism of fonnation of 3.28, and subsequent elimination of acetic 
acid to produce the variolin core structure 1.63. 
It is not difficult to envisage that the elimination of acetic acid from 3.28 would give the variolin 
core structure 1.63. If this could be shown to be the case, this would provide persuasive 
evidence that 3.28 is, indeed, an intennediate in the fonnation of 1.63. To test this theory, 
was heated in DCE with TF A to induce elimination of the acetate. However, this reaction 
resulted in a complex mixture in which, neither 3.28, nor the variolin core could be 
detected. This leaves the question of the role of unanswered. 
It may be that the predominant pathway involves hydride attack at C5a of 3.29, leading to the 
variolin core 1.63, with a small amount of C7 attack leading to the side-product 3.28. Even if 
3.28 is not involved in the fonnation of its isolation is still significant, in that it shows that 
cyc1isation to the pyridopyrrolopyrimidine core can precede deoxygenation of the acetate. 
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3.3.3 
The TF AJTES hydrogenolysis pair was found to be an effective reagent system for the 
deoxygenationlcyclisation of triarylmethanol 1.65, producing the variolin core structure 1.63 in 
47% yield. If, however, the alcohol is protected as the acetate, the reaction proceeds much more 
cleanly and the yield of 1.63 is increased to 75%. A minor product of the reaction was 
identified, which lends some insights into the mechanism of cyclisation. However, further work 
is required in this regard, if a definitive mechanism is to be established. 
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3.4 Synthesis of 
Now that the variolin core 1.63 could be produced in good yield, the completion of the total 
synthesis of variolin B (1.17) requires substitution of the thiomethyl groups with amines and 
deprotection of the methoxy group. While the introduction of protected amines and their 
deprotection to free NH2 groups had already been accomplished for the deoxy-system (see 
Chapter Two), an efficient means of cleaving the methoxy group had to be found. In addition to 
selecting an appropriate reagent, the specific order of the remaining steps would be important. 
As p-methoxybenzyl groups would be used to protect the amines, methoxy deprotection on the 
bis-protected amine could result in mixtures of products, due to the presence of the two extra 
methoxy groups. For this reason, it was felt that methoxy deprotection would best be perfonned 
prior to amine substitution on structure 1.63. 
3.4.1 Preliminary Deprotection of the Methoxy Group 
3.4.1.1 Boron Tribromide 
A particularly mild and effective method for the cleavage of ethers utilises boron tribromide.115 
This agent complexes strongly to Lewis bases, such as the ethereal oxygen of a methyl aryl ether 
(Figure 3.13). Cleavage of the ether produces methyl bromide and a boron-phenolate complex 
which is protonated on acidic workup to give the phenol. It is recommended that an extra 
equivalent of the reagent be added for every Lewis basic group in the substrate, as these can 
complex to the boron and thus remove it from solution. 
OH 
MeBr o 
R 
Figure 3.13 Deprotection of methyl aryl ethers by boron tribromide. 
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A solution of 1.63 in CH2Clz was treated with boron tribromide (10 equivalents) at -70 DC, and 
allowed to warm to room temperature, producing an orange precipitate. However, TLC analysis 
indicated that only starting material was present. It is thought that the nitrogen atoms in the 
substrate were coordinating to the boron, causing the variolin-boron tribromide complex to 
precipitate out of solution. When more forcing conditions were applied (heating the 
heterogeneous mixture at 65 DC in DCE), several new products were formed. However, the 
bright orange precipitate would not dissolve in either CH2Clz or water. After filtering and 
washing the solid, a IH NMR spectrum was obtained in CD30D. A singlet at (5 4.13 indicated 
that the methoxy group was still intact. Six aromatic protons were observed, as expected. 
Surprisingly, however, only one thiomethyl signal (integrating for three protons) could be seen. 
The l3C NMR spectmm (in DMSO-d6) confirmed both the presence of the methoxy group, with 
a signal at (5 56.8, and the loss of onc of the thiomethyl groups (only one thiomethyl signal was 
seen at (5 13.7). 
When the iH NMR spectmm was obtained in DMSO-d6, a broad signal at (5 13.0 was seen which 
was not present in the CD30D spectmm. Such a signal is indicative of a hydrogen bonded 
exchangeable proton. Electrospray MS revealed that the molecular formula of this product was 
C16Hl3NsOS2. Thus, it would appear that although the molecule contains two sulfurs, only one 
of these belongs to a thiomethyl group. It seemed that the other thiomethyl group had been 
cleaved to give a thiol, in preference to deprotection of the methoxy group on the pyridine ring. 
Using 2D NMR spectroscopy, the position of the thiol was shown to be at C9, as indicated in 
stmcture 3.31. This regiochemistry is to be expected, based on the chemical shift of the thiollH 
signal, as it allows hydrogen bonding ofthc thiol proton to the pyridinc nitrogen (Nl). This type 
of hydrogen bonding was observed for the amine 2.70 (Chapter Two), and of course, for 
deoxyvariolin B (1.50) and variolin B (1.17).32a Important correlations observed in the CIGAR 
experiment are shown in Figure 
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3.31 
Figure 3.14 Important CIGAR correlations for 3.31. 
Presumably, 3.31 arises by a similar mechanism to that expected for methoxy deprotection. As 
the 9-SMe group appeared to be more reactive than the methoxy group when using boron 
tribromide, an alternative reagent was required. Based on the experience with boron tribromide, 
it was decided to avoid Lewis acid reagents, as insoluble complexes would always be a 
possibility if such reagents were applied to the variolin poly-N-heterocyclic system. 
3.4.1.2 Sodium Ethanethiolate 
Sodium ethanethiolate is a commonly used reagent for the deprotection of methyl aryl ethers.116 
Reactions are usually carried out in an aprotic dipolar solvent such as DMF, usually at reflux-
although in exceptional cases, reactions proceed at room temperature. Deprotection occurs by 
SN2 attack at the methoxy group to produce a phenolate anion, which is protonated on workup to 
give the phenol. Such a mechanism would be well-suited to the present case, as the resulting 
pyridinol anion would be stabilised by delocalisation onto the pyridine nitrogen (N1). 
The reaction was initially conducted at 95°C with an excess of sodium ethanethiolate (20 
equivalents) and monitored by TLC. After only 0.5 h, it was observed that the starting material 
1.63 had been consumed and several new products had been generated. IH NMR spectroscopy 
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of the crude mixture revealed at least three products, all of which appeared to have undergone 
clean methoxy-deprotection. However, varying degrees of nucleophilic substitution of the SMe 
groups (both, one or none) by sodium ethanethiolate had also taken place. Despite the mixtures 
of products, these results were encouraging. If substitution of the thiomethyl groups could be 
avoided, this reagent would serve our purposes well. 
In an attempt to preclude SMe substitution, the reaction was repeated, but at room temperature. 
After 1 h, a IH NMR spectrum of a small aliquot was obtained, which indicated that a significant 
amount of methoxy deprotection had occurred (~20%). However, one of the SMe groups had 
been almost completely substituted with SEt. Based on the results of selective amine 
substitution discussed in Chapter Two, it is presumed that substitution of the 9-SMe group had 
taken place. It would appear that this reaction proceeds at a much faster rate than methoxy 
deprotection. To avoid this complication, it was decided to leave the methoxy deprotection until 
after the SMe groups had been replaced with the protected amines. These groups would be far 
less readily substituted by sodium ethanethiolate. While they do contain potentially reactive 
methoxy groups, it seemed that cleavage of the pyridyl methyl ether was an especially facile 
process. The resulting phenolate would be a much better leaving group than an ordinary 
phenolate, and thus it was felt that selective cleavage may be possible in the presence of the p-
methoxybenzylamines. 
3.4.2 Oxidation/Nucleophilic Substitution of Thiomethyl Groups 
Thus, core structure 1.63 was subjected to oxidation with m-CPBA using the conditions that 
were used for the oxidation of the thiomethyl groups of the deoxy-variolin core As 
expected, the major product was the bis-sulfoxide 3.32. When the reaction was repeated at lower 
temperature (-40°C) using 2 equivalents of oxidising agent, the bis-sulfoxide was produced 
much more cleanly than before. In the 1 H NMR spectrum of the crude product, a very small 
peak at 62.69 indicated that oxidation of one of the SMe groups was not quite complete. An 
equally small peak at 6 3.40 suggested a small degree of oxidation to the sulfone. However, the 
bis-sulfoxide comprised >90% of the mixture (judging by IH NMR spectroscopy). As with the 
deoxy-equivalent 2.69, the product exists as a 1:1 mixture of diastereomers, due to the chirality 
of the two sulfoxides. The signals for the SOMe protons appeared at 6 3.02 and 3.19 which, as 
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explained in Chapter Two, is typical for this type of system. The aromatic signals shifted 
downfield from those of the starting material, in a manner analogous to that observed in the 
deoxy-series. 
3.32 
While the crude mixture should undergo amine substitution to give just one product, purification 
was attempted for the purpose of completely characterising the bis-sulfoxide Silica flash 
chromatography of this compound requires methanol/CH2Ch mixtures due to its high polarity. 
However, IH NMR analysis of the "purified" product revealed a new compound, present in 
~30%, along with the bis-sulfoxide. The most notable features in the spectrum of the new 
product were that one SOMe peak was absent, while a new peak at () 4.39, integrating for three 
protons, had appeared. As this product was not observed in the IH NMR spectrum of the crude 
mixture, it must result from decomposition of the bis-sulfoxide on silica. Structure 3.33 is 
proposed for this product. The methoxy group must come from the eluant used in the 
chromatography (8% methanoI/CH2Ch). This facile substitution, which is possibly catalysed by 
the acidic silica, highlights the highly electron-deficient nature of the fused pyrimidine ring, 
especially upon oxidation of sulfur to the sulfoxide. 
3.33 
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Despite trying a variety of other solvent systems on both silica and alumina TLC plates 
(including ethyl acetate, THF and CH3CN as the polar components), none could be found that 
would allow the polar bis-sulfoxide to move appreciably off the baseline. Thus, only 'H NMR 
data for 3.32 is included in the Experimental section of this thesis. It was decided to continue 
with the amine substitutions on the crude oxidised mixture. 
Therefore, the crude oxidised mixture, consisting mainly of 3.32, was heated at 85°C in neat p-
methoxybenzylamine. After 15 h, complete substitution of all SOxMe groups (where x 0, 1,2) 
had taken place. The mixture was, without workup, purified by flash chromatography to give the 
desired product, bis-protected amine 3.34, in 78% yield over the two steps (Scheme 3.13). The 
identity of the product was clear, based on comparison of its 'H NMR spectrum with that of the 
deoxy-equivalent 2.70. In particular, the two NH signals were easily recognised, with the 9-NH 
signal appearing as a broadened triplet at (5 10.39 due to hydrogen bonding with the pyridine 
nitrogen (Nl), and the 21-NH signal appearing as a broad signal at (5 5.51. The COSY 
experiment showed that the NH signals are coupled to separate doublets, which correspond to the 
methylene protons of the two p-methoxybenzyl groups. All other spectroscopic data are in 
agreement with the structure 3.34. 
N 2' NH(PMB) ~ ~ /- NOMe 
ii 
1.63 3.32 3.34 
Scheme 3.13 Reagents and yields: (i) m-CPBA (2 equiv)/CHCb/-40 DC; (ii) p-methoxybenzylamine 
(11 equiv)/85 DC (78% from 1.63). 
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3.4.3 Group 
As the thiomethyl groups were no longer of consequence, methoxy deprotection was re-
attempted with sodium ethanethiolate. When heated at 95 °e, a new product formed rapidly 
Gudging by TLe analysis). IH NMR analysis of the mixture revealed clean deprotection of the 
pyridine methoxy group, while those of the PMB groups remained intact. Even when the 
mixture was heated at 130 °e for h with 20 equivalents of sodium ethanethiolate, the PMB 
methoxy groups were untouched. After optimisation of the conditions, the pyridine methoxy 
group was fonnd to be readily cleaved on heating at 55 °e for 7.5 h to give the pyridino13.35 as 
the only variolin-type product. Flash chromatography on silica allowed the isolation of 3.35 in 
pure form in 95% yield (Scheme 3.14). 
N NH(PMB) ~ ~ /, NOMe 
N NH(PMB) ~ 5'~ /, Ns' OH 
3.34 3.35 
Scheme 3.14 Reagents and yields: (i) NaSEt (10 equiv)/DMF/55 °C (95%). 
The most distinctive feature in the 1 H NMR spectrum of is a broad sigrIal at 8 1 This 
very deshielded signal was assigned to the hydroxyl proton and its chemical shift probably 
reflects internal hydrogen bonding to N3' of the pendant pyrimidine ring. Interestingly, the most 
sigrIificant change in the aromatic region involves H6 and H7. The signals for these protons 
were at 8 7.29 and 7.43 respectively in the starting material 3.34. Upon deprotection of the 
ether, the signal for H6 has moved further upfield to 8 7.03, while the signal for H7 has moved 
further downfield to 8 7.68. These shifts were rather unexpected, as the putative hydrogen bond 
between N3' and the OH proton is expected to bring the pendant pyrimidine ring more into the 
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plane of the pyridopyrrolopyrimidine ring system. An intense NOE correlation between HS' and 
H6 shows that these protons do lie quite close togther in space. It was thought that the aromatic 
ring current of the pendant pyrimidine ring would cause deshielding of H6, and the signal would 
be expected to be seen further down field than in 3.34. 
An argument that may account for the observed values relies on electronic effects rather than 
conformational effects. It is thought that once the free hydroxyl group is uncovered, the 
hydrogen bond between 9-NH and the pyridine nitrogen is strengthened. This assertion is 
supported by the fact that the IH signal for 9-NH appears at 0 10.9 for the pyridinol 3.35, 
compared to 0 10.4 for the precursor, 3.34. This would result in a redistribution of the lone-pair 
of electrons on 9-N, with more electron density in the fused pyrimidine ring. This would 
particularly affect the signal for H6, causing it to move upfield. 
3.4.4 Removal of the p-Methoxybenzyl Protecting 
Dissolution of 3.35 in triflic acid immediately produced a blood-red solution, which was left at 
room temperature for 17 h. Upon careful neutralisation of the mixture with aqueous ammonia, a 
bright yellow precipitate developed. I H NMR analysis of the product indicated that clean 
deprotection of both amines had taken place, to give the target compound variolin B (1.17, 
Scheme 3.15). 
N~NH(PMB) 
~ /-N OH 
3.35 
Reagents and yields: (i) triflic addlrt (80%). 
1.17 
variolin B 
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The purification of the natural product was made difficult by its insolubility in most common 
solvents, other than DMSO.32a However, if it is converted to the trifluoroacetate salt, its 
solubility in methanol is increased. In this form, flash chromatography could be carried out on 
reversed phase silica to remove the PMB impurities, giving variolin B as its trifluoroacetate salt. 
This product was neutralised with aqueous ammonia/methanol and the ammonium 
trifluoroacetate, thus produced, was removed by high-vacuum sublimation (35°C, 0.03 mm Hg). 
Variolin B was obtained as a brown-orange solid in 80% yield. 
In the original paper reporting the isolation of variolin B, NMR data was reported for both the 
TF A salt and the free base. However, no clear definition was given as to what the "salt" is, other 
than stating that "Most NMR spectral data were obtained in a mixture of deuterated DMSO and 
TFA (salt) or DMSO alone (free base) ... ".32a In addition, it was found that chemical shifts ofthe 
salt were variable depending on the exact amount of TF A present. To avoid this ambiguity, all 
spectral data for synthetic variolin B were obtained as the free base. 
The IH NMR spectrum of synthetic variolin B (Figure 3.15) is gratifyingly simple. Six doublets 
falling between 8 6.8 and 8.3 represent the aromatic ring protons. A singlet integrating for two 
protons is due to the 2'-NH2 group, while the 9-NH2 protons give rise to separate broadened 
signals due to restricted rotation about the C9-NH2 bond, as explained in Chapter One. The only 
other signal (at 8 16.05) is from the hydroxyl proton. 
'1'"'1""1""1""1""1""1''''1 
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Figure 3.15 500 MHz IH NMR spectrum of synthetic variolin B (1.17) in DMSO-d6 
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As can be seen from Table 3.1, both the lH and l3C chemical shift values agree very well with 
those of natural variolin B. A slight discrepancy can be seen regarding the assignments of C2' 
and C4'. The CIGAR experiment (on the synthetic material) showed a strong correlation from 
H6' to the carbon at 0 161.4, which confirms that this peak belongs to C2'. Both H5' and H6' 
showed correlations to the carbon at 0 158.3, which is to be expected if this peak belongs to C4'. 
Upon personal communication with the authors of the original paper, it was conceded that these 
l3C signals may have been mis-assigned. 
lH l3C 
position synthetica naturalb syntheticC natural 
2 8.17 8.14 143.1 143.2 
3 6.81 6.78 107.5 107.6 
4 159.8 159.9 
4a 111.2 111.2 
5 99.6 99.6 
5a 137.1 137.1 
6 7.23 7.19 100.3 100.4 
7 7.63 7.61 144.6 144.6 
9 150.3 150.3 
lOa 144.9 145.0 
2' 161.4 158.4 
4' 158.3 161.5 
5' 7.14 7.11 106.0 106.1 
6' 8.27 8.25 160.0 160.1 
9-NH2 8.45 8.5 
9-NH2 9.79 9.8 
2'-NH2 6.97 6.95 
4-0H 16.05 16.0 
Table 3.1 Comparison of lH and l3C J\TMR chemical shifts for synthetic and natural variolin 
B.32a 
a Recorded in DMSO-d6 at 500 MHz. b These values have been adjusted by -0.12 ppm from those in the 
original paper, so that the solvent reference peak (0 2.62) corresponds to the present system (0 2.50 ppm). 
C Recorded in DMSO-d6 at 75 MHz. 
Chapter Three - The Total Synthesis of Variolin B 131 
As shown in Table the melting point and IR data of synthetic variolin B do not correspond 
well to those of the natural material. The reason for these differences is not known-it may be 
that the data of the natural material were obtained from the TF A salt. However, the TF A salt of 
synthetic variolin B (obtained by erystallisation from an aqueous 
indication of any decomposition at, or near, 45°C. 
solution) showed no 
MS 
Mp (OC) 
IR (em-I) 
Table 3.2 
synthetic (free base) 
ESMS: 294.1096 (MH+) 
~320 (dec) 
3085, 1670, 1572, 1477, 1458, 
1298 
natural (salt?) 
HREIMS: 293.102 (M+) 
45 (dec) 
3100, 1684, 1614, 1540, 1497, 1310, 
1188, 1135 
Comparison of spectroscopic data for synthetic and natural variolin B. 32a 
As a sample of natural variolin B in the salt form was available, IH NMR spectra of the TF A 
salts of synthetic and natural variolin B were obtained side by side under the same conditions. It 
should be noted that the texture of the natural material was that of a paste, whereas synthetic 
variolin B was obtained as a free-flowing powder, or in micro-crystalline form when 
recrystallised from water/TF A. 
The IH NJVIR spectra of the two samples are shown in Figure 3.16a and h. It is clear that the 
chemical shifts in these spectra differ somewhat-this is presumably due to different amounts of 
TFA being present in each sample. To prove that the synthetic and natural samples are, indeed, 
one and the same compound, the two NMR solutions were thoroughly mixed together and the 
NMR spectrum was re-run. The result is shown in Figure 3.16c. Only one compound can be 
seen, making it absolutely clear that the synthetic material is, indeed, variolin B (1.17). 
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Figure 3.16 (a) 500 MHz IH NMR spectrum of synthetic variolin B (TFA salt); (b) 500 MHz 
IH NMR spectrum of natural variolin B (TFA salt);* (c) 500 MHz lH J\lMR spectrum of a 
mixture of synthetic and natural variolin B (TFA salt) . 
• The three peaks between 8 6.9 and 7.2 had also been observed in synthetic samples of variolin B early on-
sometimes in such great proportions that they overwhelmed all other peaks in the spectrum. They appear to be a 
consequence of incomplete neutralisation of the TF A salt with aqueous ammonia solution. The three peaks arise 
from the protons of NH4 +. In strongly acidic solutions, the quadrupolar coupling of these protons to 14N can be 
observed, giving rise to a 1: 1: 1 triplet (Tony Canoll, personal communication). 
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3.5 
The target compound variolin B (1.17) has been synthesised in just eight steps from 
commercially available 4-chloro-2-(methylsulfanyl)pyrimidine (2.13, Scheme 3.16). Some 
modifications to the strategy described in Chapter Two were required for the synthesis of 
triarylmethanoI1.65, as addition of the pyrimidinyllithio-species 1.66 to acid chloride 1.67 was 
too slow at -95°C. However, the more stable lithiated pyridine 3.16 and bipyrimidinyl ketone 
3.15 were found to react smoothly at -78°C to give the desired triarylmethanol 
yield. 
in 76% 
After careful optimisation of the cyclisation reaction conditions, the variolin core structure 1.63 
could be produced in 47% yield from 1.65. However, if the triarylmethylacetate 3.26 was used 
as an alternative to 1.65, the cyclisation step proceeded much more cleanly and efficiently to 
give 1.63 in 75% yield. Further modification of this compound involved the substitution of the 
thiomethyl groups for protected amines and subsequent deprotection of both the amines and the 
methoxy group. This resulted in the first total synthesis of variolin B, in an overall yield of 13 % 
for the eight steps.39b 
This route is attractive due to its brevity and efficiency. It compares favourably to the total 
synthesis reported recently by Molina, Fresneda and coworkers, which required 16 steps and 
proceeded in an overall yield of 1.2%.36 Importantly, our route will provide a supply of synthetic 
variolin B, which will allow further exploration of its biological properties and potential as a 
therapeutic agent. 
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J viii 
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ii 
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vi 
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Scheme 3,16 Reagents and yields: (i) 55% aq HIIrt (79%); (ii) n-BuLi (1 equiv)/THFI-95 DC, 30 min 
then diethyl carbonate (0.5 equiv)/THFI-95 °C to rt (53%); (iii) 3.8: n-BuLi (1 
equiv)/THFI-90 °C to -78°C, 1 h then 3.15 (1 equiv)lTHF /-90 °C to -78 DC, 3 h then 
AcCI (4 equiv)/-78 °C to rt (68%); (iv) TFA (2 equiv)/TES (8 equiv)IDCE/80 DC/sealed 
tube (75%); (v) m-CPBA (2 equiv)/CHCb/-40 DC; (vi) p-methoxybenzylamine (10 
equiv)/85 °C (78% from 1.63); (vii) NaSEt (10 equiv)IDMFl55 °C (95%); (viii) triflic 
acidlrt (80%). 
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4.1 Introduction 
It was stated in the Introduction of this dissertation that a total synthesis of variolin B should not 
only be direct and efficient, but also be amenable to the production of a wide variety of 
analogues. Analogue synthesis is an important part of drug development, as it can allow the 
fine-tuning of important pharmacological parameters. These include potency, toxicity, 
bioavailablity, solubility in cellular fluids, biostability and site selectivity of the drug. 
Inadequate performance in anyone of these areas could rule the drug out as a medicinal agent. 
With a range of analogues, however, these obstacles may be overcome if a candidate can be 
found which meets all the necessary requirements. 
Analogues are also important in structure-activity relationship (SAR) studies. The structure of 
the drug can be altered in degrees by chemical transformation and the biological activity of each 
analogue can be determined. Correlation of the observed activity with chemical structure leads 
to SARs, thereby allowing the determination of the structural elements of the drug that are 
essential to its biological properties. This may eventually lead to a simpler target which is more 
easily obtainable, while retaining a similar degree of biological activity to the natural product. In 
addition, SARs may provide insights into the mode of action of the drug. For example, the 
essential components may be required for some intermolecular interaction with a 
macromolecule, such as an enzyme or other protein, the result of which will modulate its 
activity. Such knowledge will allow further development of the drug by modifying its structure 
so as to maximise these interactions. 
4.1.1 Definitions 
While the term "drug" strictly refers to a chemical which has been approved for medicinal use, it 
is used here of any compound made for the purpose of investigating its biological activity. The 
term "biological activity" is often used vaguely to describe the property of any chemical which 
may cause an alteration of a cell's normal state. In this Chapter, it refers specifically to 
performance in the P388 assay. This assay measures the growth inhibition of a murine 
leukaemia cell line in the presence of a known concentration of the drug. The parameter derived 
from the assay, ICso, represents the concentration of drug required to reduce the P388 cell growth 
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by 50% comparative to control cells. ICso is measured in ng/mL; thus, a lower value 
corresponds to a higher degree of potency. The reported ICso value for natural variolin B is 210 
ng/mL.32a Thus, compounds tested in the P388 assay in this thesis are compared to variolin B 
and can be said to have increased or decreased activity, as compared to the natural product. 
Compounds with an ICso >20,000 ng/mL are classed in this Chapter as being inactive. This 
value has been somewhat arbitrarily chosen, although it corresponds to a 100-fold loss of activity 
compared with variolin B. 
4.1.2 Biological Data of Synthetic Variolin B 
Before undertaking a project in the synthesis of variolin analogues, it was of crucial importance 
to first determine the biological properties of synthetic variolin B. With any biologically active 
extract, there exists the possibility that the activity of the natural material is not due to the 
characterised product (in this case, variolin B) but rather an unknown trace impurity. Therefore, 
synthetic variolin B was tested in the P388 assay, along with a sample of natural variolin B for 
comparison. 
Pleasingly, synthetic variolin B was found to have an ICso = 189 ng/mL, which is essentially 
equal to that reported for the natural material (ICso 210 ng/mL)?2a It should be pointed out 
that the P388 assay is only accurate to ~50%. Thus, the difference between these two values is 
trivial-significant differences are measured in orders of magnitude. In the present assay, the 
naturally derived variolin B showed significantly lower activity, with an ICso = 465 ng/mL. It 
may be that this sample has degraded over the years. Also of relevance is that this sample of 
natural variolin B was stated to be the TF A salt form. As has been discussed, there is no clear 
definition as to what this means. It may be that up to 50% of the sample is actually TF A, which 
would explain its higher ICso. This aside, the key result is that synthetic variolin B shows at least 
equal potency to that of the natural material. This result rules out this possibility that the 
bioactivity originates from an unidentified contaminant of the natural material. 
Further testing on synthetic variolin B has been carried out by Pharma Mar (who have the 
commercial rights to this synthesis). Preliminary results have been encouraging, with variolin B 
displaying anti-proliferative activity against a range of human tumour cell lines. This has 
resulted in variolin B being entered into Safety Trials. 
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4.2 Structure-Activity Relationships Variolins 
4.2.1 
Throughout the course of Chapters Two and Three, it was seen that a limited range of 
nuc1eophiles were introduced into either of the variolin core structures 2.1 or 1.63-sometimes 
deliberately and sometimes unintentionally. As substitution products were obtained using 
amines (primary and secondary), methanol and thiolate as nucleophiles, it appears that this type 
of substitution is quite general in the variolin system. This type of reactivity offers a powerful 
means of rapidly producing a range of analogues. It was also noted in Chapter Two that 
selective substitution of the 9-SMe group can be conveniently achieved by simply beating 2.1 
witb the nuc1eophile in a suitable solvent. This will allow for the production of an even broader 
spectrum of analogues. Substitution of the 9-SMe group with an amine nucleophile, for 
example, followed by S-oxidation of the 2'-SMe group and subsequent replacement witb a 
different nuc1eophile should increase the variety of analogues that can be produced. It would 
also allow a comparison of the importance of these two sites for biological activity. 
Alternatively, if identical substituents are required at both C9 and C2', oxidation of 2.1 or 1.63 
followed by double substitution would provide the desired compound. This method was used in 
tbe syntheses of both deoxyvariolin B (1.50) and variolin B (1.17). Thus, the thiomethyl-
containing structures 2.1 and 1.63 are key compounds for the synthesis of analogues of the 
variolins. 
2.1 1.63 
The oxygen at C4 of 1.63 also offers a convenient handle for increasing the diversity of 
analogues that can be produced. It has been shown that deprotection of the methoxy group can 
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be readily achieved using sodium ethanethiolate to give the free hydroxyl group. A variety of 
groups could be appended to this oxygen to provide a new set of analogues, which would be 
examined for biological activity. 
Thus, the three points of variation available are a) the substituent at C9 (group X), b) the 
substituent at C2' (group Y) and c) the substituent at C4 (group Z) (Figure 4.1). As the 
intermediates in Chapters Two and Three vary in these aspects, some of these were tested for 
biological activity. In addition, a range of analogues were produced to provide further variation 
of groups X, Y and Z. 
Figure 4.1 Points of variation available in the variolins. 
4.2.2 Variation in Group Z 
4.2.2.1 Synthesis 
Comparison of the biological properties of deoxyvariolin B (1.50) (Z = H) and variolin B (1.17) 
(Z = OH) would provide some insight into the importance of group Z. A third variant where 
Z = OMe should be readily accessible by removal of the PMB groups of 3.34, without prior 
deprotection of the methoxy group. To this end, 3.34 was dissolved in neat triflic acid and left at 
room temperature to give O-methylvariolin B (4.1) (Scheme 4.1). After neutralisation with 
aqueous ammonia solution, the ammonium triflate thus produced was removed by adsorbing the 
mixture onto a small CI8 cartridge and eluting with 30% MeOHlwater. The yellow product was 
collected in a separate fraction upon elution with 25% MeOHlCH2Ch + 0.2% TF A. While silica 
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TLC of this partially purified product indicated that good separation should be achievable, when 
flash chromatography was carried out on silica, the yellow colour smeared down the length of 
the column. Addition of 0.5% triethylamine to the eluant (10% MeOH/CH2Ch) brought the 
yellow colour off cleanly, however, a small amount of silica was solubilised with this solvent 
mixture and contaminated the sample. This was removed by filtering a solution of the product in 
10% MeOHlCH2Ch through a fine frit, followed by chromatography on reversed phase silica. In 
this manner, 4.1 was isolated in 23% yield. The low yield is no doubt due to the difficulties 
experienced in purification of the product. 
N NH(PMB) ~ ~ /, NOMe 
.. 
3.34 4.1 
Scheme 4.1 Reagents and yields: (i) triflic acid/rt (23%). 
The synthesis of O-methylvariolin B (4.1) completes a three-membered group of compounds 
which vary only in their substituent at C4 (i.e. Z in Figure 4.1)-1.50 (Z = H), 1.17 (Z = OH) 
and 4.1 (Z = OMe). Testing of these compounds should give an indication of the importance of 
this substituent for biological activity. 
1.50 Z = H deoxyvariolin 8 
1.17 Z = OH variolin 8 
4.1 Z = OMe O-methylvariolin 8 
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The results of the P388 assay of the three samples are shown in Table 4.1. Immediately 
apparent is the rather startling result that deoxyvariolin B (1.50) is equally active in the P388 
assay as variolin B itself! The implications of this unexpected result are discussed below. The 
other result concerns O-methylvariolin B (4.1), which displays moderate activity in the assay, 
with an ICso of 3,660 ng/mL. 
X 
1.50 NH2 
1.17 NH2 
4.1 NH2 
y z 
R 
OR 
OMe 
ICso (ng/mL) 
157 
189 
3,660 
Table P388 assay results of variolin B (1.17), deoxyvariolin B (1.50) and 0-
methylvariolin B (4.1). 
It is difficult to rationalise these results without making some assumptions regarding the role of 
the substitutent Z. Likewise, it is difficult to consider any possible roles of the substituent Z 
without making some assumptions regarding the drug's mode of action. 
It was suggested in the original isolation paper that variolin B may belong to the same class of 
DNA intercalating compounds as ellipticine and its analogues.32a Presumably, this statement 
was made on the basis of structural similarities between the molecules. Ellipticine (4.2) and 9-
methoxyellipticine (4.3) are naturally occurring fused heteroaromatic systems 11 7 with an overall 
planar structure. The discovery of their antitumour properties in 1967118 triggered widespread 
synthetic, biological and pharmacological studies of these compounds and numerous 
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derivatives.1l9 As a consequence, their ability to intercalate into double-stranded DNA (i.e. 
slotting in between the stacked base pairs) has been well-established and this is believed to be 
responsible for their biological properties. 120 
4.2 4.3 
ellipticine 9-methoxyellipticine 
The ellipticine family is by no means unique in their intercalation into DNA. Numerous other 
natural and synthetic products have been shown to exhibit this behaviour. For example, 
synthetic dyes such as ethidium ion (4.4), proflavin (4.5) and acridine orange (4.6) are widely 
used as stains of DNA in biochemical laboratory processes. 121 These agents bind by 
intercalation into double-stranded DNA. A general requirement for DNA intercalation is the 
presence of a planar substructure within the molecule, which is generally associated with an 
aromatic system. 
4.4 4.5 4.6 
The comparison of va rio lin B (1.17) with ellipticine may, at first, seem somewhat unfounded. If 
variolin B was to exist in a planar confonnation, significant clashing between H6 of the tricyclic 
core and of the 2-aminopyrimidine ring would ensue. Steric arguments would suggest that 
the 2-aminopyrimidine ring plane should be significantly inclined to that of the tricyclic core to 
avoid this unfavourable interaction. However, as explained in Chapter One, an X-ray crystal 
structure of variolin B showed that the two ring systems were closer to coplanarity than might be 
expected, being inclined to each other at an angle of 24o.32a A hydrogen bond was observed 
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between the hydroxyl proton and N3' of the 2-aminopyrimidine ring (see Figure 4.2); this may 
be important in allowing the molecule to adopt a near-planar structure. 
Figure Internal hydrogen bonding seen in the X-ray crystal structure ofvariolin B (1.17). 
If variolin B acts as an intercalating agent, the ability to exist in a near-planar conformation may 
be important to its biological activity. The fact that O-methylvariolin B (4.1) displayed a ~20-
fold decrease in activity compared with the natural product supports this notion. Hydroxyl 
protection would prevent any hydrogen bonding between the 2-aminopyrimidine ring and the 
tricyclic core, and would also force the 2-aminopyrimidine ring out of plane for steric reasons. It 
is interesting that variolin A (1.16) showed a comparable degree of potency in the P388 assay to 
4.1, with an ICso of 3,800 ng/mL,32b The presence of the oxygen at C5' of the 
aminopyrimidine ring would be expected to force this ring further out of the 
pyridopyrrolopyrimidine mean plane than for variolin B (1.17). Indeed, the crystal structure of 
variolin A (1.16) showed that the heterocyclic ring at C5 was inclined at an angle of 42° to the 
tricyclic core-significantly more than was observed for variolin B. 32b It may be that the 
inability of both O-methylvariolin B (4.1) and variolin A (1.16) to attain coplanarity leads to 
their similar losses of activity as compared to variolin B (1.17). 
1.16 
variolin A 
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How then, does the finding that deoxyvariolin B (1.50) is of equal cytotoxicity to variolin B 
(1.17) fit in to this argument? It may be that deoxyvariolin B is quite capable of existing in a 
planar or near-planar conformation, without the need of a hydrogen bond to draw the 2-
aminopyrimidine ring into plane. In fact, the absence of the hydroxyl group at C4 may allow 
more freedom of movement of the 2-aminopyrimidine ring, such that a near-planar conformation 
is more easily attained. 
It should be reiterated that the assumptions made in this discussion are speculative. To date, 
there is no direct evidence that the variolins are intercalating agents. To pursue this theory, DNA 
binding assays of variolin B and its various analogues would be required, however such work 
was beyond the scope of this project. Neither can the results of the P388 assay be said to prove 
that a planar conformation is biologically important. Rather, this model provides a convenient 
means of rationalising the assay results. Nevertheless, both the structural similarity of the 
variolins to many known DNA intercalators, and these preliminary biological tests warrant 
further study in this area. 
4.2.3 Variation and 
4.2.3.1 Synthesis 
To determine the importance of groups X and Y, compounds 4.7 and 4.8 would be valuable. 
These compounds differ from variolin B only by the substitution of XIY = NHz with XIY SMe. 
Unfortunately, the synthetic methodology does not lend itself to the production of as 
selective substitution of the 2'-SMe group is not possible. However, relevant information 
regarding the importance of group was gained from another analogue (vide infra). 
4.7 x:: SMe, Y:: NH2 
4.8 X:= NH2, Y:= SMe 
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The synthesis of compound began by selective substitution of the 9-SMe group of the 
variolin core structure 1.63. Thus, heating 1.63 in neat p-methoxybenzylamine cleanly gave the 
product of mono-substitution 4.9, in 86% yield after flash chromatography on silica (Scheme 
4.2). No evidence of di-substitution was observed. Deprotection of the methoxy group of 4.9 
using sodium ethanethiolate at 50°C gave N-protected pyridinol 4.10 in 95% yield. The IH 
J\lMR spectrum of this product indicated that trace amounts of 4.11 were present. This is the 
result of SMe substitution by sodium ethanethiolate. However, it was not possible to remove this 
product by silica flash chromatography. When pyridinol 4.10 was treated with triflic acid, the 
PMB group was cleaved to give the free amine 4.8. After neutralisation with aqueous ammonia 
solution, the ammonium triflate thus produced was able to be removed by washing a solution of 
the product in 5% MeOH/CH2Cb with aqueous NaHC03 solution. Flash chromatography on 
silica allowed the isolation of 4.8 (~90% pure by 1 H NMR spectroscopy) in 80% yield. 
1.63 
ii 
4.9 
4.12 
4.10 Y=SMe 
4.11 Y = SEt 
4.8 
Reagents and yields: (i) p-methoxybenzylamine (14 equiv)/85 (86%); (ii) NaSEt (10 
equiv)/DMFISO DC (4.10 95%); (iii) triflie aeidlrt (80%); (iv) triflic acidlrt (100%). 
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A significant drop in solubility in halogenated solvents accompanies exposure of the free NH2 
group, a phenomenon also noted with variolin B, deoxyvariolin B and O-methylvariolin B. 
Compound 4.8 was only sparingly soluble in either CDCh or DMSO-d6. NMR spectroscopy 
was carried out in a 1: 1 mixture of these solvents. 
As the O-methyl analogue 4.12 should also be readily obtainable from 4.9, it was decided to 
include this compound in the present study. Removal of the PMB group of 4.9 was carried out 
in the usual manner-by standing in triflic acid for several hours-to give amine 4.12 in 
quantitative yield. Amine 4.12 was sufficiently soluble for NMR characterisation in CDCh, 
including 13C and 2D NMR spectroscopy. 
As stated earlier, structure 4.7 would be useful in regard to the importance of group X, but 
cannot not be easily prepared by our methodology. However, an alternative analogue which 
differs from variolin B only in the nature of group X can be made. It was briefly mentioned in 
Chapter Two that N-deprotection using TF A appeared to remove only one of the PMB groups, 
although this particular product was not characterised. This selectivity in deprotection was 
investigated on the bis-N-protected pyridinol 3.35. 
Compound 3.35 was dissolved in TF A and left at room temperature, with the disappearance of 
starting material being followed by TLC. After 5 days, most of the starting material was 
consumed. Two new yellow products were evident, both of greater polarity than the starting 
material. It was assumed that these were the desired mono-N-protected product 4.13 and variolin 
B (1.17), the result of double-N-deprotection. Indeed, both of these products were present in the 
lH NlYIR spectrum of the crude material, in a ~5: 1 ratio in favour of 4.13. Flash chromatography 
on silica allowed the isolation of 4.13 and variolin B (1.17) in 67 and 13% yields respectively 
(Scheme 4.3). While variolin B did elute from this silica column, the purity was only moderate 
and therefore, reversed phase chromatography is generally recommended for this highly polar 
product. 
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N~NH(PMB) 
~ hN OH 
3.35 
.. 
4.13 
Scheme 4.3 Reagents and yields: (i) TFAlrt (4.13 67%, 1.1713%). 
4.2.3.2 P388 Assay Results 
+ 
147 
1.17 
The family of compounds thus generated was tested in the P388 assay, the results of which are 
shown in Table 4.2. It is immediately seen that none of these compounds display significant 
activity. One can conclude, therefore, that the variolin core skeleton is insufficient for biological 
activity-groups X and Y must playa role in the drug's cytotoxicity. 
X Y Z IC50 (ng/mL) 
1.17 NH2 J\TH2 OR 189 
4.8 NH2 SMe OR >25,000 
4.13 NH(PMB) NH2 OR >25,000 
4.9 NH(PMB) SMe OMe >25,000 
4.10 NH(PMB) SMe OR >25,000 
4.12 NH2 SMe OMe >25,000 
Table 4.2 P388 assay results of va rio lin B (1.17) and analogues. 
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Even if only one of the groups X or Y is altered from those of variolin B (1.17), this results in a 
> 1 OO-fold loss of activity. For example, compound 4.8 differs from variolin B (1.17) only by the 
substitution ofY = NH2 for Y = SMe. The inactivity of this compound indicates that the nature 
of this group is essential for biological activity. It cannot be said, however, that an amine is 
specifically required at this position until a variety of other substituents have been tested. 
Compound 4.13 is more closely related to variolin B in that, both X and Y are amines, with X 
bearing a PMB group. However, even this analogue conveys no activity. This shows that an 
amine substituent at C9 is not, in itself, sufficient for cytotoxicity. Presumably, the PMB group 
is too bulky to allow interaction with the cellular target, whatever that target may be. Based on 
these results, it is not surprising that compounds 4.9, 4.10 and 4.12 are also devoid of biological 
activity. 
While these assay results may seem disappointing, the purpose of producing these analogues was 
not to improve the potency of the drug, but rather to find out what features of variolin Bare 
important to its biological function. In this regard, these studies have served their purpose very 
well. They have shown that the antitumour activity of va rio lin-type compounds is very sensitive 
to the nature of both X and Y. Alteration of either group (in the above examples, at least) results 
in a> 1 OO-fold loss of activity compared to variolin B. This information is of relevance when it 
comes to designing further analogues of va rio lin B. 
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4.3 ofVarioHn 
4.3.1 
Two alternative approaches can be taken to the synthesis of analogues of a lead compound. One 
approach is to make random incremental modifications to the structure--either by alteration of 
appendages or by modification of the gross architecture of the molecule--in the hope that some 
will display increased activity over the parent drug. A second approach centres around the 
systematic design of modified drugs, based on a knowledge of the structure ofthe drug's cellular 
target. In this rational design approach, one tries to maximise favourable interactions between 
the drug and its target by incorporating structural elements complementary to those found in the 
target. X-ray crystallography is a powerful technique in this regard as it can provide a 
"photograph" of the drug-target complex, plainly showing any interactions which occur at the 
interface of the complex. 
While the cellular target of variolin B is not known, the suggestion that it may act by 
intercalation into DNA is not unreasonable and deserves further attention. An examination of 
some current DNA intercalators that are promising anticancer agents reveals some important 
structural features. A group of drugs known as acridine-4-carboxamides have been widely 
studied for their antitumour properties. 122 One of these, known as DACA or N-[2-
(dimethylamino)ethyl]acridine-4-carboxamide (4.14), is currently in clinical trials as an 
antitumour agent. An X-ray crystal structure of a derivative of DACA, 9-amino-6-bromo-
DACA (4.15), complexed to a portion of duplex DNA demonstrates the specific interaction 
between the intercalator and DNA.122a In this complex, the planar acridine moiety slots between 
the d(CG)2 base pairs (d refers to duplex DNA, C = cytosine, G guanine) while the 2-
(dimethylamino)ethyl chain can be seen to bind in the major groove, with a hydrogen bond 
between the Me2NH+ of this side chain and N7 of one of the guanine bases. A similar complex 
has been characterised with 9-amino-DACA (4.16) and a duplex DNA hexanucleotide and shows 
similar interactions. 122c 
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x 
y 
4.14 X, Y =. H 
4.15 X::: NH21 Y= Br 
4.16 X::: NH21 Y == H 
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Upon the recommendation of Professor Bill Denny of The University of Auckland, it was 
decided to incorporate a Me1N(CHz)xNH- (where x = 2 or 3) side chain into either C9 or C21 of 
the variolin core. This "semi-rational" approach to analogue synthesis was based on the 
assumption that if variolin B does intercalate, then such a side chain may enhance binding 
affinity for DNA and, consequently, increase the activity of the drug. A useful set of analogues 
would incorporate the side chain at either C9 or C21, with an NHz group at the other position, to 
give compounds 4.17--4.20. 
Synthesis 
4.17 (x::: 2) 
4.18 (x:::: 3) 
N.::::{NH(CH2)xNMe2 
~ /-N OH 
4.19 (x::: 2) 
4.20 (x = 3) 
Incorporation of the side chain MezN(CH1)xNH- (where x 2 or 3) into C9 of the variolin core 
structure 1.63 was readily achieved by heating the substrate at 100°C with Me1N(CHz)xNH2, 
using toluene as solvent. This reaction would probably benefit from being conducted in a sealed 
tube, as addition of further portions of the amine were required throughout the course of the 
reaction-presumably due to loss of the reagent by evaporation. The mono-substituted products 
and 4.22 were obtained in 84 and 89% yields respectively, after flash chromatography on 
either silica or alumina (Scheme 4.4). Product 4.22 (where x 3) was considerably more polar 
on silica than 4.21, however it could be purified readily by flash chromatography on alumina 
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using much less polar solvent mixtures than were required on silica. Deprotection of the 
methoxy groups by heating with sodium ethanethiolate in DMF gave pyridinols 4.23 and 4.24, 
along with small amounts of the inseparable SEt substituted products and 4.26. Both 4.23 
and 4.24 required very polar solvent systems for flash chromatography on silica (20-30% 
MeOH/CH2Ch + 0.5% NEt3). Attempted purification of 4,24 (the more polar compound of the 
two) on alumina or reversed phase silica was unsuccessful and contributed to the lower yield of 
4,24 (58%) compared with that of 4,23 (91 %). 
1.63 
4.23 (x::: 2) 
4.24 (x = 3) 
4.21 (x = 2) 
4.22 (x = 3) 
+ 
4.25 (x 2) 
4.26 (x 3) 
Scheme 4.4 Reagents and yields: (i) Me2N(CH2)xNH2 (2-6 equiv)/toluene/lOO °C (4.21 84%, 4.22 
89%); (ii) NaSEt (7 equiv)/DMF/60 °C (4.23 91%, 4.2458%). 
Introduction of an amine at C2 f requires prior oxidation of the remaining thiomethyl group. 
Unfortunately, attempted S-oxidation of 4.22 using m-CPBA did not cleanly produce the 
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corresponding sulfoxide or sulfone. The products of these reactions were not isolated but are 
thought to be products of tertiary N-oxidation. Even when the reaction was carried out at -60°C 
with only one equivalent of m-CPBA, it appeared that N-oxidation had taken place preferentially 
to S-oxidation. This conclusion was based on the IH NMR chemical shifts of the SCH3 signal, 
the N(CH3)2 signal and the -CH2NMe2 signal. First, the SCH3 signal was essentially unchanged 
from the starting material, at 0 2.63. However, the N(CH3)2 signal (easily identifiable as it 
integrates for six protons) appeared at 0 3.45-greater than 1 ppm downfield than was observed 
for the starting material. Similarly, the -CH2NMe2 signal, which was at 0 2.47 in the starting 
material, appeared at 0 3.78 in the new product. These values indicated that it was the nitrogen 
which had been oxidised rather than the sulfur. 
This result appeared to be a mmor drawback in the general usefulness of this system for 
analogue production, as selective introduction of a nucleophile followed by S-oxidation was a 
central element in our plan. However, an alternative option for the selective incorporation of 
different groups at C9 and C2' was available. It may be recalled from Chapter Three that 
attempted chromatography of the bis-sulfoxide 3.32 using MeOHlCH2Ch mixtures as the eluant 
led to the formation of a new product, thought to be structure 3.33. 
3.32 3.33 
This product is thought to arise from nucleophilic substitution of the 9-S0Me group at room 
temperature. Based on this result, the selective introduction of an amine nucleophile at C9 of 
3.32, without affecting the sulfoxide group at C2', may be feasible. Subsequent incorporation of 
a second substituent could be achieved at elevated temperature, as the sulfur is already at the 
required oxidation state for substitution to occur. 
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To investigate this possibility, the bis-sulfoxide was produced by reaction with 2 equivalents of 
m-CPBA at -60°C, rather than the usual -40 °C (Scheme 4.5). The lower temperature resulted 
in very clean production of no SMe peaks could be detected in the 1 H NMR spectrum, 
although some of the putative sulfoxide/sulfone 4.27 was produced. For the introduction of the 
amine, it was decided to conduct the reaction in CDCh so that the reaction could be easily 
followed by NMR spectroscopy. Thus, 1 equivalent of 3-(dimethylamino)propylamine was 
added to a solution of 3.32 and the corresponding sulfone 4.27 in CDCh, and the mixture was 
examined by IH NMR spectroscopy after 10 minutes. Pleasingly, most of the starting material 
had been consumed to give what appeared to the product of mono-substitution. No substitution 
of the 2'-S(O)xMe groups could be detected. 
To ensure complete reaction, the solution was left for a total of 17 h at room temperature. The 
reaction mixture was purified by flash chromatography on silica (using 30% MeOH/CH2Cb + 
1 % NEt3 as eluant), followed by reversed phase chromatography (using 50% MeOH/water + 
0.1% TFA), to give a mixture of amines 4.28 and 4.29 (Scheme 4.5). IH NMR spectroscopy 
indicated the ratio of sulfoxide 4.28 and sulfone 4.29 to be ~8: 1. These were not separated and 
the mixture was enriched enough in the sulfoxide to allow spectroscopic characterisation of this 
product. The extreme polarity of these compounds should be mentioned. The mixture of 
products was quite readily soluble in water, and yet was still easily characterised in CDCh. The 
(dimethylamino )propyl chain appears to be responsible for this solubilising effect. 
1.63 
N~S(O)xMe 
~ hN OMe 
3.32 (x 1) 
4.27 (x:::: 2) 
ii 
N~S(O)xMe 
~ hN OMe 
4.28 (x:::: 1) 
4.29 (x 2) 
Scheme 4.5 Reagents and yields: (i) m-CPBA (2 equiv)/CHCh/-60 °C to rt; (ii) 3-( dimethyl-
amino)propylamine (1 equiv)/CDC13/rt (8: 1 mixture of 4.28 and 4.29, 44% from 1.63); 
(iii) ~25% aq NH3/95 sealed tube. 
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Substitution of the sulfoxide/sulfone groups with an amine and subsequent methoxy deprotection 
would compound 4.18, an analogue directly comparable to variolin B (1.17), in which the 
C9 substituent NH2 has been swapped with X = NH(CH2)3NMe2. Due to a limited amount 
of material available in this late stage of the project, it was decided to directly introduce the 
amino group using aqueous ammonia rather than our p-methoxybenzylamine/deprotection 
protocol. Alvarez et al. had introduced the 2'-NH2 group of deoxyvariolin B in this manner, in 
good yield (90%).38 
However, when the mixture of sulfoxide 4.28 and sulfone 4.29 was heated in aqueous ammonia 
solution, mixtures of products were obtained. Characterisation could not be achieved due to 
difficulties in purifYing the mixture, and a lack of material prevented further investigation of this 
reaction. In the future, it may be prudent to use the protected amine with subsequent removal of 
the PMB group, as this has always resulted in clean substitution. 
While the desired analogues 4.17-4.20 have not yet been produced, the intermediates 
were tested for antitumour activity in the P388 assay. 
P388 Assay Results 
y Z IC50 (nglmL) 
4.8 NH2 SMe OH >25,000 
4.21 NH(CH2)2NMe2 SMe OMe 10,630 
NH( CH2)2NMe2 SMe OH 12,930 
4.22 NH(CH2)3NMe2 SMe OMe 3460 
4.24 NH(CH2)3NMe2 SMe OH 4130 
Table 4.3 P388 assay results of several variolin analogues. 
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Table 4.3 shows the results of the four (dimethylamino)alkyl variolin analogues. Included in the 
Table is the result of compound 4.8 from the earlier assay, so that a specific analysis can be 
made regarding the effect of substituting an amino group with a (dimethylamino ) alkyl chain. 
Pleasingly, all of the analogues showed increased activity over the free amine 4.8. 
This gives an indication that inclusion of the (dimethylamino)alkyl chain may be a useful 
method for increasing the activity ofthe variolins. 
When comparing the two different chains, it can be seen that the 3-carbon chain (4.22 and 4.24) 
gives greater activity than the 2-carbon chain (4.21 and 4.23). It is also apparent from these 
results that deprotection of the methoxy group results in a slight drop in activity. This was 
unexpected based on the assay results of variolin B (1.17) and O-methylvariolin B (4.1) shown in 
Table 4.1, where the natural product showed 20-fold greater activity than the O-methyl analogue 
4.1. 
It is difficult to rationalise these results without any knowledge of how these compounds are 
interacting with the biological system. That will be the focus of a separate study. The present 
results show that antitumour activity can be enhanced by appropriate substitution of the 9-NH2 
group. Based on these results and the results discussed earlier in the Chapter, it is reasonable to 
suggest that replacement of the thiomethyl group of compounds 4.21-4.24 with NH2 would 
further increase the activity, perhaps even beyond that of va rio lin B. 
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4.4 Summary 
Clearly, further work is required in this area. This will be detailed in the following Chapter. 
However, it is hoped that this brief examination has demonstrated the versatile nature of this 
synthesis for analogue production. Displacement of the 9-SMe group proceeds cleanly and 
selectively with all nucleophiles that have been investigated so far. Subsequent oxidation of the 
2'-SMe group should be straightforward provided that the C9-substituent does not contain any 
oxidisable groups. However, if this presents a problem, it has been shown that oxidation of both 
thiomethyl groups to the sulfoxides, followed by selective substitution of the 9-S0Me group at 
room temperature, is a viable process. Subsequent substitution of the 2'-SOMe at elevated 
temperature should not present any problems. Alternatively, if the same group is required at 
both C9 and C2', these can be introduced in the same step. 
Regarding the biological assays that have been carried out, it can be said that the results gained 
thus far are certainly of interest and provoke some thought regarding the biological role of the 
variolin compounds. Apart from the pleasing result that synthetic variolin B showed at least 
equal potency to the natural material, the most significant result concerned deoxyvariolin B 
(1.50). The fact that this analogue is also equipotent was unexpected, yet not unreasonable. In 
light of the fact that O-methylvariolin B (4.1) was 20-fold less active, this may be regarded as 
tenuous evidence that a general overall planar structure is required for biological activity. 
It has been shown that the degree of cytotoxicity is quite dependent on the nature of groups X, Y 
and Z (at C9, C2' and C4, respectively). Preliminary results show that incorporation of a 
(dimethyl amino ) alkyl chain at C9 can lead to a significant increase in cytotoxicity. These results 
certainly warrant a more thorough investigation into the effects of different substituents at these 
three points of variation. 
Su 
d 
tudies 
Chapter Five 1 
General 
This dissertation has covered the development of methodology that has culminated in the first 
total synthesis of variolin B (1.17). At the commencement of this work, no synthetic efforts 
directed towards the variolins had been reported in the literature. However, throughout the 
course of the work described in this thesis, several publications emerged regarding the syntheses 
of either fragments of the pyrido[3',2':4,5]pyrrolo[1 ,2-c ]pyrimidine ring system/5 or this system 
itself with subsituents attached at various positions?6, 37, 38 All of these syntheses consist of 
fundamentally the same retrosynthetic strategy-disconnection of the C9-NIO bond to give a 
substituted 7-azaindole (Figure 5.1a). The strategy used in this thesis employs an alternative 
disconnection, breaking the NIO-CIOa bond of the variolin core (Figure 5.1b). 
a b 
Figure 5.1 Retrosynthetic strategies for construction of the variolin core. 
To investigate this strategy, the triarylmethanol 2.3 was required. Chapter Two describes the 
synthesis of triarylmethanol by lithiation of iodopyrimidine and subsequent 10w-
temperature addition to the acid chloride (Scheme 5.1). After considerable experimentation, 
procedures were found to minimise the formation of several unwanted side-products, enabling 
the triarylmethanol to be produced in 56% yield for the double addition. Following this, a 
number of methods were attempted for forming the variolin core structure . Most of these 
were unsuccessful, being either too harsh for the present system or too unreactive. However, it 
was found that heating triarylmethanol 2.3 with a combination of triethylsilane and 
trifluoroacetic acid led to the formation of the variolin core structure 2.1 in low yield. 
Optimisation of this reaction allowed the core structure to be isolated in 34% yield. While this 
yield is modest, it should be noted that is produced in only three steps from 2.13. A number 
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of side-products isolated from this reaction give insights into the mechanism of cyc1isation, 
which appears to proceed by a quite different mechanism to that originally proposed. 
[ 
2.13 X = CI 
2.12 X = I 2.3 
TFAfTES 
34% 
2.1 
Scheme 5.1 Synthesis oftriarylmethanol2.3 and cyc1isation to the variolin core structure 2.1. 
The elaboration of core structure 2.1 to deoxyvariolin B (1.50) is also described in this Chapter. 
Oxidation of both thiomethyl groups using m-CPBA gave the bis-sulfoxide 2.69, which was 
readily substituted with 2 equivalents of p-methoxybenzylamine to give the bis-protected amine 
2.70 (Scheme 5.2). Removal of the PMB groups was accomplished using triflic acid at room 
temperature to give deoxyvariolin B (1.50) in six steps from commercially available 2-chloro-4-
(methylsulfanyl)pyrimidine (2.13). 
2.1 
[ 2.69 X = SOMe 
2.70 X = NH(PMB) 
1.50 
deoxyvariolin B 
Scheme 5.2 Elaboration of va rio lin core structure 2.1 to deoxyvariolin B (1.50). 
Chapter Five 160 
Application of the methodology described above to a syntbesis of variolin B required access to 
acid chloride 1.67 (Scheme 5,3). As detailed in Chapter Three, this was produced by a 
modification of Kasum and Prager's synthesis of the bromo-analogue.96 However, the double 
addition of lithio-species 1.66 to this acid chloride was unreliable, with the desired 
triarylmetbanol 1.65 never being isolated in greater than 15% yield. Despite investigating other 
pyrimidinyl-metal species (magnesium, cerium) and different conditions, no improvement could 
be made to the yield of 1.65. 
o OMe (MeOhCMe c,:o 
CI N 
5 steps 
" 
+ 
2.12 1.66 1.67 
1<15% 
1.65 
Scheme 5.3 Initial synthesis oftriarylmethanol1.65. 
Accordingly, a new synthesis of the triarylmethanol was developed. The knownl03-105 2-chloro-
4-methoxypyridine (3.8) was produced in three steps from commercially available 4-
nitropyridine-N-oxide (Scheme 5.4). It was found that clean metalation at C3 of 3.8 could be 
achieved using n-BuLi at low temperature (below -78°C). The resulting lithiated pyridine was 
to be reacted with symmetrical ketone (produced by reaction of 2 equivalents of the lithio-
species 1.66 with dietbyl carbonate). In the event, the reaction of these two species at -78°C 
resulted in the formation ofthe desired triarylmethanol1.65 in a reproducible yield of76%. 
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\76% 
1.65 
Scheme 5.4 Improved synthesis oftriarylmethanol1.65. 
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Unfortunately, sUbjection oftriarylmethanol1.65 to the optimum conditions for the formation of 
deoxy-core structure 2.1 resulted in the formation of 1.63 in only 9% isolated yield. However, 
further optimisation of this system improved the yield of 1.63 to 47% (Scheme 5.5). The major 
side-product in this reaction, uncyclised ether 3.25, was isolated in 28% yield. It was reasoned 
that this product could be eliminated by carrying out the cyclisation reaction on an alternative 
substrate, triarylmethylacetate 3.26. The acetate was produced in the same fashion as the 
triarylmethanol 1.65, except that the reaction was quenched with acetyl chloride. To our delight, 
when 3.26 was treated to the same cyclisation conditions that were used for the triarylmethanol 
1.65, the desired variolin core 1.63 was obtained in 75% yield, with no trace of the uncyclised 
product being detected. 
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47% 
+ 
Hi5 1.63 3.25 
3.15 
+ 
3.8 
3.26 
Scheme Synthesis of the variolin core 1.63 from triarylmethanol 1.65 and improved 
synthesis from the acetate 3.26. 
Core structure 1.63 was elaborated to the target, variolin B (1.17), following precedent 
established in the deoxy-series. However, one extra step is required for deprotection of the 
methoxy group. While boron tribromide was unsuccessful in this regard, sodium ethanethiolate 
proved very effective. However, due to nucleophilic substitution of the SMe groups when this 
step was carried out on 1.63, it was deemed more appropriate to conduct this step once the 
protected amines had been introduced. Thus, S-oxidation and nucleophilic substitution led to the 
bis-protected amine 3.34, the methoxy group of which was readily cleaved using sodium 
ethanethiolate (Scheme 5.6). To complete the synthesis, the PMB groups were removed with 
triflic acid to produce the target compound, variolin B (1.17). The overall yield for the eight step 
sequence was 13%, calculated from 2-chloro-4-(methylsulfanyl)pyrimidine (2.13)." 
• Two months after the publication of this work, Molina, Fresneda and coworkers published their total synthesis of 
variolin B, which proceeded in 16 steps and an overall yield of 1.2%.36b 
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1.63 
3.32 X::: SOMe. Y ::: Me 
3.34 X = NH(PMB). Y = Me 
3.35 X = NH(PMB). Y ::: H 
Scheme 5.6 Elaboration ofvariolin core structure 1.63 to variolin B (1.17). 
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1.17 
variolin B 
Significantly, now that a supply of synthetic variolin B has been established, further biological 
evaluation is now able to be carried out. As has been mentioned, preliminary results against a 
range of human tumour cell lines have seen variolin B enter into Safety Trials. This represents 
an important step forward in the development of variolin B into a therapeutic agent. 
Chapter Four highlights the utility of this synthesis for the production of analogues. Some 
preliminary undertakings in this area and the biological testing of these analogues were carried 
out, revealing that several analogues displayed modest to good activity in the P388 assay. It is 
hoped that further work in this area will bring to light other compounds of biological interest, 
and that ultimately, these studies will play a part in the effective treatment of cancer in its 
various forms. 
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The synthetic strategy utilised in the syntheses of both deoxyvariolin B (1.50) and the natural 
product, variolin B (1.17) must be fully exploited in the production of a wide range of analogues. 
In this regard, solid phase and/or combinatorial synthesis would be particularly suited to the 
variolins due to the high yielding and clean substitution of the thiomethyl groups, and facile 
deprotection of the methoxy group. The establishment of a library of compounds, varying in 
groups X, Y and Z (see Figure 5.2) would provide the basis for enhancement of the drug's 
biological activity and the fine-tuning of important pharmacological properties (stability, 
solubility, toxicity etc.). In particular, the family of (dimethylamino)alkyl analogues discussed 
in Chapter Four requires further investigations due to the promising early results. The synthesis 
of analogues 4.17-4.20 must be a specific goal in this area, with a particular emphasis on those 
compounds with a 3-carbon chain. 
Figure Points of variation available in the variolins. 
4.17 (x = 2) 
4.18 (x = 3) 
4.19 (x 2) 
4.20 (x 3) 
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Analogues which differ from variolin B in their gross architecture may also be accessible and of 
biological value. For example, the oxygen-containing products 2.42 and 2.44, which were 
obtained in the cyc1isation reaction to fonn the deoxy-core structure 2.1, would be expected to 
possess a slightly different shape from that of the natural product, which may result in increased 
or modified biological activity. Replacement of the thiomethyl groups with NH2 would be 
necessary to make a direct comparison of the shapes and bioactivities of these compounds with 
deoxyvariolin Band variolin B (Figure 5.3). 
Figure 5.3 
2.42 
.. 
2.44 
N--
H2N--4:. h 
N 
r N 
N:=:\ 
NH2 
Possible analogues of va rio lin B, differing in their overall shape. 
As has been mentioned, the successful total synthesis of variolin B has allowed its further 
biological investigation, which is necessary for its potential development into a medicinal agent. 
To complement these efforts, studies into the mode of action would allow the full potential of 
this compound to be realised. It has been suggested that variolin B may fonn a complex with 
DNA by intercalation. Accordingly, DNA binding studies123 may help to detennine what, if any, 
interaction variolin B has with DNA. If a positive connection is established, NMR studies and 
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X-ray crystallography may be useful in determining the sequence-specificity of the binding 
interaction and may identify specific points of contact between the drug and the DNA sequence. 
This would allow a more rational approach to the design of analogues with higher binding 
affinities and/or increased potency. It would be interesting to compare the outcome of this 
approach to drug-design to the results of producing a library of essentially random variolin 
analogues. 
However, an open mind must always be maintained as to the biological role of va rio lin B. Only 
once the cellular target is firmly established can any concrete hypothesis be given regarding the 
mode of action. Studies in this area will not only reveal how variolin B interacts with cellular 
processes, but may also open up new avenues to block the processes that cause the proliferation 
of cancerous cells. 
CHAPTER SIX 
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6.1 General 
Physical and Spectroscopic Techniques 
Melting points were obtained on either an Electrothennal heating block or a Reichert microscope 
hot-stage and are uncorrected. 
IH NMR spectra were obtained on either a Varian Unity 300 or Varian Inova 500 spectrometer, 
operating at 300 and 500 MHz respectively. l3C NMR were obtained on either a Varian Unity 
300 or a Varian XL 300 instruments at 75 MHz, or a Varian Inova 500 spectrometer operating at 
126 MHz, typically with a delay (d t ) of 2-3 s. In some cases, the Inova 500 was fitted with a 
Broadband Probe for l3C NMR spectra of very small or insoluble samples, as required; otherwise 
an Inverse Detection Probe was used. Chemical shifts are reported in parts per million (ppm) on 
the D scale, and were referenced to residual protonated solvent peaks: deuteriochlorofonn spectra 
were referenced to CHCh at DH 7.26 and CDCh at Dc 77.0; DMSO-d6 spectra were referenced to 
(CHDz)(CD3)SO at DH 2.50 and (CD3)zSO at Dc 39.6; methanol-d4 spectra were referenced to 
(CHDz)OD at DH 3.30. 
2D NMR experiments were canied out on either a Varian Unity 300 or Varian Inova 500 
spectrometer, operating at 300 and 500 MHz respectively. Both instruments were fitted with an 
Inverse Detection Probe and Pulsed Field Gradient driver. Assignments of H and C signals are 
given on the basis of COSY, HSQC, and HMBC or CIGAR experiments. In some cases, 
difference NOE or ID NOESY experiments were employed if uncertainty regarding structural 
assignments remained. HMBC and CIGAR experiments were usually obtained with an arrayed 
value ofnJcH = 4,9 Hz. 
IR spectra were obtained on a Shimadzu FTIR-8201 PC spectrophotometer. Spectra of solids 
were obtained from KBr pellets or by the diffuse reflectance method, or in a solution of CDCb 
using CaF 2 solution cells. Oils were run neat on KBr plates. Values are reported in 
wavenumbers (em-I). 
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Electron impact mass spectrometry was can"ied out on a Kratos MS80RFA at 70 eV and 4 kV 
accelerating potentiaL Electrospray mass spectrometry was carried out on a Micromass LCT at 
3.2 kV and 150°C (probe temperature), with nitrogen nebulisation at 150 Llh and desolvation at 
500 Lih. 
Chromatography 
Preparative HPLC was perfonned on a Shimadzu LC-4A instrument equipped with a Hewlett 
Packard 3390A integrator, using a reversed phase Dynamax® column (60 A; 250 x 10 mm) with 
a flow rate of 10-13 mL/min. 
MPLC was perfomed on a Merck Lobar® size B (310-25) LiChroprep® (RP-18) column (40-63 
11m), connected to a Mill-Royal D pump with a flow rate of mLimin. The system was 
equipped with a LKB Broma 2238 UVICORD SIT detector and a LKB Broma 2210 recorder 
with detection at 254 nm. 
Analytical thin layer chromatography (TLC) was conducted on aluminum-backed Merck 
:Kieselgel KG60F254 silica plates or aluminum-backed alumina type H plates. Plates were 
visualised by both short- and long-wave UV light. For compounds possessing the 
pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidine core, long-wave UV light was particularly usefuL 
Flash chromatography was routinely carried out using Merck Silica 60 (40-6311) following the 
procedure of Still and coworkers.92 Where stated, alumina flash chromatography employed 
Laporte Alumina, Grade (100-200 mesh). Reversed phase flash chromatography employed 
BakerBond Octadecyl CI8 (40 11m) reversed phase packing, which was recycled by successive 
washings with DMSO, CH2Ch, MeOH + 1% TF A and MeOH. Solvents used for 
chromatography were either purified by simple distillation (methanol) or from calcium hydride 
(ethyl acetate, dichloromethane and hexanes). Hexanes consisted of the fraction boiling at 50-70 
°C. Occasionally "CI8 cartridges" were used for removal of salts from very polar compounds. 
These were Bakerbond spe™ Octadecyl (CI8) Disposable Extraction Columns, packed with 500 
mg reversed phase octadecylsilane (CI8) bonded to silica gel (40 f.tm APD, 60 A). 
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Reagents and Solvents 
Reagents and solvents used in reactions were purified according to well-established 
procedures. 124 Tetrahydrofuran, diethyl ether and benzene were distilled from sodium 
benzophenone ketyl immediately prior to use. Toluene and dichloromethane were distilled from 
calcium hydride. Acetic anhydride was distilled from phosphorus pentoxide. 1,2-
Dichloroethane was distilled from phosphorus pentoxide and stored over 4 A molecular sieves 
under an atmosphere of nitrogen. Acetyl chloride was distilled from quinoline (10% v/v) 
immediately prior to use. N,N-Dimethylformamide was sequentially dried over two batches of 
freshly activated 4 A molecular sieves (2 x 24 h), before finally being stored under nitrogen over 
a third batch of 4 A molecular sieves.125 To remove residual dimethyl amine, the solvent was 
evacuated (~0.1 mm Hg) for at least 15 min prior to use. Methanol was distilled from 
Mg(OMe h and stored under nitrogen. Diethyl carbonate was dried over calcium chloride and 
then distilled under argon, collecting the fraction boiling at 124°C. Phosphorus oxychloride was 
fractionally distilled, collecting the fraction boiling at 106°C. Solutions of n-BuLi in hexanes 
were titrated in diethyl ether with 2-butanol, using 1,10-phenanthroline as an indicator.126 p-
Bromoanisole was passed through a plug of neutral alumina immediately prior to use. Unless 
otherwise stated, m-CPBA was washed with pH 7.5 buffer to remove m-chlorobenzoic acid. 
Concentrated aqueous ammonia solution was of analytical grade, and was stated to contain ~25% 
ammonia, density 0.91 g/mL. 
Unless otherwise stated, all reactions were performed in oven- or flame-dried glassware under an 
atmosphere of dry argon or nitrogen. Reaction temperatures refer to the external bath 
temperature. Where the term "standard workup" or a similar phrase is used, aqueous phases 
were extracted with at least three portions of ethyl acetate or dichloromethane. The organic 
extracts were washed with brine and dried over MgS04 or Na2S04. Drying agents were filtered 
off, prior to concentration of solvents on a Buchi rotary evaporator. A high vacuum pump was 
used to remove any remaining solvent. 
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Notes on Nomenclature 
Due to the need for consistency and clarity of compound names, the naming of some compounds 
described in this dissertation deviates from IUP AC nomenclature in the following manner. For 
fused polycyclic compounds (with the exception of the ketone in 2.44), no characteristic groups 
have been cited as suffix (i.e. appointed as principal group). This in no way creates any 
ambiguity in the naming of compounds, and is in accord with the IUP AC recommendations in 
such a situation. il7 
For example, in this thesis, compound 4.9 is named 
4-Methoxy~9-(4-methoxybenzylamino)-5-[2-(methylsulfanyl)pyrimidin-4-yl]pyrido[3',2':4,5]pyrrolo 
[1,2-c]pyrimidine 
rather than IUP AC nomenclature 
(4-Methoxybenzyl)-{4-methoxy-5-[2-(methylsulfanyl)pyrimidin-4-yl]pyrido[3',2':4,5]pyrrolo[1,2-c] 
pyrimidin-9-yl}amine. 
4.9 
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Antitumonr P388 Assay 
Samples were prepared for P388 assays by dissolving a known mass (0.3-1.0 mg) in MeOH or 
MeOH/CH2Cb (up to 1:3). In some cases, small amounts «1 JlL) of TFA were added to 
increase solubility. Solvent blanks were also submitted in the assay as controls. A two-fold 
dilution series of the sample was incubated for 72 h with P388 (murine leukaemia) cells. The 
concentration of sample required to reduce the P388 cell growth by 50% (comparative to control 
cells) is determined using the absorbance values obtained when the yellow dye MTT tetrazolium 
is reduced by healthy cells to the purple MTT formazan (Figure 6.1). The result is expressed as 
an ICso in ng/mL. 
MTT tetrazolium 
(yellow) 
[R] 
P388 cells 
.. 
MTT formazan 
(purple) 
Figure 6.1 Reduction ofMTT tetrazolium by viable cells of the P388 assay. 
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6.2 in Chapter 
4-Iodo-2-(methylsulfauyl)pyrimidine 2.1260 
This was prepared from 4-chloro-2-(methylsulfanyl)pyrimidine (2.13, 14.3 g), following the 
procedure of Undheim et al.6o To ensure the optimum yield, a magnetic flea of at least 50 mm 
was required for efficient stirring, and it was essential that large lumps were regularly broken up 
with a glass rod, to give a homogeneous brown paste. After isolation of the crude material, 
recrystallisation from hexanes gave pure iodide 2.12 as large white needles (17.8 g, 79%). 
Mp: 48-50 °C (hexanes) (lit60 °C). 
IH NMR (300 MHz, CDCb): 82.54 (s, 3H, SCH3), 7.40 (d, J= 5.1 Hz, 1H), 8.00 (d, J= 5.1 Hz, 
1H). 
2-Chloronicotiuoyl chloride 2.461 
o 
CI~ 
CI N 
2-Chloronicotinic acid (2.19, 4.90 g, 31.1 mmol), thionyl chloride (12 mL, 0.16 mol) and dry 
DMF (0.3 rnL, 12 mol%) were stirred at reflux for 26 h, using a CaCh drying tube to exclude 
atmospheric moisture. After cooling, thionyl chloride was removed in vacuo, and the product 
was purified by Kugelrohr distillation (110 °c, 0.03 mm Hg) to give acid chloride as a white 
crystalline solid (5.30 g, 97%). The solid was stored under argon and used within days of 
distillation. 
Mp: 38-41 °C, sweats at 34°C (lit50 39-44 0c). 
IH NMR (300 MHz, CDCb): 87.45 (dd, J= 4.6,7.9 Hz, 1H), 8.41 (dd, J 1.8, 7.9 Hz, 1H), 
8.61 (dd, J= 1.8,4.6 Hz, lH). 
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(2-Chloropyridin-3-yl)bis-[2-(methylsulfanyl)pyrimidin-4-yl] methanol 2.3 
o 
+ CI~ 
CI N 
The reactor (Figure 2.8, p 41) was charged with iodide 2.12 (5.00 g, 19.8 mmol) and freshly 
distilled (270 mL), and cooled to -95°C (MeOH!Nz). A solution of n-BuLi in hexanes 
(1.57 M, 12.6 mL, 19.8 mmol) was carefully added to the stirred solution over 20 min, while 
maintaining the temperature at -95°C. After 20 min, a solution of acid chloride 2.4 (1.17 g, 6.67 
mmol) in (10 mL) was added to the dark mixture over 5 min. After 3.5 hat -95°C, the 
reaction was quenched with methanol (1 mL) and allowed to warm overnight. Excess THF was 
removed in vacuo and the residue was taken up in waterlEtOAc and worked up according to the 
standard procedure to give the crude material. Flash chromatography on silica, eluting with 
50% EtOAc/hexanes, gave triarylmethanol 2.3 (1.24 g, ~93% pure by lH NMR spectroscopy) in 
addition to a number of other side products, one of which was the biarylmethanol 
Fractions which contained mixtures of 2.3 and 2.23 were subjected to oxidation by MnOz (2 g) 
in refluxing benzene (12 mL). Filtration through celite (rinsing with boiling EtOAc) and 
concentration in vacuo gave a mixture of ketone 2.11 and the desired triarylmethanoI2.3, which 
was readily separated by chromatography to yield a further 343 mg of 2.3 (~95% pure by 1 H 
NMR spectroscopy). Thus, 2.3 was obtained as an orange foam (1.58 g, ~93% pure, 56% yield). 
An analytical sample was obtained by flash chromatography on reversed phase silica, eluting 
with 75% MeOH/water, to give an off-white solid. 
Mp: 54-58°C. 
(300 MHz, CDCh): 82.49 (s, 6H, SCH3), 6.33 (s, IH, OH), 7.17 (dd, J= 4.9, 7.8 Hz, 
IH, H-5), 7.23 (dd, J 2.0,7.8 1H, H-4), 7.40 (d, J= 5.1 Hz, 2H, H-5'), 8.38 (dd, J= 2.0, 
4.9 Hz, 1H, H-6), 8.56 (d, 5.1 2H, H-6'). 
BC NMR (75 MHz, CDCh): 8 14.2 (SCH3), 79.4 (Ar3COH), 114.8 (C-5'), 121.7 (C-5), 136.8 
(C-3), 138.9 (C-4), 149.1 (C-6), 151.5 (C-2), 158.0 (C-6'), 168.8 (C-4'), 171.8 (C-2'). 
(CDCh): \)max 3381, 1549. 
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MS (EI): mlz (reI intensity) 3911393 (59/25),356 (100), 2661268 (71129), 
HRMS (El): Calcd for C16HllsClNs032S2 (M+) 391.0328, found 391.0332. 
(68),45 (53). 
Other compounds isolated from this reaction and their spectroscopic data are listed below. 
a) 2-(Methylsulfanyl)-4,6-bis[2-(methylsulfanyl)pyrimidin-4-yl] pyrimidine 
N?' -:/ N h 14' 5 ~ ~ 
MeS 2' N I ""::::: 4 N SMe 
N~N 
MeS 
This compound was isolated as a tan solid. 
Mp: dec at 236°C. 
175 
1H NMR (300 MHz, CDCh): 82.69 (s, 6H, 2'-SCH3), 2.72 (s, 3H, 2-SCH3), 8.05 (d, J 5.1 Hz, 
2H, H-6'), 8.73 (d, 5.1 2H, H-5'), 9.08 (s, 1H, H-5). 
BC NMR (75 MHz, CDCb): 8 14.2 (2'-SCH3), 14.4 (2-SCH3), 109.6 (C-5), 112.8 (C-5'), 158.9 
(C-6'), 160.5 (C-4' or C-4), 162.7 (C-4 or C-4'), 173.1 (C-2'), 173.2 (C-2). 
MS (EI): mlz (reI intensity) 374 (100),359 (16), 345 (15). 
HRMS (El): Calcd for ClsH14Nl2S3 (M+) 374.0442, found 374.0452. 
b) 4,4'-Bis-(2-methylsulfanyl)pyrimidine 2.2160 
N~N 
>=1'1 N-\ 
MeS SMe 
This compound was isolated as an off-white solid. 
Mp: 187-189 °C, softens at 185°C (lit60 184-185 °C). 
1H NMR (500 MHz, CDCh): 82.65 (s, 6H), 8.04 (d, J= 5.1 Hz, 2H), 8.71 (d, J= 5.1 Hz, 2H). 
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c) (2-Chloropyridin-3-yl)- [2-( methylsulfanyl)pyrimidin-4-yl]methanone 2.11 
o 
This compound was isolated as colourless blocks after recrystallisation from benzenelhexanes. 
Mp: 107-109 °C (benzene/hexanes). 
(300 MHz, CDCh): 02.37 (s, 3H, SCH3), 7.40 (dd, J 4.9, 7.6 Hz, tH, H-5), 7.64 (d, 
J 4.9 tH, H-5'), 7.88 (dd, J 2.0, 7.6 Hz, 1H, H-4), 8.56 (dd, J = 2.0, 4.9 Hz, lH, H-6), 
8.82 (d, J= 4.9 Hz, 1H, H-6'). 
13C (75 MHz, CDCb): 0 14.0 (SCH3), 113.4 (C-S'), 122.0 (C-S), 133.3 (C-3), 139.1 (C-4), 
148.5 (C-2), 151.4 (C-6), 158.6 (C-4'), 159.4 (C-6'), 173.6 (C-2'), 192.8 (C=O). 
IR (KBr): t)max 1690, 1556. 
MS (El): mlz (reI intensity) 267/269 (S/6), 230 (100), 140/142 (55/18), 1121114 (39/13). 
AllJl"-lYlllU> (El): Calcd for CllHl5CIN3032S (Ml265.0077 found 265.0072. 
d) (2-Chloropyridin-3-yl)- [2-( methylsulfanyl)pyrimidin-4-yI] methanol 2.23 
This compound was isolated as a viscous gum. 
(SOO MHz, CDCh): 0 2.58 (s, 3H, SCH3), 4.88 (d, J 3.9 Hz, 1H, OH), 6.13 (d, J 
3.9 lH, Ar2CHOH), 7.00 (d, J 5.1 Hz, 1H, H-5'), 7.28 (dd, J 4.8, 7.8 Hz, tH, H-5), 7.80 
(dd, 1.8, 7.8 Hz, 1H, H-4), 8.36 (dd, J 1.8,4.8 Hz, 1H, H-6), 8.46 (d, J= S.l Hz, 1H, H-6'). 
13C (7S MHz, CDCb): 0 14.0 (SCH3), 70.5 (Ar2CHOH), 113.0 (C-5'), 123.0 (C-5), 136.0 
(C-3), 137.7 (C-4), 148.9 (C-6), 149.5 (C-2), 157.6 (C-6'), 168.0 (C-4'), 172.3 (C-2'). 
IR (CDCb): t)max 3416, 1562. 
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MS (El): mlz (reI intensity) 267/269 (6/2), 265 (10),232 (83), 231 (61),230 (100), 216 (39), 214 
(30), 140/142 (84/50), 125 (42), 112/114 (80/34), 76 (46). 
HRMS (El): Calcd for Cl1HlON3032S (~ Cl) 232.0545, found 232.0542. 
9-(Methylsulfanyl)-5-[2-( methylsulfanyl)pyrimidin-4-yl]pyrido [3' ,2' :4,5]pyrrolo [1 ,2-c] 
pyrimidine 2.1 
Triarylmethanol2.3 (97% pure, 497 mg, 1.23 mmol) was heated with TFA (0041 mL, 5.3 mmo1) 
and TES (1.65 mL, 10.3 mmo1) at 75°C for 66 h. After concentration of excess reagents in 
vacuo the residue was dissolved in CH2Clz (65 mL) and neutralised with 5% aq NaHC03 
solution (40 mL). After extraction with CH2Clz the extracts were worked up in the usual 
manner. Analysis of the IH NMR spectrum of the crude mixture revealed the presence of the 
title compound, and lesser amounts of 2.39 and 2.42, in addition to several unidentified products. 
Repeated flash chromatography on silica, eluting with 37-70% EtOAc/hexanes, gave the variolin 
core 2.1 as a yellow solid (143 mg, 34%). 
Mp: 210-211 °C (MeOH/1,2-dichloroethane). 
NMR (500 MHz, CDCh): 02.68 (s, 3H, 2'-SC1l3), 2.74 (s, 3H, 9-SC1l3), 7.36 (d, J = 5.1 
lH, H-5'), 7.52 (dd, J= 4.5,8.2 Hz, tH, H-3), 7.83 (d, J 6.8 Hz, lH, H-7), 8.07 (d, J= 6.8 
lH, H-6), 8.52 (d, J 5.1 Hz, 1H, H-6'), 8.61 (dd, J 1.5,4.5 Hz, 1H, H-2), 8.65 (dd, J = 1.5, 
8.2 1H, H-4). 
NMR (75 MHz, CDCh): 0 14.3 (2'-SCH3), 14.9 (9-SCH3), 101.4 (C-5), 108.3 (C-6), 112.9 
(C-5'), 120.7 (C-4a), 120.8 (C-3), 128.0 (C-4), 137.5 (C-5a), 139.9 (C-7), 141.8 (C-2), 143.0 (C-
lOa), 1 1 (C-9), 156.6 (C-6'), 160.9 (C-4'), 172.4 (C-2'). 
(El): mlz (rel intensity) 339 (100), 306 (10), 220 (14), 133 (12). 
(El): Calcd for C16H13Nl2S2 ~) 339.0612, found 339.0617. 
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Other compounds isolated from this reaction and their spectroscopic data are listed below (from 
least to greatest polarity). 
a) 9-(Methylsulfanyl)-5-[2-( methylsulfanyl)pyrimidin -4-yloxy] pyddo [3' ,2': 4,5] pyrrolo 
[1,2-c]pyrimidine 2.42 
~}-SMe 
o 
.. 1-0 
( ~W-ZN~ 
N==\ 
SMe 
This could be further purified by reversed phase preparative HPLC, eluting with 85% 
CH3CN/water + 0.05% TF A, to give a yellow solid. 
Mp: 205-207 °C, sweats at 203°C (MeOHlwater). 
NlVIR (300 MHz, CDCb): 02.21 (s, 3H, 2'-SCH3), 2.72 (s, 3H, 9-SCH3), 6.62 (d, J= 5.4 Hz, 
IH, H-5'), 6.96 (d, J 6.6 Hz, IH, H-6), 7.39 (dd, J = 4.8,8.2 Hz, IH, H-3), 7.49 (d, J= 6.6 Hz, 
lH, H-7), 7.85 (dd, J 1.5, 8.2 Hz, IH, H-4), 8.39 (d, J 5.4 Hz, IH, H-6'), 8.56 (dd, J= 1.5, 
4.8 Hz, IH, H-2). 
Be NMR (75 MHz, CDCh): 0 13.9 (2'-SCH3), 14.6 (9-SCH3), 102.2 (C-5'), 104.8 (C-6), 115.6 
(C-4a), 119.0 (C-5), 119.7 (C-3), 125.4 (C-4), 126.2 (C-5a), 135.4 (C-7), 139.0 (C-I0a), 141.5 
(C-2), 153.5 (C-9), 158.8 (C-6'), 168.5 (C-4'), 173.2 (C-2'). 
MS (EI): mlz (reI intensity) 355 (94), 308 (17),230 (100), 143 (19), 113 (18), 73 (15). 
JI. ...... ,J.V.lL1J (EI): Calcd for C16H13Ns0 32S2 (M+) 355.0562, found 355.0559. 
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b) (2-Chloropyridin-3-yl)-[2-(methylsulfanyl)pyrimidin-4-yl]-[2-(metbylsulfanyl) 
pyrimidin-4-yioxy]metbane 2.39 
179 
This could be further purified by flash chromatography on reversed phase silica, eluting with 
80% MeOHlwater, followed by flash chromatography on silica, eluting with 50% 
EtOAclhexanes, to give a viscous gum. 
NMR (300 MHz, CDCh): (52.43 (s, 3H, 2"-SCH3), 2.44 (s, 3H, 2'-SCH3), 6.58 (d, J= 5.9 
IH, H-5"), 7.19 (d, J = 4.9 IH, H-5'), 7.27 (dd, J 4.8, 7.6 Hz, IH, H-5), 7.43 (s, IH, 
Ar2CHOAr), 7.84 (dd, J = 1.8, 7.6 Hz, IH, H-4), 8.31 (d, J = 5.9 IH, H-6"), 8.38 (dd, J = 
1.8,4.8 Hz, IH, H-6), 8.54 (d, 4.9 Hz, IH, H-6'). 
(75 MHz, CDCh): (5 13.91 (SCH3), 13.93 (SCH3), 74.3 (Ar2CHOAr), 103.2 (C-5"), 
113.4 (C-5'), 122.6 (C-5), 132.5 (C-3), 137.6 (C-4), 149.3 (C-6), 150.1 (C-2), 157.8 (C-6'), 158.0 
(C-6"), 165.3 (C-4'), 166.8 (C-4"), 172.3 (C-2"), 172.9 (C-2'). 
MS (ES): mlz (reI intensity) 392/394 (100/40), 356 (19), 250/252 (39/18). 
HRMS (ES): Calcd for C16H1535ClN5032S2 (MH+) 392.0407, found 392.0409. 
9-(Methylsulfanyl)-5a-[2-( methylsulfanyl)pyrimidin-4-yl]-5aH-pyrido [3',2 i: 4,5] pyrrolo 
[1,2-c]pyrimidin-5-one 2.44 
Triarylmethano12.3 (500 mg, 1.28 mmol) was heated with TF A (0.82 mL, 11 mmol) at 80°C for 
10 h. After removal of excess TFA in vacuo, the residue was dissolved in CH2Ch (65 mL) and 
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neutralised with 5% aq NaHC03 solution (40 mL). After extraction with CH2Ch the extracts 
were worked up as usual. NMR analysis of the crude material showed it to contain 2.44 as the 
major product, together with lesser amounts of 2.39, 2.42 and 1. Flash chromatography on 
silica, eluting with 30-50% EtOAclhexanes, followed by flash chromatography on reversed 
phase silica, eluting with 75% MeOHlwater, gave ketone 2.44 (~95% pure by lH NMR, 70 mg, 
15%). An analytical sample was obtained by reversed phase preparative HPLC, eluting with 
75% CH3CN/water + 0.05% TFA, to give a yellow solid. This compound slowly decomposes 
over a matter ofweelcs at room temperature. 
Mp: 52~55 °c. 
1H NMR (500 MHz, CDC13): b 2.38 (s, 3H, 2'-SCH3), 2.52 (s, 3H, 9-SCH3), 5.96 (d, J 6.6 Hz, 
IH, H-6), 6.76 (d, J= 6.6 1H, H-7), 7.12 (dd, J= 4.9,7.4 Hz, 1H, H-3), 7.14 (d, J 4.9 Hz, 
1H, H-5'), 7.96 (dd, J 1.6, 7.4 Hz, 1H, H-4), 8.47 (d, J = 4.9 Hz, 1H, H-6'), 8.66 (dd, J 1.6, 
4.9 Hz, 1H, H-2). 
13C NMR (75 MHz, CDCh): b 14.08 (SCH3), 14.14 (SCH3), 70.8 (C-5a), 107.1 (C-6), 112.66 
(C-5'), 112.71 (C-4a), 118.8 (C-3), 134.6 (C-4), 136.9 (C-7), 154.6 (C-9), 156.2 (C-2), 158.1 (C-
6'), 164.3 (C-10a), 165.4 (C-4'), 172.8 (C-2'), 193.2 (C-5). 
IR (CDCh): Dmax 1732, 1414. 
HRMS (ES): Calcd for C16HI4Ns032S2 (~) 356.0640, found 356.0642. 
(2-Chloropyridin-3-yl)-( 4-methoxyphenyl)-[2-( methylsulfanyl)pyrimidin-4-yl] methanol 
2.49 
OMe 
A solution of n-BuLi in hexanes (1.6 M, 85 ilL, 0.14 mmol) was added dropwise to a stirred 
solution of p-bromoanisole (17 ilL, 0.14 mmol) in freshly distilled THF (1.4 mL) at -78°C 
(acetone/C02), After 20 min at -78 °c the reaction was cooled to -97°C (MeOHIN2) and a 
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similarly cooled solution of 2.11 (36 mg, 0.14 mmol) in THF (1.5 mL) was added. After 0.5 hat 
-97 DC, the reaction was allowed to warm to rt over ~3 h. The mixture was shaken with sat aq 
]'ffi4CI solution and worked up with EtOAc in the usual maImer. Flash chromatography on 
silica, eluting with 45% EtOAc/hexanes, gave alcohol 2.49 as a pale yellow gum (23 mg, 45%). 
IH NMR (300 MHz, CDCh): 8 2.48 (s, 3H), 3.82 (s, 3H), 5.32 (s, 1H), 6.88-6.91 (m, 2H), 6.95 
(d, J= 5.1 Hz, 1H), 7.15 (dd, J= 4.4,7.8 Hz, 1H), 7.29-7.33 (m, 3H), 8.35 (dd, J= 2.0,4.4 Hz, 
1H), 8.50(d,J=5.1 Hz, 1H). 
IR (CDCh): U max 3420, 1560. 
MS (El): mlz (reI intensity) 373/375 (96/38), 355/357 (47/25), 340 (33), 338 (37), 322 (53), 321 
(72),294 (30), 261 (30),248/250 (100/37), 140 (50), 135 (76), 125 (48), 77 (28). 
HRMS (El): Calcd for C18H1635CIN30/2S (M+) 373.0652, found 373.0660. 
5-(2-Chloropyridin-3-yl)-8-methoxy-1-( methylsulfanyl)pyrimido [1 ,6-a] indole 2.52 
OMe 
Alcohol 2.49 (12 mg, 0.032 mmol) was dissolved in TFA (0.5 mL), producing a yellow-green 
solution. TES (6 ilL, 0.04 mmol) was added and the mixture was stirred at 70 DC for 24 h. 
Further portions of TF A (0.5 mL) were added after 3 and 20 h. After neutralisation with sat aq 
NaHC03 solution and standard workup (EtOAc), the crude material was purified by flash 
chromatography on silica, eluting with 35% EtOAc/hexanes, to give the title compound 2.52 as a 
yellow-green solid (6 mg, 53%). Recrystallisation by slow evaporation of a hexanes solution 
gave pale green needles suitable for X-ray diffraction analysis. 
Mp: 136-137 DC (hexanes). 
IH NMR (300 MHz, CDCh): 82.82 (s, 3H, SCH3), 3.98 (s, 3H, OCH3), 6.86 (d, J= 6.6 Hz, 1H, 
H-4), 7.15 (dd, J= 2.3,9.0 Hz, 1H, H-7), 7.37 (dd, J= 4.6,7.6 Hz, 1H, H-5'), 7.44 (d, J= 6.6 
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lH, H-3), 7.49 (d, J 9.0 lH, H-6), 7.S3 (dd, J= 2.0,7.6 Hz, lH, H-4'), 8.26 (d, J 2.3 
Hz, lH, H-9), 8.47 (dd, 2.0,4.6 1H, H-6'). 
NMR (75 MHz, CDCh): 3 14.7 (SCH3), 55.9 (OCH3), 100.1 (C-9), 103.5 (C-5), 107.8 (C-
4), 114.4 (C-7), 119.3 (C-6), 122.4 (C-5'), 123.5 (C-5a), 129.3 (C-3'), 130.0 (C-9a), 133.3 (C-4a), 
134.1 (C-3), 141.4 (C-4'), 148.4 (C-6'), 151.6 (C-2'), 153.2 (C-l), 1 .5 (C-S). 
MS (EI): mlz (reI intensity) 355/357 (100/37), 340/342 (69/26). 
HRMS (EI): Calcd for ClsHll5ClN3032S (M+) 355.0546, found 355.0536. 
Crystal data and structure refinement for 2.52: 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 22.48° 
Refinement method 
Data 1 restraints 1 parameters 
2 
Goodness-of-fit on F 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole 
C18H14CIN30S 
355.83 
169(2) K 
0.71073 A 
Rhombohedral 
R-3 
a = 34.678(7) A 
b = 34.678(7) A 
c = 7.510(2) A 
7821(3) A3 
18 
3 
1.360 Mg/m 
-1 
0.349mm 
3312 
3 
0.90 x 0.08 x 0.07 mm 
2.03 to 22.48°. 
a =90°. 
-37:::;h:::;37,-37:::;k:::; -8:::;1:::;4 
24735 
2268 [R(int) = 0.1483] 
100.0 % 
Full-matrix least-squares on F2 
2268/0/254 
1.160 
R1 = 0.1317, wR2 0.31 
R1 = 0.1664, wR2 = 0.3406 
1.654 and -0.660 e.A-3 
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5-[2-(Metbylsulfanyl)pyrimidin-4-yl]-9-(1-pyrrolidinyl)pyrido[3',2' :4,5]pyrrolo[1,2-c] 
pyrimidine 2.66 
183 
A mixture of 2.1 (20 mg, 0.059 mmol) , and pyrrolidine (50 ilL, 0.60 mmol) were heated in 
dioxane (0.5 mL) at 80°C. A further portion ofpyrrolidine (50 ilL, 0.60 mmol) was added after 
15 h. After 27 h, the reaction mixture was concentrated in vacuo, and the residue was purified 
by flash chromatography on silica, eluting with 55-75% EtOAclhexanes, to give amine 2.66 as a 
yellow solid (11 mg, 51 %). 
In NMR (500 MHz, CDCh): 8 1.98-2.01 (m, 4H, H-3"), 2.65 (s, 3H, 8CH3), 3.82 (t, J= 6.6 Hz, 
4H, H-2"), 7.27 (d, J = 5.4 Hz, 1H, H-5'), 7.38 (dd, J = 4.6, 7.9 Hz, 1H, H-3), 7.58-7.61 (m,2H, 
H-6, H-7), 8.42-8.44 (m, 2H, H-2, H-6'), 8.62 (dd, J= 1.5, 7.9 Hz, IH, H-4). 
13e NMR (75 MHz, CDCb): 8 14.2 (8CH3), 25.5 (C-3"), 51.3 (C-2"), 100.5 (C-5), 103.5 (C-6), 
112.9 (C-5'), 120.1 (C-3), 121.7 (C-4a), 127.6 (C-4), 140.9 (C-2), 141.8 (C-5a), 142.2 (C-7), 
143.6 (C-lOa), 149.9 (C-9), 156.3 (C-6'), 161.3 (C-4'), 172.2 (C-2'). 
9-(Metbylsulfallyl)-5-[2-( metby lsulfillyl)pyrimidin-4-yl]pyrido [3',2' :4,5]pyrrolo[1 ,2-c] 
.. LO"' ..... " .... 2.67 
A solution of Oxone® (55 mg, 0.18 mmol) in water (1 mL) was added dropwise to a solution of 
(10.0 mg, 29.5 /lmol) in freshly distilled THF (3 mL) at rt. After 40 min the reaction was 
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quenched with sat aq NaHC03 solution and worked up in the usual manner with CH2Ch to give 
7.9 mg of crude material. Flash chromatography on silica, eluting with 5-10% MeOHIEtOAc, 
mono-sulfoxide as a yellow gum (2.5 mg, 24%). 
(500 MHz, CDCh): () 2.74 (s, 3H, 9-SCH3), 3.03 (s, 3H, 2'-S(O)CH3), 7.56, (dd, J 
4.5,8.2 1H, H-3), 7.72 (d, J 5.6 Hz, 1H, H-5'), 7.94 (d, J= 6.5 Hz, lH, H-7), 8.32 (d, J 
6.5 IH, H-6), 8.61 (dd, J= 1.5, 4.5 Hz, 1H, H-2), 8.70 (dd, J = 1.5, 8.2 Hz, 1H, H-4) 8.77 (d, 
5.6 Hz, IH, H-6'). 
13C (75 MHz, CDCh): () 15.0 (9-SCH3), 40.3 (2'-S(O)CH3), 100.5 (C-5), 108.8 (C-6), 
116.9 (C-5'), 120.6 (C-4a), 121.4 (C-3), 128.1 (C-4), 139.3 (C-5a), 141.6 (C-7), 142.2 (C-2), 
143.4 (C-I0a), 155.6 (C-9), 157.6 (C-6'), 162.5 (C-4'), 173.6 (C-2') . 
...... .11.,.1 .... "" (ES): Calcd for C16H14N5032S2 (MH+) 356.0640, found 356.0648. 
9-(MethylsulfinyJ)-5-[2-( methylsulfinyl)pyrimidin-4-yl]pyrido [3' ,2' :4,5]pyrrolo[1 ,2-c] 
pyrimidine 2.69 
Under atmospheric conditions, a solution of m-CPBA in chloroform (10 mg/mL) was cooled to 
-15°C (icelNaCl), and a portion (1.9 mL, 0.11 mmol) was added dropwise to a similarly cooled 
solution of core structure (20 mg, 0.059 mmol) in chloroform (3.4 mL). Analysis by TLC 
showed all starting material to be consumed. The mixture was allowed to warm to ~O °C and 
was neutralised with sat aq NaHC03 solution. Extraction with CH2Ch and standard workup 
gave a yellow solid which was predominantly a mixture of diastereomeric bis-sulfoxides 2.69. 
The crude mixture was used without purification, however the bis-sulfoxides had the following 
spectroscopic characteristics: 
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1H NMR (500 MHz, CDCh): (As most signals for the diastereoisomers coincide, they are all 
quoted as multiplets.) (5 3.03 (m, 3H), 3.23 (m, 3H), 7.62-7.65 (m, IH), 7.77 (m, IH), 8.23 (m, 
IH), 8.63 (m, IH), 8.66-8.69 (m, IH), 8.78-8.80 (m, IH), 8.85 (m, IH). 
9-( 4-Methoxybenzylamino )-5-[2-( 4-methoxybenzylamino )pyrimidin-4-yl]pyrido[3' ,2' :4,5] 
pyrrolo[1,2-c]pyrimidine 2.70 
OMe ~~4'" 3 UI H :0-N 2' N 1'" 2'" 
6' \ ~ 
,\ /)N 
5' 
---.JIo>-JIo' 5 
6 If 
7 ~ N 
N~9 
HNo" 2" ~ ~ 3" 
- 411 
OMe 
The crude oxidised material 2.69 was heated with an excess of p-methoxybenzylamine (0.20 mL, 
1.5 mmol) at 90°C for 14 h. The red paste thus obtained was directly purified by flash 
chromatography on silica, eluting with 10% CH3CN/CHzClz then 2-2.5% i-PrOHlCHzClz, to 
give bis-amine 2.70 as a yellow-orange solid (~95% pure by [H NMR spectroscopy, 20 mg, 62% 
over two steps). 
Mp: 54-60°C. 
1 H NMR (300 MHz, CDCh): (5 3.808 (s, 3H, OCH3), 3.811 (s, 3H, OCH3), 4.69 (d, J 5.9 Hz, 
2H, 2'-NHCH2Ar), 4.89 (d, J = 5.4 Hz, 2H, 9-NHCH2Ar), (br, 1H, 2'-NH), 6.89-6.93 (m, 
4H, PMB H-3", PMB H-3"'), 6.98 (d, J 5.4 Hz, 1H, H-S'), 7.33-7.42 (m, 6H, H-6, PMB 
H-2", PMB H-2"'), 7.63 (d, J= 6.8 Hz, 1H, H-7), 8.27 (dd, 1.0,5.2 Hz, 1H, H-2), 8.31 (d, J= 
5.4 Hz, lH, H-6'), 8.56 (br m, 1H, H-4), 10.36 (br t, J = 5.4 lH,9-NH). 
Be NMR (75 MHz, CDCh): (5 44.3 (9-NHCHzAr), 45.1 (2'-NHCHzAr), 55.3 (both OCH3), 
100.6 (C-5), 101.5 (C-6), 107.9 (C-5'), 113.9 (PMB C-3" or PMB C-3"'), 114.0 (PMB C-3'" or 
PMB C-3"), 120.0 (C-3), 121.9 (C-4a), 128.4 (C-4), 128.6 (PMB C-2'''), 128.8 (PMB C-2"), 
130.3 (PMB C-1"), 131.4 (PMB C-1"'), 138.4 (C-5a), 139.5 (C-2), 143.0 (C-7), 143.4 (C-10a), 
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149.0 (C-9), 157.4 (C-6'), 158.7 (PMB C-4" or PMB C-4"'), 158.9 (PMB C-4'" or PMB CAli), 
162.1 (C-4' or C-2'), 162.2 (C-2' or C-4'). 
(KBr): U max 3240,2959-2835 (series of weak bands), 1560, 1512. 
(EI): mlz (reI intensity) 517 (56),397 (12),382 (12), 121 (100) . 
.aAA"''''UUJ (EI): Calcd for C30H27N702 (M+) 517.2226, found 517.2242. 
Deoxyvariolin B 1.50 
N NH(PMB) 
::::( 
~ ..-;:N 
Bis-amine 2.70 (95%, 6.7 mg, 0.012 mmol) was dissolved in neat TfDH (0.05 mL) in a small 
vial under atmospheric conditions. The vial was capped and the deep red solution was left at rt 
for 38 h. The reaction was cooled to -20 °C and carefully quenched with cold, cone aq NH3 
(-25% NH3, 0.1 mL). The suspension was diluted with water (1 mL) and mixed thoroughly to 
ensure complete neutralisation, followed by removal of water in vacuo. The yellow solid was 
taken up in CH2ChIMeOH (50:1, ~50 mL), filtered through a fine frit to remove ammonium 
triflate, and dried (Na2S04) to give the crude product. Flash chromatography on silica, eluting 
with 8% MeOHlCH2Ch then 8% MeOHlCH2Ch + 1 % NEt3, followed by flash chromatography 
on reversed phase silica, eluting with 45% MeOHlwater then 70% MeOHlwater + 0.1 % TF A, 
gave an acidic product. This was dissolved in CH2ChIMeOH (20:1) and neutralised with solid 
K2C03. After filtration and concentration, the resulting yellow-brown solid was extracted with 
boiling CH2Ch. The fluorescent yellow solution was filtered and concentrated to give 
deoxyvariolin B (1.50) as a yellow solid (2.0 mg, 56%). 
dec at ~220-240 DC (lies 161-162 DC). 
(500 MHz, (CD3)2S0): 8 6.51 (s, 2'-NH2), 7.05 (d, J = 5.4 Hz, 1H, H-5'), (dd, 
J 4.8,8.2 Hz, 1H, H-3), 7.62 (d, J 6.3 1H, H-7), 7.67 (d, J= 6.3 Hz, IH, H-6), 8.22 (d, J 
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= 5.4 IH, H-6'), 8.44 (dd, J = 1.5, 4.8 Hz, IH, H-2), 8.5 (br, IH, 9-NH), 8.90 (dd, J 1 
8.2 Hz, IH, H-4), 9.4 (br, IH, 9-NH). 
13C (75 MHz, (CD3)2S0): 899.6 (C-5), 101.9 (C-6), 107.1 (C-5'), 121.0 (C-3), 121.7 (C-
4a), 129.4 (C-4), 138.3 (C-5a), 140.3 (C-2), 143.0 (C-I0a), 144.0 (C-7), 149.9 (C-9), 158.2 (C-
6'), 161.6 (C-4'), 163.6 (C-2'). 
(KBr): Dmax 3304, 3142-2849 (series of weak bands), 1647, 1574, 1514, 1472, 1456, 1269. 
MS (EI): mlz (reI intensity) 277 (100),236 (54). 
HRMS (EI): Calcd for C,JIllN7 (M+) 277.1076, found 277.1072. 
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6.3 in Chapter 
Ethyl 2-cyano-3-methoxybut-2-enoate 3.496 
This reaction was perfonned in a two-necked flask with a 15 cm Vigreux column and condenser 
fitted to one neck. A graduated receiver was attached to the condenser so that the volume of 
distillate could be ascertained. Trimethylorthoacetate (61.4 g, 0.511 mol), ethyl cyanoacetate 
(47.2 g, 0.417 mol) and acetic acid (2.4 mL) were heated together in an oil bath (~120 °C), 
causing MeOH to distil. Further portions of acetic acid (1.2 mL) were added after 19, 29 and 38 
mL of MeOH had collected. The solid mass that remained was recrystallised from hot benzene 
to give the title compound 3.4 as fine off-white needles (49.3 70%). IH NMR analysis 
indicated the presence of only one stereoisomer, however the actual stereochemistry (E or Z) is 
undefined. 
Mp: 130-132 °C (lit96 133°C). 
IH NMR (500 MHz, CDCh): 8 1.32 (t, J = 7.1 Hz, OCHzCH3), 2.62 (s, 3H, 
CH3C(OMe)=CRz), 3.99 (s, 3H, OCH3), 4.23 (q, J 7.1 Hz, 2H, OCH2CH3). 
HC NMR (75 MHz, CDCh): 8 14.0 (OCHzCH3), 14.9 (C-4), 56.6 (OCH3), 61.0 (OCHzCH3), 
85.6 (C-2), 114.9 (CN), 163.6 (C-1), 184.4, (C-3). 
IR (KBr): U max 2216, 1713, 1582, 1319, 1281, 1144, 1088. 
MS (EI): mlz (reI intensity) 169 (36), 124 (100), 123 (37). 
HRMS (EI): Calcd for ClsHlIN03 (M+) 169.0739, found 169.0743. 
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EthyI2-cyano-5-( dimethylamino )-3-methoxypenta-2,4-dienoate 3.596 
+ 
Enamine 3.5 was prepared from 3.4 (57 g) using the procedure of Kasum and Prager,96 and was 
obtained as a bright yellow solid (~92% pure by IH NMR spectroscopy, 65 g, 79%). The 
impurities were conveniently removed later in the synthesis. A small sample, however, was 
recrystallised from EtOAc/hexanes for analytical purposes. IH NMR analysis indicated the 
presence of only one stereoisomer, however the actual stereochemistry (E or Z) is undefined. 
Mp: 68-72 DC (lit96 68.5-70 DC). 
IH NMR (500 MHz, CDCh): 8 1.31 (t, J= 7.1 Hz, 3H, OCH2CH3), 2.96 (s, 3H, NCH3), 3.18 (s, 
3H, NCH3), 4.02 (s, 3H, OCH3), 4.20 (q, J= 7.1 Hz, 2H, OCH2CH3), 6.21 (br, H-4), 7.48 (d, J= 
12.7 Hz, H-5). 
l3e NMR (75 MHz, CDCh): 8 14.4 (OCH2CR3), 37.5 (NCR3), 45.6 (NCR3), 60.0 (OCR2CH3), 
62.4 (OCR3), 75.7 (C-2), 91.5 (C-4), 119.1 (CN), 152.9 (C-5), 166.0 (br, C-1), 181.6, (C-3). 
IR (KBr): U max 2197, 1688, 1622, 1529, 1391, 1232, 1060. 
MS (EI): mlz (reI intensity) 224 (100),179 (73),152 (28),151 (39),121 (23), 119 (50),112 (61) 
108 (44), 98 (39), 82 (38). 
HRMS (EI): Calcd for Cl1H16N203 (M+) 224.1161, found 224.1153. 
Ethyl 2-chloro-4-methoxynicotinoate 3.7 
Enamine 3.5 (2.30 g, 10.3 mmol) was stirred with freshly distilled acetic acid (10 mL) at 67 DC 
for 5.5 h, while dry HCI gas (prepared by the action of cone H2S04 on solid NH4CI and a few 
drops of cone hydrochloric acid, and dried by bubbling through cone H2S04) was constantly 
bubbled into the reaction. After cooling, the reaction mixture was poured into water (20 ml) and 
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neutralised with solid NaHC03 to pH 8. Standard workup (CH2Ch) gave the crude material 
which was partially purified by Kugelrohr distillation (175 °C at 0.07 mm Hg, after removing 
more volatile components) to give a yellow oil. The remaining impurities were removed in the 
following step, however a small sample of the ester 3.7 was purified by flash chromatography on 
silica, eluting with 50% EtOAc/hexanes, to give a colourless oil. 
IH NMR (500 MHz, CDCh): 8 1.38 (t, J= 7.2 Hz, 3H, OCH2CH3), 3.89 (s, 3H, OCH3), 4.41 (q, 
J= 7.2 Hz, 2H, OCH2CH3), 6.81 (d, J= 5.9 Hz, IH, H-5), 8.28 (d, J= 5.9 Hz, IH, H-6). 
13C NMR (126 MHz, CDCh): 8 13.7 (OCH2CH3), 56.2 (OCH3), 61.9 (OCH2CH3), 106.0 (C-5), 
119.5 (C-3), 147.7 (C-2), 150.9 (C-6), 163.7 (C=O), 163.9 (C-4). 
IR (KBr): U max 1738, 1580, 1477, 1304, 1040. 
MS (El): mlz (reI intensity) 215/217 (12/6), 187/189 (15/5), 170/172 (100/32), 112/114 (1515). 
HRMS (El): Calcd for C9H1035CIN03 (M+) 215.0349, found 215.0347. 
2-Chloro-4-methoxynicotinic acid 3.9 
The partially purified ester 3.7 was hydrolysed by refluxing with 1.5 M aq NaOH solution (65 
mL) for 0.5 h. After cooling, the alkaline solution was washed with EtOAc (x3) and then 
acidified to pH 2 with conc hydrochloric acid. The acidified solution was saturated with solid 
NaCI, extracted with THF (x4) and dried (Na2S04) to give carboxylic acid 3.9 as a white solid 
(1.49 g, 77% over two steps). 
Mp: 170-176 °C (dec). 
IH NMR (500 MHz, (CD3)2S0): 8 3.91 (s, 3H, OCH3), 7.23 (d, J= 5.9 Hz, IH, H-5), 8.34 (d, J 
= 5.9 Hz, IH, H-6). 
13e NMR (75 MHz, CDCh): 8 57.0 (OCH3), 107.8 (C-5), 120.7 (C-3), 146.1 (C-2), 151.3 (C-6), 
163.6 (C-4), 165.0 (C=O). 
IR (KBr): U max 3107, 2970-2400 (series of broad bands), 1719, 1585, 1304, 1042. 
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(El): (reI intensity) 1871189 (83128), 170/172 (86/30), 140 (53), 133 (45), 123 (63), 
1121114 (62/22), 105 (100), 78 (33), 77 (32) . 
.l.Jl.Jl'J.U.U (El): Ca1cd for C7H635ClN03 (MlI87.0036, found 187.0037. 
2-Chloro-4-methoxynicotinoyl chloride 1.67 
o OMe CI:Q 
CI N 
Carboxylic acid 3.9 (1.27 g, 6.77 nunol), oxalyl chloride (2.4 mL, 28 nunol) and DMF (3 drops) 
were stirred in CH2Ch at rt for 19 h, with a CaCh drying tube used to exclude atmospheric 
moisture. After concentration in vacuo, the crude product was purified by Kugelrohr distillation 
(150°C, 0.07 mm Hg) to give acid chloride 1.67 as a white crystalline solid (1.36 97%). 
Mp: 66-69 °c, sweats at 62°C. 
(500 MHz, CDCh): i5 3.98 (s, 3H, OCH3), 6.89 (d, J = 5.9 Hz, 1H, H-5), 8.36 (d, J 
5.9 Hz, 1H, H-6). 
BC (126 MHz, CDCh): i5 56.8 (OCH3), 106.4 (C-5), 123.9 (C-3), 146.1 (C-2), 152.1 (C-
6), 162.9 (C-4), 164.3 (C=O). 
(CDC13): U max 1792, 1578, 1302, 1047. 
MS (EI): mlz (reI intensity) 170/172 (100/34),1121114 (27/9). 
JLJLJL ... .lVJLU (El): Calcd for C7Hs3sCIN02 (M+ - Cl) 170.0009, found 170.0007. 
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(2-Chloro-4-metboxypyridin~3-yl)bis-[2-(methylsulfanyl)pyrimidin-4-yl] methanol 
o OMe 
+ CI~ 
CI N 
HO 
"': 
192 
The reactor (Figure 2.8, p 41) was charged with iodide 2.12 (4.44 g, 17.6 mmol) and freshly 
distilled THF (180 mL), and cooled to -95°C (MeOHIN2). A solution of n-BuLi in hexanes 
(1.55 M, 11.4 mL, 17.7 mmol) was added dropwise to the stirred solution over 19 min, while 
maintaining the temperature at -95°C. After 30 min, a solution of acid chloride 1.67 (1.21 g, 
5.86 mmol) in THF (9 mL) was added to the dark mixture over 7 min. The reaction was stirred 
for 4.5 h at -95°C, quenched with MeOD (1.2 mL) and allowed to warm to rt. Excess THF was 
removed in vacuo and the residue was taken up in waterlEtOAc and extracted with EtOAc (x4). 
The extracts were washed with brine and dried over MgS04. Partial concentration of the EtOAc 
solution gave a precipitate of the pyrimidine trimer 2.22, which was filtered and washed with a 
little more EtOAc. Concentration of the filtrate and washings gave the crude materiaL Flash 
chromatography on silica, eluting with 55-80% EtOAclhexanes, gave triarylmethanol1.65 as a 
tan solid (-93% pure by IH NMR spectroscopy, 383 mg, 14%). 
The spectroscopic data for 1.65 is listed on p 198. Other (new) compounds isolated from this 
reaction and their spectroscopic data are listed below: 
a) (2-Chloro-4-methoxypyddin-3-yl)-[2-(methylsulfanyl)pyrimidin-4-yl]methanone 
o OMe 
This compound was isolated as colourless blocks after recrystallisation from EtOAc. 
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Mp: 148-151 °C (EtOAc). 
(500 MHz, CDCb): 0 2.31 (s, 3H, SCH3), 3.81 (s, 3H, OCH3), 6.89 (d, J 5.9 Hz, 1H, 
H-5), 7.64 (d, J 4.9 Hz, 1H, H-5'), 8.38 (d, J= 5.9 Hz, 1H, H-6), 8.80 (d, J 4.9 Hz, IH, H-6'). 
Be NMR (75 MHz, CDCb): 0 14.0 (SCH3), 56.3 (OCH3), 105.9 (C-5), 112.7 (C-5'), 122.9 (C-
3),148.2 (C-2), 151.5 (C-6), 158.1 (C-4'), 159.3 (C-6'), 165.0 (C-4), 173.7 (C-2'), 191.9 (C=O). 
IR (CDCb): U max 1705, 1578, 1555, 1047. 
MS (El): mlz (reI intensity) 295/297 (7/3), 260 (97), 1701172 (100/46), 112 (40). 
HRMS (El): Ca1cd for C12H\035C1N30232S (M+) 295.0182, found 295.0178. 
Crystal data and structure refinement for 3.10 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 26.52° 
Absorption correction 
Refinement method 
Data / restraints / parameters 
2 
Goodness-of-fit on F 
Final R indices [1>2sigma(I)] 
C12HlOCIN302S 
295.74 
168(2) K 
0.71073 A 
Monoclinic 
P2(I)/c 
a = 7.486(3) A 
b = 22.718(10) A 
c = 7.591(3) A 
1288.8(10) A 
4 
3 
1.524Mg/m 
-1 
0.459mm 
608 
3 
3 
0.5 x 0.4 x 0.22 mID 
2.73 to 26.52°. 
~ 93.297(7)°. 
Y 90°. 
-9 :s h :s 9, -28 :s k:S -3 :s 1 :s 7 
5356 
2356 [R(int) = 0.0847] 
87.9% 
Empirical 
. 2 
Full-matnx least-squares on F 
2356/0/174 
1.114 
Rl = 0.0902, wR2 = 0.2170 
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R indices ( all data) 
Largest diff. peak and hole 
R1 = 0.1311, wR2 = 0.2488 
-3 
0.521 and -0.744 e.A 
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b) (2-Chloro-4-methoxypyridin-3-yl)-[2-(methylsulfanyl)pyrimidin-4-yl] methanol 3.11 
This compound was isolated as a viscous gum. 
IH NMR (500 MHz, CDCh): 82.51 (s, 3H, SCH3), 3.78 (s, 3H, OCH3), 4.62 (d, J= 7.3 Hz, 1H, 
OlI), 6.30 (d, J= 7.3 Hz, 1H, Ar2CHOH), 6.78 (d, J= 5.4 Hz, 1H, H-5), 6.93 (d, J= 4.9 Hz, 1H, 
H-5'), 8.26 (d, J= 5.4 Hz, 1H, H-6), 8.43 (d, J= 4.9 Hz, 1H, H-6'). 
13C NMR (75 MHz, CDCh): 8 14.1 (SCH3), 56.2 (OCH3), 69.5 (Ar2CHOH), 106.6 (C-5), 112.2 
(C-5'), 123.4 (C-3), 150.4 (C-6), 151.9 (C-2), 157.1 (C-6'), 165.5 (C-4), 168.9 (C-4'), 171.9 (C-
2'). 
IR (CDCh): U max 3450, 1578, 1562, 1043. 
MS (El): mlz (rel intensity) 297/299 (32/13), 262 (100), 260 (22), 244 (32), 172/174 (80/25), 170 
(32), 136 (33), 125 (34), 111 (38), 78 (49). 
HRMS (El): Calcd for C12H1235C1N30232S (M+) 297.0339, found 297.0342. 
c) MethyI2-chloro-4-methoxynicotinoate 3.12 
OMe 
Me02C~ 
~ . .J CI N 
This compound was isolated as a colourless oil. 
IH NMR (500 MHz, CDCh): 83.90 (s, 3H, 4-0CH3), 3.94 (s, 3H, C02CH3), 6.83 (d, J= 5.9 Hz, 
IH, H-5), 8.30 (d, J= 5.9 Hz, 1H, H-6). 
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Be NMR (126 MHz, CDCh): 8 52.8 (C02CH3), 56.3 (4-0CH3), 106.0 (C-5), 119.2 (C-3), 147.9 
(C-2), 151.1 (C-6), 164.0 (C-4), 164.3 (C=O). 
IR (CDCh): Dmax 1738, 1582, 1306, 1047. 
MS (EI): mlz (reI intensity) 2011203 (21/7),1701172 (100/38),112/114 (14/5). 
HRMS (EI): Calcd for CsHs35CIN03 (M+) 201.0193, found 201.0183. 
4-Methoxypyridine-N-oxide 3.181OS 
A solution of sodium methoxide, prepared by dissolving sodium (2.00 g, 87.0 mmol) in dry 
MeOH (100 mL), was quickly poured into a stirred suspension of 4-nitropyridine-N-oxide (12.0 
g, 85.7 mmol) in MeOH (80 mL). Dissolution was complete within 1 h and the reaction was left 
stirring in a stoppered flask overnight. Partial concentration of the yellow solution produced a 
precipitate, which was filtered and washed with MeOH (2 x 10 mL). The filtrate and washings 
were evaporated to dryness, and the solid that remained was extracted with boiling CH2Clz to 
give (after filtration and concentration) a yellow-brown solid. Recrystallisation from acetone 
gave fine off-white needles of 3.18, which were dried overnight in a vacuum dessicator at 0.07 
mm Hg, (8.04 g, 75%). 
Mp: 103-106 DC (lit12S 82-85 DC for the hydrate). 
IH NMR (500 MHz, CDCh): 8 3.86 (s, 3H), 6.80 (d, J= 7.6 Hz, 2H), 8.12 (d, J= 7.6 Hz, 2H). 
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4-Methoxy-2(lH)-pyridone 3.19110 
OMe 
6 
+N I 
-0 
196 
& N 0 
H 
This was prepared from 4-methoxypyridine-N-oxide (3.18, 5.00 g) following a literature 
procedure. l1O Recrystallisation from CH3CN gave colourless plates (3.05 g, 61 %). 
Mp: not well defined (~150-170 DC). No melting point was given in reference 110. 
lH NMR (500 MHz, CDCh): B 3.79 (s, 3H), 5.88 (d, J= 2.5 Hz, 1H), 5.97 (dd, J= 2.5,7.4 Hz, 
1H), 7.20 (d, J= 7.4 Hz, 1H), 12.6 (br, 1H). 
2-Chloro-4-methoxypyridine 3.8103-105 
& N 0 
H 
4-Methoxy-2(1H)-pyridone (3.19) (2.86 g, 22.8 mmol) was stirred with POCb (28 mL) at 95°C 
for 16 h. Excess POCh was removed in vacuo and the resultant viscous oil was cooled in ice 
and carefully neutralised with sat aq NaHC03 solution. The mixture was extracted with EtOAc 
and worked up in the usual manner to give a golden oil. Flash chromatography on silica, eluting 
with 30% EtOAc/hexanes, gave 2-chloro-4-methoxypyridine (3.8) as a colourless oil (2.60 g, 
79%). 
NMR (300 MHz, CDCh): B 3.85 (s, 3H, OCI-h), 6.75 (dd, J . 2.3, 5.9 1H, H-5), 6.83 (d, 
J= 2.3 Hz, 1H, H-3), 8.18 (d, J 5.9 Hz, 1H, H-6). 
BC NMR (75 MHz, CDCh): B .6 (OCH3), 109.4 (C-3), 109.7 (C-5), 150.2 (C-6), 152.6 (C-2), 
167.3 (C-4). 
(KBr): Dmax 1589,1556, 1032. 
MS (El): mlz (reI intensity) 143/145 (100/43), 1131115 (32/10), 108 (39), 78 (19). 
HRMS (El): Calcd for C()lii5ClNO (Ml143.0138, found 143.0141. 
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Bis-[2-(methylsulfanyl)pyrimidin-4-yl] methanone 3.15 
The reactor (Figure 2.8, p 41) was charged with iodide 2.12 (3.90 g, 15.5 mmol) and distilled 
THF (47 mL), and cooled to -97 DC (MeOHIN2). A solution of n-BuLi in hexanes (1.55 M, 10.0 
mL, 15.5 mmol) was slowly added to the stirred solution over 21 min, while maintaining the 
temperature at -97 DC. After 30 min, a solution of diethyl carbonate (0.94 mL, 7.8 mmol) in 
THF (4 mL) was added over about 3 min. After 15 min at -97 DC the reaction was allowed to 
warm to -35 DC over 2 h, and then to rt. The reaction mixture was shaken with sat aq NH4CI 
solution, extracted with EtOAc and subjected to standard workup. The crude material was 
partially purified by Kugelrohr distillation (160 DC, 0.03 mm Hg after removing more volatile 
components), then subsequently by flash chromatography on silica, eluting with 25, 30 and then 
50% EtOAc/hexanes, to give ketone 3.15 as a pale yellow solid (1.14 g, 53%). 
Mp: 106-107 DC (benzene/hexanes). 
IH NMR (500 MHz, CDCh): 82.51 (s, 6H, SCH3), 7.54 (d, J= 4.9 Hz, 2H, H-5), 8.79 (d, J= 
4.9 Hz, 2H, H-6). 
l3C NMR (75 MHz, CDCh): 8 14.2 (SCH3), 114.9 (C-5), 158.8 (C-6), 159.2 (C-4), 173.2 (C-2), 
190.7 (C=O). 
IR (KBr): Drnax 1695, 1564, 1553, 1420, 1356, 1319. 
MS (EI): mlz (reI intensity) 278 (100), 214 (23), 125 (76). 
HRMS (EI): Calcd for Cl1HlON4032S2 (M+) 278.0296, found 278.0289. 
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(2-Chloro-4-methoxypyridin-3-y 1) bis- [2-( methylsulfanyl)pyrimidin -4-yl] methanol 1.65 
LiD~e 
+ I 
/-
CI N 
6' N~SMe I "12' 
5' /- N 
HO OMe 
~ 
198 
2-Chloro-4-methoxypyridine (3.8, 0.633 g, 4.41 mmol) was dissolved in freshly distilled THF 
(18 mL). The flask was cooled to below -90°C (acetone/N2) and a solution of n-BuLi in 
hexanes (1.55 M, 2.9 mL, 4,5 mmol) was slowly added over 17 min to the stirred solution, 
keeping the temperature below -90°C. The orange solution was then stirred at -78 °C for 1 h, by 
which time it had become a wine-red colour. The reaction mixture was again cooled to below -
90°C, and a solution of ketone 3.15 (1.14 g, 4.09 mmol) in THF (10 mL) was added over 11 min 
while maintaining the temperature below -90°C. The dark mixture was then stirred at -78 °C for 
3.5 h, quenched with methanol and allowed to warm to rt. The reaction mixture was shaken with 
sat aq NH4CI solution, extracted with EtOAc and subjected to standard workup. Flash 
chromatography on silica, eluting with 80% EtOAc/hexanes, gave triarylmethanoll.65 as a pale 
yellow solid (1.32 g, 76%). 
Mp: 135-137 °C (t-BuOH). 
IH NMR (500 MHz, CDCh): 02.49 (s, 6H, SCH3), 3.43 (s, 3H, OCH3), 6.55 (s, 1H, OH), 6.76 
(d, J = 5.4 Hz, 1H, H-5), 7.39 (d, J = 5.4 Hz, 2H, H-5'), 8.25 (d, J = 5.4 Hz, 1H, H-6), 8.46 (d, J 
= 5.4 Hz, 2H, H -6'). 
BC NMR (75 MHz, CDCh): 0 14.1 (SCH3), 55.8 (OCH3), 78.0 (Ar3COH), 107.1 (C-5), 113.7 
(C-5'), 124.8 (C-3), 149.8 (C-6), 152.3 (C-2), 157.2 (C-6'), 165.9 (C-4), 171.0 (C-4'), 171.1 (C-
2'). 
IR (CDCh): Drnax 3344 (br), 1576, 1551, 1348, 1209, 1043. 
MS (El): mlz (reI intensity) 421/423 (65/29), 387 (19), 370 (21), 369 (21), 342 (38), 338 (57), 
296 (44), 268 (60),260 (100), 125 (98), 112 (22). 
HRMS (El): Calcd for C17H163SClNsol2S2 (M+) 421.0434, found 421.0448. 
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(2-Chloro-4-meihoxypyridin-3-yl)bis-[2-(methylsulfanyl)pyrimidin-4-yl] methyl acetate 3.26 
OMe 
+ 
Li~ 
A.J CI N 
2-Chloro-4-methoxypyridine (3.8, 0.141 g, 0.980 mmol) was dissolved in freshly distilled THF 
(4 mL). The flask was cooled to below -90°C and a solution of n-BuLi in hexanes (1.6M, 0.61 
mL, 0.98 mmol) was added over 2 min to the stirred solution. The orange solution was then 
stirred at -78°C for 1 h, by which time it had become a wine-red colour. The reaction mixture 
was again cooled to below -90°C and a solution of ketone 3.15 (271 mg, 0.974 mmol) in THF 
(2.2 mL) was added over 2 min. The dark mixture was stirred at -78°C for 3 h, whereupon, 
freshly distilled acetyl chloride (0.30 mL, 4.2 mmol) was added. After warming to rt overnight, 
the reaction mixture was shaken with sat aq NaHC03 solution, extracted with EtOAc and 
subjected to standard workup. Flash chromatography on silica, eluting with 80% 
EtOAclhexanes, gave acetate 3.26 (308 mg, 68%). 
Mp: 151-154 °C (t-BuOH). 
IH NMR (500 MHz, CDCh): 8 2.30 (s, 3H, OCOCH3), 2.39 (s, 6H, SCH3), 3.49 (s, 3H, OCH3), 
6.76 (d, J= 5.6 Hz, IH, H-5), 7.18 (d, J= 5.4 Hz, 2H, H-5'), 8.23 (d, J= 5.6 Hz, IH, H-6), 8.39 
(d, J= 5.4 Hz, 2H, H-6'). 
13C NMR (126 MHz, CDCh): 8 14.0 (SCH3), 21.4 (OCOCH3), 55.9 (OCH3), 84.5 (Ar3COAc), 
107.0 (C-5), 114.8 (C-5'), 122.5 (C-3), 149.7 (C-6), 152.1 (C-2), 156.6 (C-6'), 166.3 (C-4), 
168.16 (C-4' or C=O), 168.22 (C=O or C-4'), 171.7 (C-2'). 
IR (KBr): U max 1755, 1572, 1549, 1346, 1207, 1038. 
MS (EI): mlz (reI intensity) 463(2), 428 (51),423/421 (61/27),420 (55), 404 (24), 370 (37), 369 
(100), 268 (32), 125 (48), 83 (31). 
HRMS (EI): Calcd for C19H18N50332S2 (M+ - CI) 428.0851, found 428.0860. 
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4-Methoxy-9-(methylsulfanyl)-5- [2-(methylsuUanyl)pyrimidin-4-yJ]pyrido [3',2' :4,5]pyrrolo 
[1,2-c]pyrimidine 1.63 
R = H or Ac 
z) preparation from triarylmethanol 1. 65 
A mixture of triarylmethanol 1.65 (100 mg, 0.237 mmol) and TFA (37J.!L, 0.48 mmol) was 
dissolved in 1,2-dichloroethane (0.5 mL). The resulting orange solution was transferred to a 
Young's tube, fitted with a rubber septum, containing TES (0.30 mL, 1.9 mmol). With a strong 
stream of argon flowing, the septum was replaced with a teflon screw-cap, and the sealed 
reaction vessel was heated at 100°C for 43 h. After cooling, the vessel was opened and the 
contents diluted with CH2Cb (12 mL). The solution was neutralised with 5% aq NaHC03 
solution (8 mL) and worked up with CH2Cb according to the standard procedure. Flash 
chromatography on silica, eluting with 48-75% EtOAc/hexanes, gave in order of elution 
a) 4-Methoxy-9-(methylsulfanyl)-5-[2-(methylsulfanyl)pyrimidin-4-yl]pyrido[3',2' :4,5] 
pyrrolo[1,2-c]pyrimidine 1.63 as a yellow solid (41 mg, 47%). 
Mp: 192-194 °c. 
IH NMR (500 MHz, CDCh): 82.65 (s, 3H, 2'-SCH3), 2.70 (s, 3H, 9-SCH3), 4.03 (s, 3H, OCH3), 
6.92 (d, J= 5.4 Hz, IH, H-3), 7.40 (d, J= 5.4 Hz, 1H, H-5'), 7.71 (d, J= 6.8 Hz, 1H, H-7), 7.98 
(d, J= 6.8 Hz, 1H, H-6), 8.48 (m, 2H, H-2, H-6'). 
13e NMR (75 MHz, CDCh): 8 14.1 (SCH3), 14.9 (SCH3), 55.6 (OCH3), 101.9 (C-3), 102.5 (C-
5), 108.5 (C-6), 110.8 (C-4a), 117.7 (C-5'), 135.9 (C-5a), 138.6 (C-7), 143.5 (C-2), 144.3 (C-
lOa), 154.2 (C-9), 155.6 (C-6'), 159.6 (C-4), 161.1 (C-4'), 171.2 (C-2'). 
IR (CDCh): U max 1570, 1468, 1285, 1013. 
MS (El): mlz (reI intensity) 369 (100), 354 (13), 112 (10), 70 (10). 
HRMS (El): Calcd for C17HlSNs032S2 (M+) 369.0718, found 369.0720. 
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b) (2-Chloro-4-methoxypyridin-3-yl)- [2-( methylsulfanyl)pyrimidin-4-yJ] -[2-( methylsul-
fanyl)pyrimidin-4-yloxy]methane 3.25 as a viscous gum (28 mg, 28%). Trituration 
with n-hexane gave an off-white solid. 
Mes~ /; N~
N 4" 
o OMe 
4' 3 4 
I ~ I ~ 
N~NCI 2 N~ 
SMe 
Mp: 113-121 DC. 
1H NlVIR (500 MHz, CDCh): 8 2.36 (s, 3H, 2'-SCH3), 2.44 (s, 3H, 2"-SCH3), 3.84 (s, 3H, OCH3) 
6.57 (d, J= 5.9 Hz, lH, H-5"), 6.80 (d, J= 5.9 Hz, lH, H-5), 7.17 (d, J= 4.9 Hz, lH, H-5'), 7.79 
(s, lH, Ar2CHOAr), 8.27 (d, J = 5.9 Hz, IH, H-6), 8.30 (d, J = 5.9 Hz, IH, H-6"), 8.49 (d, J = 
4.9 Hz, lH, H-6') .. 
13C NMR (75 MHz, CDCh): 8 13.88 (SCH3), 13.90 (SCH3), 56.2 (OCH3), 71.8 (Ar2CHOAr), 
103.5 (C-5"), 106.4 (C-5), 112.9 (C-5'), 120.8 (C-3), 150.7 (C-6), 152.5 (C-2), 157.1 (C-6'), 
158.0 (C-6"), 166.0 (C-4), 167.1 (C-4'), 167.3 (C-4"), 172.1 (C-2'), 172.4 (C-2"). 
MS (El): mlz (rel intensity) 4211423 (94/43), 387 (21), 374/376 (33/13),296 (79), 280 (39), 246 
(79),212 (100), 184 (28), 147 (43), 125 (58), 112 (45),104 (48), 77 (53), 76 (50), 70 (44). 
HRMS (El): Calcd for C17Hll5C1N50232S2 (M+) 421.0434, found 421.0444. 
ii) preparation from acetate 3.26 
A mixture of acetate 3.26 (112 mg, 0.241 mmol) and TFA (37flL, 0.48 mmol) was dissolved in 
1,2-dichloroethane (0.5 mL). The resulting orange solution was transferred to a Young's tube, 
fitted with a rubber septum, containing TES (0.31 mL, 1.9 mmol). With a strong stream of argon 
flowing, the septum was replaced with a teflon screw-cap, and the sealed reaction vessel was 
heated at 80 DC for 26 h. After cooling, the vessel was opened and the contents diluted with 
CH2Ch (15 mL). The solution was neutralised with 5% aq NaHC03 solution (8 mL) and the 
phases separated. The aqueous layer was further extracted with CH2Ch and the organic extracts 
were worked up according to the standard procedure. Flash chromatography on silica, eluting 
with 48% EtOAc/hexanes, gave core structure 1.63 (67 mg, 75%). 
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6-Acetoxy-4-methoxy-9-(methylsulfanyl)-S-[2-(methylsulfanyl)pyrimirlin-4-yJ]-6,7-
:4,S]pyrrolo[1,2-c]pyrimirline 3.28 
,..JSMe 
N_\ 
~ /.IN OMe 
A mixture of acetate 3.26 (110 mg, 0.233 mmol), HOAc (30f.LL, 0.52 mmol) and 
202 
0.50 mmol) was heated at reflux in 1,2-dichloroethane (0.56 mL) for 18 h. After cooling, the 
reaction mixture was diluted with CH2Ch (15 mL) and neutralised with 5% aq NaHC03 solution 
(8 mL). After further extraction with CH2Ch, the organic extracts were worked up according to 
the standard procedure to give the crude product, which contained 1.63 as the major component. 
A minor product, the cyclised acetate 3.28, was isolated after extensive flash chromatography on 
silica, eluting with 15% EtOAc/CH2Ch then 60% EtOAclhexanes, followed by reversed phase 
silica, eluting with 80-90% MeOHlwater, of sufficient purity for characterisation by lH, 13C and 
2D NMR spectroscopy. 
(500 MHz, CDCh): 3 2.03 (s, 3H, OCOCH3), 2.54 (s, 3H, 9-SCH3), 2.58 (s, 3H, 2'-
SCH3), 3.66 (dd, 3.4, 17.0 Hz, 1H, H-7a), 3.92 (s, 3H, OCH3) 4.33 (dd, J= 1.7, 17.0 Hz, 1H, 
H-7b), 6.50 (dd, J 1.7,3.4 Hz, 1H, H-6), 6.75 (d, J= 5.4 Hz, 1H, H-3), 7.30 (d, J= 4.9 Hz, IH, 
H-5'), 8.40 (d, 5.4 1H, H-2), 8.53 (d, J= 4.9 Hz, 1H, H-6'). 
Be (126 MHz, CDCh): 3 14.0 (SCH3), 14.4 (SCH3), 21.1 (OCOCH3), 50.2 (C-7), 55.5 
(OCH3), 61.3 (C-6), 101.2 (C-3), 108.2 (C-4a), 113.1 (C-5), 117.9 (C-5'), 130.6 (C-5a), 146.8 
(C-2), 147.7 (C-10a), 150.1 (br, C-9), 156.0 (C-6'), 159.7 (C-4'), 160.9 (C-4), 169.7 (C=O), 
172.0 (C-2'). 
(CDCh): \)rnax 1738. 
JULU.J.V,"-U (ES): Calcd for C19H20N50332S2 (MH+) 430.1008, found 430.1010. 
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4-Methoxy-5-[2-(methylsulfanyl)pyrimidin-4-yl]-9-sulfanylpyrido[3' :4,5]pyrrolo[1,2-c] 
pyrimidine 
Core structure 1.63 (9.1 mg, 0.025 mmol) was dissolved in CH2Cb (1 mL) and cooled to -75°C. 
A solution of boron tribromide in CH2Cb (~1 M, 0.25 mL, 0.25 mmol) was added to the cooled 
solution with stirring, causing a colour change from yellow to orange. After 1 h at °C, the 
reaction was allowed to warm to ct, resulting in the formation of an orange precipitate. A small 
aliquot was worked up and shown by TLC to contain predominantly unreacted starting material. 
Therefore, 1,2-dichloroethane (1 mL) was added and the suspension was heated at 65°C for 4 h. 
After cooling and dilution with CH2C12, water was added. The orange precipitate, which was not 
soluble in either phase, was filtered and washed with water and CH2Cb to give thiol 3.31 (3.7 
mg,42%). 
IH NMR (500 MHz, CD30D): 15 2.60 (s, 3H), 4.14 (s, 3H), 7.12 (d, J= 7.6 Hz, IH), 7.38-7.41 
(m, 2H), 7.43 (d, J= 7.6 Hz, IH), 8.51 (d, J= 6.3 Hz, IH), 8.55 (d, J= 5.4 Hz, IH); (500 MHz, 
(CD3)2S0): 15 2.56 (s, 3H, SCH3), 4.04 (s, 3H, OCH3), 7.23 (d, J= 7.4 Hz, H-7), 7.37 (br, IH, H-
3),7.41-7.43 (m, 2H, H-6, H-5'), 8.54 (hr, IH, H-2), 8.63 (d, J= 5.2 Hz, H-6'), 13.0 (hr, IH, 
SR). 
Be NMR (75 MHz, (CD3)2S0): 15 13.7 (SCH3), 56.8 (OCH3), 101.6 (C-6), 104.1 (C-3), 104.9 
(C-5), 112.3 (C-4a), 118.6 (C-5'), 128.5 (C-7), 134.2 (C-5a), 142.0 (C-2), 143.9 (hr, C-I0a), 
156.7 (C-6'), 159.6 (C-4'), 161.4 (C-4), 168.6 (C-9), 170.6 (C-2'). 
HRMS (ES): Calcd for C16H14N5032S2 (MH+) 356.0640, found 356.0647. 
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4-Methoxy-9-( methylsulfinyJ)-S-[2-( methylsulfinyl)pyrimidin-4-yl] pyrido [3' ,2' :4,S]pyrrolo 
[1,2-c]pyrimidine 
Core structure 1.63 (37 mg, 0.1 0 mmol) was dissolved in CHCh (5 mL) under atmospheric 
conditions and cooled to -40°C (CH3CNIC02)' A solution of m-CPBA in CHCh (10 mg/mL) 
was similarly cooled and added dropwise to the solution of mvc until TLC analysis indicated the 
consumption of all starting material (after about 2 equiv of m-CPBA). The solution was warmed 
to It and neutralised with sat aq NaHC03 solution. This was extracted with CH2Ch and standard 
workup gave a yellow solid which was predominantly a mixture of diastereomeric bis-sulfoxides 
3.32. The crude mixture was used without purification, however the bis-sulfoxides had the 
following spectroscopic characteristics: 
IH NMR (500 MHz, CDCh): (As most signals for the diastereoisomers coincide, they are all 
quoted as multiplets.) 8 3.02 (m, 3H), 3.19 (m, 3H), 4.12 (m, 3R), 7.00-7.01 (m, 1H), 7.98-7.99 
(m, 1H), 8.12-8.14 (m, IH), 8.48-8.49 (m, IH), 8.64-8.67 (m, 1H), 8.79-8.81 (m, IH). 
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4-Methoxy-9-( 4-methoxybenzylamin 0)-5- [2-(4-methoxybenzylamin 0 )pyrimidin-4-yl]pyrid 0 
[3' ,2' :4,5]pyrrolo[1,2-c]pyrimidine 3.34 
JJ~,Me '\ 3'" H 0---2' N 1'" 2'" N§ 
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The crude oxidised material 3.32 was heated with an excess ofp-methoxybenzylamine (0.15 mL, 
1.1 mmol) at 85 DC for 15 h. The red paste thus obtained was directly purified by flash 
chromatography on silica, eluting with 2.5-4% MeOH/CH2Clz. This was chromatographed 
again on silica, eluting with 50% EtOAc/CH2Clz then 100% EtOAc, to give bis-amine 3.34 as a 
yellow-orange solid (43 mg, 78% over two steps). 
Mp: 74-77 DC. 
1H NMR (500 MHz, CDCh): 0 3.81 (s, 6H, both PMB OCH3), 3.99 (s, 3H, 4-0CH3), 4.66 (d, J 
= 5.6 Hz, 2H, 2'-NHCH2Ar), 4.85 (d, J = 5.5 Hz, 2H, 9-NHCH2Ar), 5.51 (br, 1H,2'-NHPMB), 
6.82 (d, J = 5.6 Hz, 1H, H-3), 6.89-6.91 (m, 4H, PMB H-3", PMB H-3"'), 7.00 (d, J = 5.2 Hz, 
1H, H-5'), 7.29 (br, 1H, H-6), 7.34 (d, J = 8.5 Hz, 2H, PMB H-2"'), 7.39 (d, J = 8.5 Hz, 2H, PMB 
H-2"), 7.43 (br d, J= 6.3 Hz, 1H, H-7), 8.16 (d, J= 5.6 Hz, 1H, H-2), 8.26 (d, J= 5.2 Hz, 1H, H-
6'), 10.39 (br t, J = 5.5 Hz, 1H, 9-NHPMB). 
l3e NMR (75 MHz, CDCh): 0 44.3 (9-l'-THCH2Ar), 44.9 (2'-NHCH2Ar), 55.3 (both PMB 
OCH3), 55.5 (4-0CH3), 101.3 (C-5), 101.6 (C-3), 101.8 (C-6), 111.4 (C-4a), 112.2 (C-5'), 113.96 
(PMB C-3'" or PMB C-3"), 114.03 (PMB C-3" or PMB C-3"'), 128.5 (PMB C-2"'), 128.8 (PMB 
C-2"), 130.5 (PMB C-1"), 131.4 (PMB C-1"'), 137.5 (C-5a), 141.5 (C-2), 141.9 (C-7), 144.7 (C-
lOa), 148.7 (C-9), 154.6 (br, C-6'), 158.7 (PMB C-4"'), 158.9 (PMB C-4"), 159.4 (C-4), 160.9 
(C-2'), 162.6 (C-4'). 
IR (KBr): Omax 3242, 2997-2833 (series of weak bands), 1570. 
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MS (EI): mlz (rel intensity) 547 (65), 427 (14), 426 (9), 425 (12), 136 (38), 135 (53), 121 (100), 
112 (21), 77 (24). 
HRMS (El): Calcd for C31H29J\b03 (M+) 547.2332, found 547.2334. 
4-Hydroxy-9-( 4-methoxybenzylamino )-5-[2-( 4-methoxybenzylamino )pyrimidin-4-yl]pyrido 
[3' ,2' :4,5] pyrrolo [1,2-c] pyrimidine 3.35 
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A solution of sodium ethanethiolate (80%, 202 mg, 1.92 mmol) in dry DMF (2 mL) was added 
to a solution of his-amine 3.34 (106 mg, 0.193 mmol) in DMF (2 mL), and the mixture was 
stirred at 55 DC for 7.5 h. After cooling, aq NH4CI solution was added and the mixture was 
extracted with EtOAc. The organic extracts were washed three times with water to remove DMF 
and worked up as usual. Flash chromatography on silica, eluting with 4% MeOHlCH2Cb, gave 
pyridinol 3.35 as a yellow solid (98 mg, 95%). 
Mp: 195-196 DC (CH2Cb/MeOH). 
IH NMR (500 MHz, CDCb): 0 3.80 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 4.61 (d, J= 5.5 Hz, 2H, 
2'-NHCH2Ar), 4.85 (d, J= 5.5 Hz, 2H, 9-NHCH2Ar), 5.35 (hr, 1H, 2'-NHPMB), 6.76 (d, J= 5.5 
Hz, 1H, H-3), 6.88-6.92 (m, 4H, PMB H-3", PIVIB H-3"'), 7.03 (d, J= 6.8 Hz, 1H, H-6), 7.06 (d, 
J= 5.7 Hz, 1H, H-5'), 7.32 (d, J= 8.4 Hz, 2H, PMB H-2"'), 7.40 (d, J= 8.4 Hz, 2H, PMB H-2"), 
7.68 (d, J= 6.8 Hz, 1H, H-7), 8.05 (d, J= 5.5 Hz, 1H, H-2), 8.29 (d, J= 5.7 Hz, 1H, H-6'), 10.94 
(hr t, J= 5.5 Hz, 1H, 9-NHPMB), 15.7 (hr, 1H, OH). 
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(75 MHz, CDCb): 0 44.3 (9-NHCR2Ar), 45.2 (2'-NHCR2Ar), 55.3 (both OCR3), 
100.3 (C-6), 100.5 (C-5), 106.9 (C-5'), 107.5 (C-3), 111.4 (C-4a), 114.1 (PMB C-3", PMB C-
3"'), 128.8 (PMB C-2"), 129.2 (PMB C-2"'), 130.2 (PMB C-1", PlVIB C-l"'), l37.5 (C-5a), 142.8 
(C-2), 143.8 (C-7), 145.4 (C-I0a), 149.7 (C-9), 158.6 (C-6'), 158.9 (PMB C-4"), 159.0 (PMB C-
4"'), 159.5 (C-4'), 159.8 (C-4), 160.0 (C-2'). 
IR (KBr): U max 3223,2820-2835 (series of weak bands), 1574. 
MS (El): mlz (reI intensity) 533 (38), 413 (19),412 (18), 411 (15), 121 (100). 
HRMS (El): Calcd for C30H27N703 (M+) 533.2175, found 533.2185. 
VarioLin B 
N NH(PMB) ~ ~ fiN OH 
Pyridinol (31 mg, 0.058 mmol) was dissolved in neat TfOH (0.5 mL) under atmospheric 
conditions. The flask was stoppered and the deep red solution was left at rt for 17 h. The 
reaction was cooled in ice and carefully quenched with ice-water (1 mL), followed by cone aq 
NH3 solution (1 mL) which produced a bright yellow precipitate. After mixing thoroughly to 
ensure complete neutralisation, the precipitate was filtered through a fine frit, washing with 
water and then MeOH/water (1:1). The solid was then suspended in MeOH/CH2Ch (a small 
amount of TF A was added to convert the free base to the more soluble salt form) and adsorbed 
onto a small amount of reversed phase silica for flash chromatography, eluting with 50% 
MeOH/water then 70% MeOH/water + 0.5% TF A. The bright yellow fractions were combined 
and concentrated in vacuo to give variolin B as its trifluoroacetate salt. The salt was neutralised 
by sonication with cone aq NH3/MeOH to give the free base. Concentration in vacuo (35°C, 
0.03 mm Hg to remove ammonium trifluoroacetate) gave variolin B (1.17) as a brown-orange 
solid (l3.6 mg, 80%). 
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dec at ~320 °c (lit32a 45 °c, dec). 
(500 MHz, (CD3)2S0): 06.81 (d, J= 5.6 Hz, lH, H-3), 6.97 (s, 7.14 (d,J 
= 5.6 1H, H-5'), 7.23 (d, J= 6.7 Hz, 1H, H-6), 7.63 (d, J 6.7 Hz, H-7), 8.17 (d, J 5.6 Hz, 
1H, H-2), 8.27 (d, J= 5.6 Hz, 1H, H-6'), 8,45 (br, 1H, 9-NH), 9.79 (br, 1H, 9-NH), 16.05 (s, IH, 
OH). 
Be NMR (75 MHz, (CD3)2S0): 099.6 (C-5), 100.3 (C-6), 106.0 (C-5'), 107.5 (C-3), 111.2 (C-
4a), 137.1 (C-5a), 143.1 (C-2), 144.6 (C-7), 144.9 (C-I0a), 150.3 (C-9), 158.3 (C-4'), 159.8 (C-
4), 160.0 (C-6'), 161.4 (C-2'). 
IR (KBr): U max 3085, 1670, 1572, 1477, 1458, 1298. 
AAA",UJUJ (ES): Calcd for C14H12N70 (MH+) 294.1103, found 294.1096. 
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Described in Chapter Four 
9-Amino-4-mefhoxy-5-(2-aminopyrimidin-4-yl)pyrido [3',2' :4,5 Jpyrrolo [1,2-c ] pyrimidine 
N NH(PIVIB) ~ ~ ~N OMe 
Bis-amine 3.34 (10 mg, 0.018 mmol) was dissolved in neat TfDH (0.1 mL) in a small vial under 
atmospheric conditions. The vial was capped and the deep red solution was left at rt for 13 h. 
The reaction was cooled to -10°C and carefully quenched with MeOH (0.2 mL), followed by 
cone aq NH3 solution (0.1 mL). After mixing thoroughly to ensure complete neutralisation, the 
precipitate was filtered through a CI8 cartridge to remove ammonium triflate, washing with water 
and then 30% MeOHlwater. The yellow precipitate was then dissolved in 25% CH2ChIMeOH + 
0.2% and eluted through the cartridge to give, after concentration in vacuo, a yellow solid. 
Flash chromatography on silica, eluting with 5-8% MeOH/CH2Ch then 10% MeOH/CH2Ch + 
0.5% NEh, followed by flash chromatography on reversed phase silica, eluting with 70, 80 and 
then 90% MeOHlwater, gave O-methylvariolin B (4.1) as a yellow-brown solid (1.3 mg, 23%). 
NMR (500 MHz, (CD3)2S0): (54.02 (s, 3H, OCH3), 6.43 (s, 2H, 2'-Nlh), 6.94 (d, J 5.6 Hz, 
lH, H-5'), 7.17 (d, J 5.6 Hz, lH, H-3), 7.46 (d, J= 6.6 Hz, 1H, H-7), 7.60 (d, J= 6.6 Hz, 1H, 
H-6), 8.17 (br d, J 5.6 Hz, 1H, H-6'), 8.3 (br, lH, 9-NH), 8.34 (d, J = 5.6 Hz, IH, H-2), 9.35 
(br, lH, 9-NH). 
(75 MHz, CDCh): (5 56.1 (OCH3), 100.7 (C-5), 101.8 (C-6), 102.7 (C-3), 110.9 (C-
4a), 111.5 (C-5'), 136.4 (C-5a), 141.7 (C-7), 142.2 (C-2), 143.9 (C-10a), 149.1 (C-9), 156.7 (C-
6'),159.3 (C-4), 161.4 (C-4' or C-2'), 163.2 (C-2' or C-4'). 
IR (KEr): U max 3320, 2922,2856, 1570. 
(BS): Calcd for C15H14N70 (MH+) 308.1260, found 308.1256. 
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4-Meth oxy-9-( 4-methoxybenzylamin 0)-5- [2-( methylsulfanyl)pyrimidin-4-yl]pyrido 
(3' :4,5]pyrrolo[1,2-c]pyrimidine 4.9 
210 
Core structure 1.63 (20 mg, 0.054 mmol) was heated with an excess of p-methoxybenzylamine 
(0.10 mL, 0.77 mmol) at 85°C for 15 h. The red paste thus obtained was directly purified by 
flash chromatography on silica, eluting with 60-80% EtOAclhexanes, to give protected amine 
4.9 as a micro-crystalline yellow solid (21 mg, 86%). 
Mp: 173-175 0c. 
(500 CDCh): 8 2.65 (s, 3H, SCH3), 3.81 (s, 3H, PMB OCH3), 4.02 (s, 3H, 4-
OCH3), 4.87 (d, J 5.2 Hz, 2H, NHCH2Ar), 6.85 (d, J= 5.6 Hz, 1H, H-3), 6.91 (d, J= 8.5 
2H, PMB H-3"), 7.37 (d, J 5.4 Hz, 1H, H-5'), 7.40 (d, J= 8.5 Hz, 2H, PMB H-2"), 7.58 (d, J 
6.6 Hz, 1H, H-6), 7.62 (d, J 6.6 Hz, 1H, H-7), 8.19 (d, J= 5.6 Hz, 1H, H-2), 8.43 (d, J 5.4 
Hz, 1H, H-6'), 10.43 (br t, 5.2 Hz, lH, NHPMB). 
13e NMR (126 MHz, CDCh): 8 14.1 (SCH3), 44.4 (NHCHzAr), 55.3 (PMB OCH3), 55.6 (4-
OCH3), 100.7 (C-5), 101.6 (C-6 or C-3), 101.7 (C-3 or C-6), 111.3 (C-4a), 114.1 (PMB C-3"), 
117.3 (C-5'), 128.8 (PMB C-2"), 130.4 (PMB C-1"), 137.7 (C-5a), 141.6 (C-2), 142.3 (C-7), 
144.8 (C-lOa), 148.7 (C-9), 1 .4 (C-6'), 158.9 (PMB C-4"), 159.4 (C-4), 161.5 (C-4'), 171.1 (C-
2'). 
IR (KBr): U max 3238,3060-2836 (series of weak bands), 1610, 1558. 
MS (El): mlz (reI intensity) 458 (77), 121 (100). 
(El): Calcd for CZ4HzzN60z3zS (M+) 458.1525, found 458.1535. 
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4-Hydroxy-9-( 4-metb oxybenzylamin 0)-5- [2-( metbylsulfanyl)pyrimidin-4-yl] pyrido 
[3',2' :4,5]pyrrolo[1,2-c]pyrimidine 4.10 
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Sodium ethanethiolate (80%, 144 mg, 1.37 mmol) was dissolved in dry DMF (1.4 mL). A 
portion (0.24 mL, 0.23 mmol) of this solution was added to a solution of amine 4.9 (10.7 mg, 
23.3 !lmol) in DMF (0.24 mL), and the mixture was stirred at 50°C for 12 h. After cooling, aq 
NH4CI solution was added, and the mixture was extracted with CH2Clz and worked up in the 
usual manner. Flash chromatography on silica, eluting with 2% MeOH/CH2Clz, gave pyridinol 
4.10 as a yellow solid, contaminated with trace amounts of the SEt-substituted analogue 
(9.9 mg, 95%). 
Mp: 198°C (dec). 
NMR (500 MHz, CDCh): 8 2.64 (s, 3H, SCH3), 3.81 (s, 3H, PMB OCH3), 4.85 (d, J = 5.4 
NHCH2Ar), 6.84 (d, J= 5.6 Hz, lH, H-3), 6.91 (d, J 8.9 Hz, 2H, PMB H-3"), 7.01 (d, 
J 6.5 Hz, 1H, H-6), 7.37 (d, J = 5.7 Hz, lH, H-S'), 7.40 (d, J 8.9 2H, PMB H-2"), 7.73 
(d, J 6.5 Hz, 1H, H-7), 8.06 (d, J = 5.6 Hz, lH, H-2), 8.42 (d, J 5.7 Hz, 1H, H-6'), 11.00 (br 
t, 5.4 Hz, 1H, NHPMB), 14.70 (s, 1H, OIl). 
(75 MHz, CDCh): 8 13.9 (SCH3), 44.4 (NHCH2Ar), (PMB OCH3), 99.97 (C-6), 
100.03 (C-5), 108.2 (C-3), 111.2 (C-4a), 112.1 (C-5'), 114.1 (PMB C-3"), 128.9 (PMB C-2"), 
130.1 (PMB C-l"), 138.5 (C-5a), 143.1 (C-2), 144.9 (C-7), 145.8 (C-I0a), 149.9 (C-9), 157.0 (C-
6'),159.0 (PMB C-4"), 159.3 (C-4'), 159.9 (C-4), 171.1 (C-2'). 
(KBr): U max 3854, 1585, 1312. 
AAA .. H ........ CBS): Calcd for C23H21N60/2S CMH1445.1447, found 445.1402. 
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9-Amino-4-bydroxy-5- [2-( metby Isulfanyl)pyrimidin-4-yI] pyrido [3' ,2' :4,5] pyrrolo [1 ,2-c] 
pyrimidine 4.8 
212 
Amine 4.10 (9.3 mg, 0.021 mmol) was dissolved in neat TfOH (0.1 mL) in a small vial under 
atmospheric conditions. The vial was capped and the deep red solution was left at rt for 19 h. 
The reaction was cooled to -10 °c and carefully quenched with cold, conc aq NH3 solution (0.1 
mL). The mixture was dissolved in CH2ClzIMeOH (20:1), washed with 5% aq NaHC03 solution 
and worked up in the usual manner. Flash chromatography on silica, eluting with 1--4.5% 
MeOHlCH2Clz, gave the deprotected amine 4.8 as a yellow solid (~90% pure by IH NMR, 6.1 
mg,80%). 
Mp: dec at ~265°C. 
IH NMR (500 MHz, 1:1 (CD3)2S0/CDCh): () 2.56 (s, 3H, SCH3), 6.77 (d, J= 5.4 Hz, 1H, H-3), 
7.15 (d, J= 6.3 Hz, IH, H-6), 7.52 (d, J= 5.9 Hz, IH, H-5'), 7.65 (d, J= 6.3 Hz, 1H, H-7), 7.97 
(residual CHCh), 8.09 (d, J= 5.4 Hz, 1H, H-2), 8.33 (br, 1H, NIl), 8.44 (d, J= 5.9 Hz, 1H, H-
6'),9.90 (br, 1H, NIl), 14.60 (s, 1H, OIl). 
l3e NMR (126 MHz, 1:1 (CD3)2S0/CDCb): () 13.5 (SCH3), 78.5 (t, CDCb) 99.0 (C-5), 99.9 (C-
6), 107.8 (C-3), 110.9 (C-4a), 112.3 (C-5'), 138.6 (C-5a), 142.9 (C-2), 145.4 (C-7), 145.6 (C-
lOa), 150.5 (C-9), 157.4 (C-6'), 158.8 (C-4'), 159.2 (C-4), 169.9 (C-2'). 
IR (KBr): U max 3248, 3120-3010 (series of bands), 1668, 1580, 1568, 1306. 
HRMS (ES): Calcd for ClsH13N6032S (MH+) 325.0872, found 325.0878. 
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9-Amino-4-methoxy-5- [2-( methylsulfanyl)pyrimidin-4-y 1] pyddo [3' ,2' :4,S]pyrrolo [1 ,2-c] 
UJUlI' .... U.'" 4.12 
N~sMe 
~ hN OMe 
f I ~ 
r N N"'::: 
No=( 
NH(PMB) 
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Amine 4.9 (7.0 mg, 0.015 mmol) was dissolved in neat TfOH (0.05 mL) in a small vial under 
atmospheric conditions. The vial was capped and the deep red solution was left at rt for 13 h. 
The reaction was cooled to -10°C and carefully quenched with cold, conc aq NH3 solution (0.05 
mL). The yellow precipitate was dissolved in CH2Clz and worked up in the usual manner. Flash 
chromatography on silica, eluting with 5% MeOHlCH2Clz, gave the deprotected amine as a 
yellow solid (5 mg, 100%). 
Mp: dec at 179°C. 
IH NMR (500 MHz, CDCh): (3 2.65 (s, 3H, SCH3), 4.03 (s, 3H, OCH3), 5.6-6.6 (br, lH, NH), 
6.90 (d, J 5.4 Hz, lH, H-3), 7.39 (d, J= 5.4 Hz, lH, H-5'), 7.54 (d, J= 6.6 Hz, lH, H-7), 7.62 
(d, J 6.6 lH, H-6), 8.28 (d, J = 5.4 Hz, 1H, H-2), 8.45 (d, J = 5.4 Hz, lH, H-6'), 9.2-10.0 
(br, 1H, NH). 
13e NMR (75 MHz, CDCh): (3 14.1 (SCH3), 55.6 (OCH3), 101.1 (C-5), 101.9 (C-3), 102.5 (C-
6), 111.6 (C-4a), 117.3 (C-5'), 137.3 (C-5a), 141.98 (C-7 or C-2), 142.04 (C-2 or C-7), 144.6 (C-
lOa), 149.2 (C-9), 155.5 (C-6'), 159.5 (C-4), 161.4 (C-4'), 171.2 (C-2'). 
(KBr): umax 3268, 3092-2924 (series of bands), 1663,1574,1011. 
(EI): mlz (reI intensity) 338 (100), 129 (24), 105 (49), 70 (23), 57 (25). 
(EI): Calcd for C16H14N6032S ~) 338.0950, found 338.0955. 
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4-Hydroxy-9-( 4-metboxybenzylamino )-S-(2-aminopyrimidin-4-yl)pyrido [3',2' :4,S]pyrrolo 
[1,2-c]pyrimidine 4.13 
~ N 
N==\ 
HNQ ~ ~ 
-
OMe 
OMe 
4 
Bis-protected amine 3.35 (20 mg, 0.037 mmol) was dissolved in neat TFA (0.75 mL) under 
atmospheric conditions, and the stoppered flask was left at rt for 5 days. After removal of excess 
TF A in vacuo, the residue was diluted with CHzCb and neutralised with sat aq NaHC03 solution. 
Repeated extraction with CHzClz gave a yellow solution which was worked up in the usual 
manner. Flash chromatography on silica, eluting with 3,4 and then 5% MeOHlCHzClz, gave the 
deprotected amine 4.13 as a yellow solid (l0.4 mg, 67%), and variolin B (1.4 mg, 13%) 
respectively. 
Mp: dec at ~260 °C. 
IH NMR (500 MHz, (CD3)zSO): 0 3.73 (s, 3H, PMB OCH3) , 4.82 (d, J 5.5 Hz, 2H, 
NHCH2Ar) , 6.81 (d, J = 5.7 Hz, 1H, H-3), 6.92 (d, J = 8.3 Hz, 2H, PMB H-3"), 7.04 (s, 2H, 
NIh), 7.17 (d, 5.2 Hz, 1H, H-5'), 7.27 (d, J 6.7 Hz, IH, H-6), 7.38 (d, J 8.3 Hz, 2H, PMB 
H-2"), 7.70 (d, J= 6.7 Hz, 1H, H-7), 8.15 (d, J= 5.7 Hz, 1H, H-2), 8.29 (d, J Hz, 1H, H-
6'), 10.76 (br t, J = 5.5 Hz, 1H, NHPMB), 16.04 (s, 1H, OR). 
13C (126 MHz, (CD3)2S0): 043.6 (NHCHzAr), 55.2 (PMB OCH3), 100.0 (C-5), 100.7 (C-
6), 106.2 (C-5'), 107.6 (C-3), l11.1 (C-4a), 114.1 (PMB C-3"), 128.9 (PMB C-2"), 130.6 (PMB 
C-1"), 136.9 (C-5a), 143.2 (C-2), 144.0 (C-7), 145.0 (C-10a), 149.2 (C-9), 158.4 (C-4'), 158.6 
(PMB C-4"), 160.0 (C-4), 160.2 (C-6'), 161.5 (C-2'). 
(KBr): \.)max 3380, 3333, 3202, 1614-1566 (series of strong bands), 1481. 
MS (EI): mlz (reI intensity) 413 (72),293 (28), 121 (l00), 91 (27). 
AJLIL .. .LVA'-' (EI): Ca1cd for CZZH19N70Z (M+) 413.1600, found 413.1611. 
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9-[2-(Dimethylamino)ethylamino]-4-methoxy-S-[2-(methylsnlfanyl)pyrimidin-4-yl]pyrido 
[3',2':4,S]pyrrolo[1,2-c]pyrimidine 4.21 
A mixture of core structure 1.63 (27.0 mg, 73.1 /lmol), and N,N-dimethylethylenediamine (18 
IlL, 0.16 mmol) was heated in toluene (0.6 mL) at 100°C. Further portions of N,N-
dimethylethylenediamine (18 IlL) were added after 48 and 80 h. After 6 days, TLC analysis 
indicated the complete consumption of starting material. Concentration of the reaction mixture, 
followed by flash chromatography on silica, eluting with 11-13% MeOHlCH2Cb, gave amine 
4.21 as a yellow-orange solid (25.1 mg, 84%). 
Mp: 138-141 0c. 
IH NlVIR (500 MHz, CDCh): 02.38 (s, 6H, N(CH3h), 2.65 (s, 3H, SCH3), 2.73 (t, J 6.3 Hz, 
2H, NHCH2CH2NMe2), 3.81 (m, 2H, NHCH2CH2NMe2), 4.02 (s, 3H, OCH3), 6.87 (d, J 5.6 
Hz, 1H, H-3), 7.37 (d, J 5.4 Hz, 1H, H-5'), 7.55 (d, J = 6.6 Hz, IH, H-6), 7.59 (d, J 6.6 
IH, H-7), 8.25 (d, J 5.6 1H, H-2), 8.42 (d, J= 5.4 Hz, 1H, H-6'), 10.25 (br t, J 4.6 Hz, 
1H,NH). 
Be NMR (126 MHz, CDCh): 0 14.1 (SCH3), 39.0 (NHCH2CH2NMe2), 45.4 (N(CH3)2), 55.5 
(OCH3), 58.0 (NHCH2CH2NMe2), 100.7 (C-5), 101.4 (C-6), 101.7 (C-3), 111.3 (C-4a), 117.2 
(C-5'), 137.7 (C-5a), 141.7 (C-2), 142.2 (C-7), 144.9 (C-lOa), 148.8 (C-9), 155.4 (C-6'), 159.3 
(C-4), 161.5 (C-4'), 171.1 (C-2'). 
IR (KBr): U max 3200-2800 (series of weak bands), 2968, 2945, 2768, 1566, 1312, 1013. 
MS (El): mlz (reI intensity) 409 (5), 351 (25),338 (l00), 58 (47). 
HRMS (El): Calcd for C2oH23N7032S (M,) 409.1685, found 409.1699. 
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9-[3-(Dimethylamino)propylamino]-4-methoxy-5-[2-(methyIsulfanyl)pyrimidin-4-yl]pyrido 
[3',2' :4,5]pyrrolo[1,2-c]pyrimidine 4.22 
A mixture of core structure 1.63 (33.5 mg, 90.7 ~mol), and 3-(dimethylamino)propylamine (15 
~L, 0.12 mmol) was heated in toluene (0.6 mL) at 100 DC. A further portion of 3-
(dimethylaminopropylamine) (11 ~L) was added after 36 h. After 53 h, the reaction mixture was 
concentrated in vacuo, and the residue was purified by flash chromatography on alumina, eluting 
with CH2Clz then 2% MeOHlCH2Clz, to give amine 4.22 as a yellow-orange solid (34.2 mg, 
89%). 
Mp: 127-129 DC (EtOAc). 
IH NMR (500 MHz, CDCh): 8 1.96 (m, 2H, NHCH2CH2CH2NMe2), 2.28 (s, 6H, N(CH3)2), 2.47 
(t, J = 7.3 Hz, 2H, NHCH2CH2CH2NMe2), 2.65 (s, 3H, SCH3), 3.76 (m, 2H, 
NHCH2CH2CH2NMe2), 4.02 (s, 3H, OCH3), 6.87 (d, J= 5.9 Hz, 1H, H-3), 7.37 (d, J= 5.4 Hz, 
1H, H-5'), 7.54 (d, J= 6.6 Hz, 1H, H-6), 7.60 (d, J= 6.6 Hz, 1H, H-7), 8.24 (d, J= 5.9 Hz, 1H, 
H-2), 8.43 (d, J = 5.4 Hz, 1H, H-6'), 10.20 (br t, J= 5.1 Hz, 1H, NH). 
Be NMR (126 MHz, CDCh): 8 14.1 (SCH3), 27.2 (NHCH2CH2CH2NMe2), 39.3 
(NHCH2CH2CH2NMe2), 45.6 (N(CH3)2), 55.5 (OCH3), 57.2 (NHCH2CH2CH2NMe2), 100.6 (C-
5), 101.1 (C-6), 101.7 (C-3), 111.3 (C-4a), 117.2 (C-5'), 137.8 (C-5a), 141.5 (C-2), 142.4 (C-7), 
144.9 (C-10a), 148.8 (C-9), 155.4 (C-6'), 159.3 (C-4), 161.6 (C-4'), 171.1 (C-2'). 
IR (KBr): Dmax 3240-2760 (series of weak bands), 2941, 2781, 1570, 1308, 1013. 
MS (El): mlz (reI intensity) 423 (94), 365 (58), 352 (100), 338 (71), 297 (49), 58 (62). 
HRMS (El): Calcd for C21H2S]\h032S (M+) 423.1841, found 423.1842. 
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Procedure for methoxy deprotection of amines 4.21 (x = 1) and 4.22 (x = 2): 
+ 
I x = 1 or 21 
Sodium ethanethiolate (80%, 52 mg, 0.49 mmol) was dissolved in dry DMF (0.53 mL). A 
portion of this (0.24 mL, 0.22 mmol) was added to a solution of either 4.21 (13.3 mg, 32.5 flmol) 
in DMF (0.37 mL) or 4.22 (12.8 mg, 30.2 flmol) in DMF (0.34 mL) and the mixture was stirred 
at 60°C for 20 h. After cooling, aq NH4CI solution was added and the mixture was extracted 
with CH2Ch and worked up in the usual manner. 
The crude product of the first reaction (x = 1) was purified by flash chromatography on silica, 
eluting with 12-20% MeOHlCH2Ch then 20% MeOHlCH2Ch + 0.5% NEt3, to give: 
9-[2-(Dimethylamino)ethylamino]-4-hydroxy-5-[2-(methylsulfanyl)pyrimidin-4-yl]pyrido 
[3',2':4,5]pyrrolo[1,2-c]pyrimidine 4.23, contaminated with ~6% of the SEt-substituted 
analogue 4.25 (11.7 mg, 91 %). 
Mp: 175-178 °c, sweats at 171°C (MeOH/CH2Ch). 
IH NMR (500 MHz, CDCh): 8 2.39 (s, 6H, N(CH3)2), 2.62 (s, 3H, SCH3), 2.73 (t, J = 6.3 Hz, 
2H, NHCH2CH2NMe2), 3.78 (m, 2H, NHCH2CH2NMe2), 6.80 (d, J= 5.6 Hz, 1H, H-3), 6.89 (d, 
J = 6.3 Hz, 1H, H-6), 7.27 (d, J = 5.8 Hz, 1H, H-5'), 7.66 (d, J =c 6.3 Hz, 1H, H-7), 8.07 (d, J = 
5.6 Hz, 1H, H-2), 8.36 (d, J= 5.8 Hz, 1H, H-6'), 10.74 (br t, J= 5.0 Hz, 1H, NH), 14.65 (s, 1H, 
OH). 
l3C NMR (126 MHz, CDCh): 8 13.9 (SCH3), 39.2 (NHCH2CH2NMe2), 45.5 (N(CH3)2), 58.0 
(NHCH2CH2NMe2), 99.6 (C-6), 99.8 (C-5), 108.1 (C-3), 111.0 (C-4a), 112.0 (C-5'), 138.4 (C-
5a), 143.0 (C-2), 144.9 (C-7), 145.7 (C-10a), 149.8 (C-9), 156.9 (C-6'), 159.1 (C-4'), 159.7 (C-
4), 170.9 (C-2'). 
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IR (KBr): Dmax 3182,2977-2733 (series of weak bands), 1823, 1610, 1590, 1312, 1013. 
MS (EI): mlz (reI intensity) 395 (11), 338 (43), 337 (54), 324 (47),58 (100). 
HRMS (EI): Ca1cd for C19H21N7032S (M+) 395.1528, found 395.1534. 
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The crude product of the second reaction (x = 2) was purified by flash chromatography on silica, 
eluting with 20% MeOHlCH2Ch then 30% MeOHlCH2Ch + 0.5% NEt3, to give: 
9- [3-(Dimethylamino )propylamino] -4-hydroxy-5- [2-( methylsulfanyl)pyrimidin-4-yl]pyrido 
[3',2' :4,5]pyrrolo[1,2-c]pyrimidine 4.24, contaminated with ~8% of the SEt-substituted 
analogue 4.26 (7.2 mg, 58%). 
Mp: 66-69 DC. 
IH NMR (500 MHz, CDCh): 8 1.96 (m, 2H, NHCH2CH2CH2NMe2), 2.30 (s, 6H, N(CH3)2), 2.49 
(t, J = 7.2 Hz, 2H, NHCH2CH2CH2NMe2), 2.62 (s, 3H, SCH3), 3.73 (m, 2H, 
NHCH2CH2CH2NMe2), 6.79 (d, J= 5.8 Hz, 1H, H-3), 6.88 (d, J= 6.7 Hz, 1H, H-6), 7.28 (d, J= 
5.8 Hz, 1H, H-5'), 7.66 (d, J= 6.7 Hz, 1H, H-7), 8.05 (d, J= 5.8 Hz, 1H, H-2), 8.36 (d, J= 5.8 
Hz, 1H, H-6'), 10.68 (br t, J = 5.2 Hz, 1H, NH), 14.67 (s, 1H, OH). 
13e NMR (75 MHz, CDCh): 8 13.9 (SCH3), 27.0 (NHCH2CH2CH2NMe2), 39.3 
(NHCH2CH2CH2NMe2), 45.4 (N(CH3)2), 57.1 (NHCH2CH2CH2NMe2), 99.5 (C-6), 99.7 (C-5), 
108.1 (C-3), 111.1 (C-4a), 112.0 (C-5'), 138.5 (C-5a), 142.8 (C-2), 145.0 (C-7), 145.7 (C-10a), 
149.8 (C-9), 156.9 (C-6'), 159.1 (C-4'), 159.7 (C-4), 170.8 (C-2'). 
IR (KBr): Dmax2968-2767 (series of weak bands), 1570, 1310. 
HRMS (ES): Calcd for C2oH24N7032S (MH+) 410.1763, found 410.1759. 
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9-[3-(Dimethylamino)propylamino]-4-methoxy-S-[2-(methyIsulfinyl)pyrimidin-4-yl]pyrido 
[3',2' :4,S]pyrrolo[1,2-c]pyrimidine 4.28 
o 
II 
,..JSMe N __ , 
~ h NOMe 
+ 
A crude mixture of 3.32 was prepared from 1.63 (55.2 mg, 0.149 mmol) and m-CPBA (~70%, 
64.5 mg, 0.26 mmol), as previously described (except that the reaction was carried out at -60 to 0 
°C). The product was dissolved in CDCh (1.0 mL), and a portion (0.70 mL, 0.10 mmol) was 
transferred to an NMR tube containing N,N-dimethylaminopropylamine (13 I-LL, 0.10 mmol). A 
IH NMR spectrum obtained 10 min after mixing showed essentially complete mono-substitution. 
After 17 h at rt, the reaction mixture was concentrated in vacuo and partially purified by flash 
chromatography on silica, eluting with 20% MeOHlCHCh then 20-30% MeOH/CHCh + 1 % 
NEt3. Further purification was achieved on reversed phase silica, eluting with 50% MeOHlwater 
+ 0.1 % TF A. After evaporation of the solvents, the protonated product was dissolved in 5% 
MeOHlCH2Ch and neutralised with anhydrous K2C03. Filtration and evaporation of the filtrate 
gave a yellow solid (19.6 mg) which was shown by IH NMR spectroscopy to be a ~8:1 mixture 
of sulfoxide 4.28 and the corresponding sulfone 4.29. Spectroscopic data for the sulfoxide is 
given below: 
IH NMR (500 MHz, CDCh): 8 1.97 (m, 2H, NHCH2CH2CH2NMe2), 2.29 (s, 6H, N(CH3)2), 2.49 
(t, J = 7.1 Hz, 2H, NHCH2CH2CH2NMe2), 3.01 (s, 3H, S(O)CH3), 3.77 (m, 2H, 
J\ffiCH2CH2CH2NMe2), 4.07 (s, 3H, OCH3), 6.92 (d, J= 5.6 Hz, lH, H-3), 7.71 (d, J= 6.6 Hz, 
1H, H-7), 7.80 (d, J= 6.6 Hz, 1H, H-6), 7.83 (d, J= 5.6 Hz, 1H, H-5'), 8.27 (d, J= 5.6 Hz, 1H, 
H-2), 8.69 (d, J= 5.6 Hz, 1H, H-6'), 10.29 (br t, J= 5.1 Hz, lH, NH). 
BC NMR (75 MHz, CDCh): 826.9 (NHCH2CH2CH2J"lMe2), 39.2 (NHCH2CH2CH2NMe2), 40.1 
(S(O)CH3), 45.3 (N(CH3)2), 55.6 (OCH3), 57.0 (NHCH2CH2CH2NMe2), 99.4 (C-5), 101.3 (C-6), 
, 
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101.9 (C-3), 110.7 (C-4a), 121.1 (C-5'), 139.2 (C-5a), 141.6 (C-2), 144.0 (C-7), 144.9 (C-lOa), 
148.6 (C-9), 156.0 (C-6'), 158.9 (C-4), 162.6 (C-4'), 172.0 (C-2'). 
HRMS (ES): Calcd for C21H26N70232S (MH+) 440.1869, found 440.1873. 
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